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ABSTRACT 
 
CHARACTERIZATION OF THE NANCI-NKX2.1 LOCUS:  
A NOVEL ROLE FOR LNCRNAS IN BUFFERING TRANSCRIPTION FACTOR EXPRESSION 
Michael Herriges 
Edward E. Morrisey 
Long noncoding RNAs (lncRNA) are capable of regulating gene transcription and other complex 
biological processes. However, the role of lncRNAs in vivo, especially within the contexts of lung 
development and homeostasis, are still poorly understood. In this work, I establish a new 
paradigm where in a subset of lncRNAs act as rheostats to buffer expression of their neighboring 
transcription factors (TFs) in vivo. Through analysis of the embryonic and adult lung 
transcriptome, I identified lncRNAs expressed in the lung and determined that lncRNAs are 
enriched near TF loci. Furthermore, lncRNAs and their neighboring TFs often share similar 
expression patterns, suggesting a regulatory relationship between the two genes. To test this 
hypothesis I used multiple mouse models, molecular, and proteomic techniques to further 
characterize the regulatory relationship between the lncRNA NANCI and its neighboring TF 
Nkx2.1, a critical regulator of pulmonary development. These experiments revealed that NANCI 
acts in cis to promote Nkx2.1 expression at the transcriptional level, while Nkx2.1 directly 
represses NANCI expression. In Nkx2.1 heterozygotes this negative feedback loop leads to 
increased expression of NANCI, which is sufficient to normalize Nkx2.1 expression and lung 
function. However, concurrent in trans mutations of NANCI and Nkx2.1 disrupt the buffering loop 
between these genes causing persistent Nkx2.1 deficiency. This in turn leads to defective 
pulmonary development as well as progressive degeneration and reprogramming of the adult 
lung epithelium. Altogether this work provides insight into regulation of the TF Nkx2.1 and a 
model for studying the in vivo function of lncRNAs associated with other critical TFs.  
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CHAPTER 1: Introduction  
 
A portion of this chapter was adapted from work published as part of a review in 
Development (Herriges and Morrisey 2014). 
 
1.1 Summary 
Long noncoding RNAs (lncRNAs) are transcripts 200 nucleotides or longer that do not 
encode a functional protein. While lncRNAs have been shown to regulate a wide variety 
of biological processes, their function within the developing and adult lung is still unclear. 
Furthermore, the importance of lncRNAs in vivo is still poorly understood and there are 
few models for their role within the complex processes of development and tissue 
homeostasis. This chapter will provide an overview of pulmonary development including 
the role of key transcription factors. It will also summarize the current understanding of 
lncRNAs and their diverse biological functions.  
 
1.2 Introduction to the lung 
Along with the cardiovascular system, the respiratory system is required for the survival 
of most terrestrial animals. The primary function of the lungs is to exchange oxygen in 
the external environment with carbon dioxide in the cardiovascular system. While this 
process sounds straightforward, it is fraught with multiple barriers to its success. The 
entire airway, like the skin, is constantly exposed to the external environment and must 
cope with challenges including temperature, particulate matter, pathogens, and 
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allergens. Terrestrial life has adapted to these and other challenges through the 
evolution of a complex respiratory system consisting of a multitude of endodermal and 
mesodermal cell lineages. These cellular components are constantly communicating 
with each other to efficiently exchange gas, block blood and fluid loss, and prevent 
dangerous infection from pathogens. Lung development has been studied extensively in 
recent years resulting in new insights into the molecular pathways that regulate lineage 
specification as well as the stereotyped structure of the lung (Cardoso and Lu 2006; 
Morrisey and Hogan 2010; Rock and Hogan 2011; Morrisey et al. 2013). In particular, 
transcription factors such as Nkx2.1, Foxa1/2, and Gata6 are critical for the coordination 
of this process. 
 
1.3 The basics of lung development 
The lungs arise from the anterior foregut endoderm, a tissue that generates multiple 
organs, including the respiratory system, esophagus, thyroid and liver (Fig. 1.1). In the 
mouse, lung specification begins around embryonic day (E) 9.0 as the transcription 
factor Nkx2.1 is expressed in endodermal cells on the ventral side of the anterior foregut. 
By E9.5, evagination of these epithelial cells results in the formation of the trachea and 
two lung buds, marking the beginning of the embryonic stage of lung development (E9.5-
E12.5). During the embryonic and pseudoglandular stages (E12.5-E16.5), the two lung 
buds undergo a highly regulated branching process called branching morphogenesis to 
generate a tree-like network of airways with thousands of terminal branches. This is 
followed by the canalicular (E16.5-E17.5) and saccular [E18.5-postnatal day (P) 0] 
stages, during which these terminal branches narrow and form clusters of epithelial sacs 
that will later develop into alveoli in preparation for respiration at birth. Finally, full 
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maturation of the alveoli occurs during the alveolarization stage (P0-P14). During all 
stages of endodermal development, the surrounding lung mesoderm develops and 
interacts with the lung endoderm to promote branching, differentiation, and the 
generation of various lineages within the lung, including airway and vascular smooth 
muscle and pericytes. 
 
1.4 Specification of the Nkx2.1+ lung endoderm in the anterior foregut 
The first evidence of respiratory system specification in the anterior foregut endoderm is 
expression of the transcription factor Nkx2.1, which occurs at ~E9.0 in the mouse and 28 
days gestation in the human. Studies have shown that Wnt signaling plays a crucial role 
in specifying Nkx2.1+ respiratory endoderm progenitors during development. Wnt2/2b 
are expressed in the ventral anterior mesoderm surrounding the region of the anterior 
foregut endoderm where Nkx2.1+ respiratory endoderm progenitors are located (Goss et 
al. 2009). In Wnt2/2b combined null mutants, there is a complete loss of Nkx2.1+ lung 
endoderm progenitors and a failure to form the trachea or branching lung (Goss et al. 
2009). This phenotype is recapitulated upon loss of β-catenin in the anterior foregut 
endoderm (Goss et al. 2009; Harris-Johnson et al. 2009). Forced activation of Wnt/β-
catenin signaling leads to an expansion of Nkx2.1+ progenitors in the posterior gut 
including the stomach suggesting that Wnt pathway activation is not only necessary, but 
also sufficient, to drive lung progenitor identity in foregut endoderm (Goss et al. 2009; 
Harris-Johnson et al. 2009). 
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Wnt signaling does not act alone in specifying lung fate, and the ability of Wnt/β-catenin 
signaling to promote Nkx2.1+ respiratory endoderm progenitor fate is dependent upon 
active Bone morphogenetic protein (Bmp) signaling. Loss of Bmp signaling in the 
anterior foregut endoderm through inactivation of Bmpr1a/b leads to tracheal agenesis 
with retention of the branching region of the lungs (Domyan et al. 2011). Bmp signaling 
appears to act by repressing the transcription factor Sox2, which allows for expression of 
Nkx2.1 in the presumptive lung endoderm (Domyan et al. 2011). Other major signaling 
pathways including Fibroblast growth factor (Fgf), Retinoic Acid (RA), and Hedgehog 
(Hh) signaling regulate respiratory specification upstream of Bmp/Wnt signaling; 
however, it is still unclear whether any of these factors directly regulate Nkx2.1 
expression (Rankin and Zorn 2014). Thus, early specification of Nkx2.1+ lung endoderm 
and pulmonary development is the product of a complex regulatory network, much of 
which we still do not understand. It is also unclear how much this regulation changes as 
Nkx2.1 expression persists during later stages of development or in the adult lung.  
 
1.5 Branching morphogenesis and cell fate specification 
After the early budding of the main bronchi, or airways, the lung buds extend into the 
surrounding mesenchyme and develop rapidly through a process called branching 
morphogenesis that is crucial for generating the highly arborized airway tree. Branching 
morphogenesis is essential for forming both the structural airways as well as the terminal 
alveolar compartments in which gas exchange occurs. Lung branching proceeds in a 
stereotypical fashion and most of the branching that takes place in early development is 
genetically hard-wired (Metzger et al. 2008). Although the molecular cues for forming 
new branch points are still somewhat unclear, signaling between the developing 
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endoderm and mesoderm appears to be crucial for instigating new branch points in the 
developing airways (Morrisey and Hogan 2010).  
 
During branching morphogenesis, the lung endoderm begins to develop distinct cell 
lineages along its proximal-distal axis. Sox2 expression marks the proximal endoderm 
progenitor lineage whereas the combined expression of Sox9 and the transcriptional 
regulator Id2 marks the distal endoderm progenitor lineage (Fig. 1.1). Importantly, these 
two populations have distinct fates. The proximal progenitors give rise to secretory cells, 
ciliated cells, neuroendocrine cells, basal cells, and mucosal cells that all contribute to 
the airways (Fig. 1.2). The distal progenitors give rise to type 1 and type 2 alveolar 
epithelial cells (AEC1s and AEC2s). 
 
The proximal airway epithelium is responsible for filtering air prior to gas exchange and 
is largely composed of secretory cells and ciliated cells. Secretory cells contribute to the 
sterilization of air through secretion of mucins, proteases, cytokines, anti-microbial 
peptides, and other molecules that entrap or degrade toxic substances (Reynolds and 
Malkinson 2010). Although normally quiescent, these cells can also proliferate and 
differentiate into the various airway cell lineages following injury, in order to maintain 
airway function (Rawlins et al. 2009; Tata et al. 2013). Ciliated cells are multi-ciliated 
cells that, through coordinated beating of cilia, contribute to the mucociliary clearance of 
the epithelium’s protective mucous barrier and any entrapped substances. Unlike 
secretory cells, ciliated cells do not appear to proliferate or differentiate in response to 
injury (Rawlins et al. 2007). In addition to these two major cell types, the airway 
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epithelium contains a smaller number of neuroendocrine cells, which function as airway 
sensors capable of inducing immune responses through neuropeptide production 
(Branchfield et al. 2016). In humans, the bronchiolar epithelium also contains goblet 
cells, which produce mucins and other molecules found in the mucous barrier lining the 
epithelium, as well as basal cells, a stem cell population capable of replacing injured 
secretory and ciliated cells (Rock et al. 2010). These two cell types are similarly found in 
the mouse trachea, but are rarely found in the airways of healthy mice. However, in both 
mice and humans, basal and goblet cell hyperplasia occur in response to epithelial injury 
or inflammation (Whitsett 2002; Kotton and Morrisey 2014).  
 
The distal alveolar epithelium is the site of gas exchange in the lung and is composed of 
AEC1s and AEC2s. AEC1s are narrow cells that cover the majority of the alveolar 
surface and perform gas exchange in the lung. AEC2s produce surfactant lipids and 
surfactant proteins that not only maintain alveolar surface tension, but also promote the 
destruction of pathogens by alveolar macrophages (Whitsett and Alenghat 2015). Thus, 
AEC2s are critical for maintaining the structure and sterility of the alveoli. Like the 
proximal airways, the adult alveolar epithelium is normally quiescent; however, type II 
cells will proliferate and give rise to type I cells in response to alveolar injury 
(Barkauskas et al. 2013).  
 
1.6 Transcription factors dictate lung epithelial development and cell fate 
specification 
A host of transcription factors have been implicated in the regulation of lung endoderm 
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specification and differentiation, including members of the homeobox factor family 
(Nkx2.1), the Gata transcription factor family (Gata6), and the forkhead box transcription 
factor family (Foxa1/2) (Wan et al. 2004a; Wan et al. 2004b; Wan et al. 2005; Zhang et 
al. 2008). Some of these, including the forkhead box (Fox) and Gata factors, are known 
to act as pioneer transcription factors which can insert themselves into compacted 
chromatin to initiate lineage-specific gene expression programs (Cirillo et al. 2002). 
While loss of any of these genes does not completely abrogate initial lung budding, they 
are required for subsequent epithelial differentiation and branching morphogenesis 
critical for forming functional lungs.  
 
Nkx2.1 is a hallmark transcription factor expressed in the lung and thyroid epithelium as 
well as in the ventral forebrain (Lazzaro et al. 1991). In the developing and adult lung, 
Nkx2.1 is expressed throughout the lung epithelium, with higher levels of expression 
found in the distal epithelium. During branching morphogenesis, Nkx2.1 promotes 
proliferation as well as the expression of genes including Bmp4, which directly regulates 
branch patterning (Weaver et al. 2000). Nkx2.1 also directly promotes the expression of 
genes critical to specific epithelial lineage functions including Scgb1a1 (secretory cells) 
and Sftpa, Sftpb, and Sftpc (AEC2s) (Boggaram 2009). Nkx2.1 null mice (Nkx2.1-/-) 
develop lung buds, but these lungs do not undergo significant growth or branching 
(Minoo et al. 1995; Minoo et al. 1997). Consequently, mice die soon after birth, as they 
do not develop the mature cell types necessary for respiration.  
 
8	  
	  
Recent evidence demonstrates that Nkx2.1 is also critical in the adult lung. Postnatal 
loss of Nkx2.1 leads to respiratory failure associated with rampant apoptosis of the lung 
epithelium as well as ectopic pulmonary expression of a hindgut transcriptional program 
(Snyder et al. 2013). In lung adenocarcinomas, loss of Nkx2.1 promotes progression to a 
metastatic state, in part due to the loss of Nkx2.1’s pro-differentiation signal (Winslow et 
al. 2011). On the other hand, increased expression of Nkx2.1 is associated with non-
metastatic lung adenocarcinomas. This is likely due to Nkx2.1’s ability to promote pro-
survival pathways, leading to cell growth, as well as tight junction proteins, which inhibit 
metastasis (Yamaguchi et al. 2013). Together these data suggest that Nkx2.1 lies at the 
center of a transcriptional network that is critical for both the developing and adult lung. 
Despite the importance of Nkx2.1 during these stages, little is known about what directly 
regulates Nkx2.1 expression during these time points. 
 
In humans, NKX2.1 haploinsufficiency is associated with the rare disorder called Brain-
Lung-Thyroid-Syndrome (BLTS) that can culminate in respiratory failure if untreated 
(Hamvas et al. 2013). Symptoms in BLTS patients include hypothyroidism along with 
serious neurological and pulmonary dysfunctions. Pulmonary symptoms are highly 
variable, but often include neonatal respiratory distress syndrome, which is characteristic 
of under-developed lungs. Recurrent respiratory infections and reduced levels of 
surfactant proteins are also common symptoms. Altogether these symptoms are 
consistent with the known role of NKX2.1 in promoting epithelial maturation and the 
production of surfactant proteins (Minoo et al. 1995; Boggaram 2009). Treatment for 
BLTS can include supplemental oxygen, steroids, and lung transplantation (Hamvas et 
al. 2013). However, since little is known about how to regulate NKX2.1 expression, 
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current treatments address only the symptoms of BLTS and not the underlying NKX2.1 
haploinsufficiency.  
 
Like many transcription factors, Nkx2.1 interacts with additional transcriptional regulators 
to affect gene expression. One of these is Gata6, which is a member of the Gata 
transcription factor family of zinc finger proteins and is highly expressed in the 
developing endoderm and vascular smooth muscle of the lung (Morrisey et al. 1996). 
During development, lung epithelial specific loss of Gata6 leads to defective epithelial 
differentiation and increased proliferation suggesting a developmental block at a more 
primitive progenitor state, while postnatal loss of Gata6 in lung epithelium leads to 
defective airway epithelial regeneration after injury (Zhang et al. 2008). Importantly, mice 
that are heterozygous for both Gata6 and Nkx2.1 have defects in lung epithelial cell 
differentiation (Zhang et al. 2007), further supporting a cooperative interaction between 
Nkx2.1 and Gata6 in regulating lung epithelial cell differentiation.  
 
Another family of transcription factors called Forkhead box or Fox proteins is a highly 
conserved and ancient transcription factor family that contains dozens of family 
members that play important roles in several aspects of lung development. In particular, 
Foxa1 and Foxa2 are key regulators of endoderm identity and development. While 
Foxa1 is not essential for lung development, Foxa2 is critical for late epithelial 
differentiation in the lung (Wan et al. 2004a; Wan et al. 2004b; Wan et al. 2005). 
Combined loss of both Foxa1 and Foxa2 leads to severe defects in lung epithelial cell 
differentiation including loss of AEC2 markers Sftpc and Sftpb as well as airway 
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epithelial markers for the secretory (Scgb1a1) and ciliated (Foxj1) epithelial lineages 
(Wan et al. 2005). Foxa1/2 also physically interact with Nkx2.1, which is required for 
Foxa1/2 to bind and activate pulmonary genes (Costa et al. 2001; Minoo et al. 2007; 
Snyder et al. 2013). Postnatal loss of Nkx2.1 results in reallocation of Foxa1/2 to hindgut 
genes, contributing to the ectopic expression of a hindgut transcriptional program in mice 
with postnatal loss of Nkx2.1 (Snyder et al. 2013).  
 
1.7 Long non-coding RNAs 
In addition to protein-based signaling pathways, recent studies have identified small 
noncoding RNAs, such as microRNAs (miRNAs), as key regulators of lung development 
(Bhaskaran et al. 2009; Dong et al. 2010; Tian et al. 2011). However, it is still unclear 
what role long noncoding RNAs (lncRNAs) have in lung development and homeostasis. 
lncRNAs are a recently identified class of noncoding RNAs that are 200 nucleotides or 
longer and regulate a wide variety of processes (Batista and Chang 2013; Ulitsky and 
Bartel 2013). Like mRNA, lncRNAs are often spliced transcripts with 5’ caps and 
polyadenylated 3’ ends. However, some lncRNAs are not polyadenylated and on 
average lncRNAs are less stable than mRNA (Clark et al. 2012). Furthermore, lncRNAs 
are spliced less efficiently than mRNAs, suggesting mRNAs and lncRNAs are processed 
differently (Tilgner et al. 2012). Although there is evidence of purifying selection of 
lncRNAs over the course of evolution, lncRNAs tend to have poorly conserved primary 
sequences (Ponjavic et al. 2007; Hezroni et al. 2015; Iyer et al. 2015). Some lncRNAs 
still perform a conserved function, likely due to small regions of conserved sequence or 
regions of conserved secondary structure (Ulitsky et al. 2011). 
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The majority of well-characterized lncRNAs function as scaffolds that interact with DNA 
and proteins to recruit macromolecular complexes that regulate gene transcription 
(Engreitz et al. 2016b) (Fig. 1.3A). These complexes often include either transcription 
factors, like Sox2, or chromatin modifying complexes, such as the polycomb repressive 
complex 2 (PRC2) and the trithorax complex (Zhao et al. 2008; Wang et al. 2011; Ng et 
al. 2013; Yang et al. 2014). Discrete domains within the lncRNAs mediate the 
interactions with these proteins; however, it is still unclear what features are necessary 
for these domains to interact with their targets (Tsai et al. 2010; Smola et al. 2016). The 
ability of lncRNAs to bind specific genomic loci is either directed by RNA-DNA 
interactions or mediated by DNA-binding proteins (Engreitz et al. 2016b). In some cases, 
physical proximity to the site of transcription also contributes to interaction specificity. 
Targeting by proximity is exemplified by the lncRNA Xist, which helps recruit PRC2 to 
silence the cis X chromosome (Engreitz et al. 2013). This lncRNA is normally expressed 
from the inactive X chromosome of female mammals and restricted to this chromosome. 
If Xist is transgenically inserted into an autosomal chromosome, this chromosome will be 
specifically silenced, indicating proximity contributes to Xist targeting (Lee and Jaenisch 
1997; Wutz and Jaenisch 2000). Other lncRNAs act in cis to regulate the expression of 
neighboring protein-coding genes and are likely also dependent on proximity to regulate 
gene expression (Pandey et al. 2008; Wang et al. 2011; Maamar et al. 2013). These 
lncRNAs often share a divergent promoter region with their target protein, but other cis-
acting lncRNAs have their own unique promoter (Wang et al. 2011; Grote et al. 2013; 
Kotzin et al. 2016; Luo et al. 2016). It is still unclear if these distinct genomic layouts are 
indicative of different functions.  
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In addition to regulating transcription, lncRNAs regulate a wide variety of post-
transcriptional processes; however, there are fewer examples of these mechanisms 
(Geisler and Coller 2013) (Fig. 1.3A). As during transcriptional regulation, these lncRNAs 
often act as scaffolds to colocalize multiple components in the nucleus or cytoplasm. 
Due to their single-strand structure, several lncRNAs are capable of binding 
complementary mRNAs. With the assistance of interacting proteins, these lncRNAs 
influence mRNA editing, translation, and turnover (Peters et al. 2003; Faghihi and 
Wahlestedt 2009; Gong and Maquat 2011; Carrieri et al. 2012). In other cases, lncRNAs 
can block miRNAs or mRNA splicing machinery from binding to specific mRNAs (Krystal 
et al. 1990; Faghihi et al. 2010). RNA complementarity also allows for some lncRNAs to 
act as miRNA sinks, binding multiple miRNAs in order to prevent them from targeting 
other transcripts (Wang et al. 2010; Cesana et al. 2011). Finally, some lncRNAs, such as 
Neat1, form nuclear compartments called paraspeckles, which help sequester nuclear 
proteins and thus regulate their activity (Mao et al. 2011).  
 
In the case of some lncRNAs, the act of transcription also has a function independent of 
the transcript produced. This is exemplified by the lncRNA Airn, which is transcribed 
anti-sense and overlapping the gene Igf2r and is required for allele-specific silencing of 
the cis-linked genes Slc22a3, Slc22a2, and Igf2r in the mouse placenta (Nagano et al. 
2008) (Fig. 1.3B). Airn directly interacts with the Slc22a3 promoter as well as the H3K9 
histone methyltransferase G9a to promote silencing of Slc22a3. In contrast, silencing of 
Igf2r is dependent on Airn expression but not G9a expression. Transcription of Airn, not 
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the Airn transcript itself, prevents recruitment of RNA polymerase II to the overlapping 
Igf2r promoter (Latos et al. 2012). Although Airn is the best-studied example of 
regulation through transcription, other lncRNAs, such as Bendr and Blustr, are also 
thought to regulate the expression of neighboring genes in a transcription-dependent 
fashion (Engreitz et al. 2016a). However, it is difficult to separate the influences of 
transcription and the specific sequences of the genomic locus, so further studies are 
needed to clarify these mechanisms.  
 
1.8 The in vivo function of lncRNAs 
Genomic transcription studies have identified thousands of lncRNAs expressed 
throughout the body. Surprisingly, lncRNAs on average have a more tissue-specific 
expression pattern relative to protein coding genes, suggesting that they may be more 
likely to serve tissue-specific functions (Cabili et al. 2011). While extensive research has 
been performed using in vitro systems to identify the mechanisms and regulatory 
functions of lncRNAs, the significance of many of these lncRNAs in vivo has yet to be 
examined (Feyder and Goff 2016). In some cases, lncRNAs with profound functions in 
vitro have been shown to have little or unexpected functions in vivo, further emphasizing 
the need for detailed in vivo functional analysis (Eissmann et al. 2012; Zhang et al. 2012; 
Amandio et al. 2016). To investigate lncRNAs in vivo, researchers have used both RNA-
targeted (RNAi, steric interference) and DNA-targeted (CRISPR) strategies (Feyder and 
Goff 2016). As many lncRNAs overlap putative promoters or enhancers of neighboring 
genes, multiple models are often necessary to clearly demonstrate the importance of the 
lncRNA itself as opposed to the overlapping genomic locus. Those lncRNAs that do 
have clear in vivo functions regulate a wide variety of biological processes including X 
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inactivation (Penny et al. 1996), myeloid cell homeostasis (Kotzin et al. 2016), 
adipogenesis (Wei et al. 2016), retinal patterning (Young et al. 2005; Rapicavoli et al. 
2010; Rapicavoli et al. 2011; Meola et al. 2012), and limb development (Wang et al. 
2011). Unfortunately, there are no known motifs or structures common among these 
lncRNAs, making it difficult to predict which other lncRNAs are critical in vivo. 
 
Hundreds of lncRNAs are expressed in the lung, including lncRNAs that regulate 
developmental processes such as differentiation and proliferation in other tissues 
(Askarian-Amiri et al. 2011; Cabili et al. 2011; Kretz et al. 2012). However, the role of 
these lncRNAs in lung development and homeostasis is still unclear. The lncRNA Malat1 
is highly expressed in the developing lung as well as other tissues and has been shown 
to have both pro-proliferative and pro-metastatic functions (Gutschner et al. 2013). 
However, Malat1-/- mice develop normally with no signs of respiratory distress (Eissmann 
et al. 2012; Zhang et al. 2012). In contrast, the pulmonary lncRNA Fendrr, which is 
upstream and antisense to the transcription factor Foxf1, is necessary for life in mice 
(Sauvageau et al. 2013). Deletion of Fendrr in mice results in perinatal lethality due to 
incomplete development of the lung mesenchyme, which normally expresses both 
Fendrr and Foxf1. Although these same phenotypes occur in Foxf1 heterozygotes it is 
still unclear whether Fendrr regulates Foxf1 expression (Mahlapuu et al. 2001; 
Sauvageau et al. 2013). In humans, deletion of a genomic locus upstream of Foxf1, 
which contains lncRNAs, is associated with lung developmental disorders normally 
associated with Foxf1 mutations (Szafranski et al. 2013). Likewise, deletion of a region 
downstream of Nkx2.1 containing a lncRNA is associated with phenotypes normally 
seen in patients with Nkx2.1 haploinsufficiency (Barnett et al. 2012). This suggests that 
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these lncRNAs may regulate their neighboring transcription factors during lung 
development and that they may be part of a larger group of lncRNAs influencing lung 
development as a whole.  
 
1.9 Conclusion 
As I have reviewed in this chapter, pulmonary development and cell fate specification 
are complex processes regulated by transcription factors including Nkx2.1, Gata6, and 
Foxa1/2. However, the role of lncRNAs within the developing and adult lung is largely 
unknown. In this dissertation I identify lncRNAs expressed in the embryonic and adult 
mouse lung, including a subset that are associated with transcription factors necessary 
for pulmonary development. I then provide a more detailed analysis of the novel lncRNA 
NANCI (Nkx2.1 Associated NonCoding Intergenic RNA), which is found downstream of 
Nkx2.1. In particular, I will characterize a negative feedback loop between NANCI and 
Nkx2.1 that is critical for maintaining Nkx2.1 expression and lung epithelial cell identity. 
This work not only establishes a new regulator of Nkx2.1, but also provides a paradigm 
for the in vivo function of other transcription factor-associated lncRNAs. 
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Figure 1.1. Overview of the stages of lung development.  
 
 
Figure 1.1. Overview of the stages of lung development. Lung endoderm 
specification begins at ~E9.0 on the ventral side of the anterior foregut endoderm 
(yellow) where initiation of Nkx2.1 expression commences. By E9.5-E10.0, the formation 
of the trachea is observed and the embryonic stage of lung development begins and 
ends at E12.5. The other stages of lung development and the time period in which they 
occur are displayed. A, anterior; D, dorsal; L, left; P, posterior; R, right; V, ventral. 
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Figure 1.2. Progenitors and cell lineages within the developing lung.  
 
 
 
Figure 1.2. Progenitors and cell lineages within the developing lung. The Nkx2.1-
positive endoderm gives rise to both Sox2+ proximal progenitors and Sox9+/Id2+ distal 
progenitors, which in turn give rise to distinct sets of differentiated cells. The proximal 
progenitors give rise to neuroendocrine (NE) cells, basal cells, secretory cells, ciliated 
cells and mucosal cells that all populate the conducting airways. By contrast, the distal 
progenitors give rise to type I and type 2 alveolar epithelial cells (AEC1 and AEC2) that 
populate the alveoli. Markers expressed in each cell type are indicated in parentheses. 
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Fig. 1.3. Models of lncRNA mechanisms 
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Fig. 1.3. Models of lncRNA mechanisms (A) Models of the regulatory mechanisms 
used by different lncRNAs. (B) In addition to the lncRNA product, the act of transcription 
can regulate the expression of overlapping genes, as exemplified by Airn. Transcription 
of Airn, blocks transcription of the overlapping Igf2r gene and the Airn product goes on to 
promote in cis silencing of Slc22a3. 
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Chapter 2: Long non-coding RNAs are spatially correlated with 
transcription factors and regulate lung development 
 
The data presented in this chapter was previously published in Genes and Development 
(Herriges et al. 2014). Dan Swarr performed experiments analyzing lncRNAs LL12, 
LL34, and LL35 as well as Ezh2 and Wdr5 pulldowns. Michael P. Morley and Komal S. 
Rathi performed bioinformatic analysis. MinMin Lu and Su Zhou performed tissue 
sectioning and histological staining. Kate Stewart collected RNA used for RNA-seq.  
 
2.1 Summary 
Long non-coding RNAs (lncRNAs) are thought to play important roles in regulating gene 
transcription, but few have well defined expression patterns or known biological 
functions during mammalian development. Using a conservative pipeline to identify 
lncRNAs that have important biological functions, I have identified 363 lncRNAs in the 
lung and foregut endoderm. Importantly, I show that these lncRNAs are spatially 
correlated with transcription factors across the genome. In-depth expression analyses of 
lncRNAs with genomic loci adjacent to the critical transcription factors Nkx2.1, Gata6, 
Foxa2, and Foxf1 mimic the expression patterns of their protein-coding neighbor. Loss of 
function analysis demonstrates that two lncRNAs, LL18/NANCI and LL34, play distinct 
roles in endoderm development by controlling expression of critical developmental 
transcription factors and pathways, including retinoic acid signaling. In particular, I show 
that LL18/NANCI acts upstream of Nkx2.1 and downstream of Wnt signaling to regulate 
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lung endoderm gene expression. These studies reveal that lncRNAs play an important 
role in foregut and lung endoderm development by regulating multiple aspects of gene 
transcription, often through regulation of transcription factor expression.  
 
2.2 Introduction 
The advent of large scale sequencing efforts has resulted in the identification of 
thousands of small (<200 nucleotides) and large (>200 nucleotides) non-coding RNAs 
that potentially play critical roles in regulating gene expression. Small non-coding RNAs 
such as microRNAs, piwi RNAS, and snoRNAs have been shown to be important 
players in regulating gene expression in many contexts including tissue development 
(Dieci et al. 2009; Wapinski and Chang 2011; Luteijn and Ketting 2013; Yates et al. 
2013). In comparison, long non-coding RNAs (lncRNAs) are less conserved and their 
function is less well understood. LncRNAs can be transcribed from a unique 
transcriptional locus or they can be transcribed from a locus overlapping a protein-
coding gene (PCG), in either the sense or antisense direction. Moreover, while many 
reported lncRNAs are polyadenylated similar to mRNA, other lncRNAs are not and on 
average lncRNAs are less stable than mRNA (Clark et al. 2012). LncRNAs are also 
spliced less efficiently than mRNA, further suggesting mRNAs and lncRNAs are 
processed differently (Tilgner et al. 2012). LncRNAs often act as scaffolds that help 
localize chromatin-modifying complexes important for activating or repressing gene 
transcription in cis or in trans (Zhao et al. 2008; Khalil et al. 2009; Wang et al. 2011; 
Ulitsky and Bartel 2013). 
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The development of the respiratory system is a highly complex process involving the 
interaction of foregut-derived Nkx2.1+ endoderm with surrounding cardiopulmonary 
mesoderm (Goss et al. 2009; Peng et al. 2013). Nkx2.1 not only marks the early lung 
endoderm progenitors within the foregut endoderm, it also plays an essential role in the 
morphological development of the airway structure and differentiation of the various 
epithelial lineages within the lung (Minoo et al. 1995; Minoo et al. 1997). Other critical 
transcription factors such as Gata6 and Foxa1/2 also play key roles in promoting foregut 
and respiratory endoderm morphogenesis and differentiation (Yang et al. 2002; Wan et 
al. 2004a; Wan et al. 2004b; Wan et al. 2005; Zhang et al. 2008). However, how these 
factors themselves are regulated during foregut and lung development, either at the level 
of expression or function, remains poorly understood. While small RNAs such as 
miRNAs have been shown to play an important role in development of the respiratory 
system (Lu et al. 2007; Ventura et al. 2008; Tian et al. 2011), little is known about the 
role of lncRNAs in this process. Several lncRNAs are expressed in the lung including 
MALAT1, which has been shown to play an important role in lung cancer progression 
(Schmidt et al. 2011; Xu et al. 2011; Lai et al. 2012). Although loss of MALAT1 does not 
effect lung development (Zhang et al. 2012), chromosomal deletions encompassing 
other lncRNAs can cause lethal lung development disorders, suggesting these lncRNAs 
may regulate lung development (Stankiewicz et al. 2009; Barnett et al. 2012; Parris et al. 
2013; Szafranski et al. 2013).  Loss of the lncRNA Fendrr has also been shown to result 
in respiratory defects and perinatal lethality (Sauvageau et al. 2013). However, there is 
little data on the specific expression patterns or function of lncRNAs in most tissues 
including foregut endoderm and the lung.  
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In this study, I used RNAseq combined with other methods to identify lncRNAs in the 
developing and adult lung. Our conservative pipeline provides a systematic and 
comprehensive bridge from transcriptome-wide analysis of lung lncRNAs to the 
interrogation of individual lncRNA biological function. I show that a subset of lncRNAs in 
the lung are located near transcription factors, including Nkx2.1, Gata6, Foxa2, and 
Foxf1, that play important roles in foregut and lung development.  In addition to this 
subset, I identified several known and novel intergenic lncRNAs that are not associated 
with PCGs and many of these have unique expression patterns suggesting an important 
functional role in lung development and homeostasis. I assessed biological function for 
two lung lncRNAs and show that they exhibit distinct and important roles in regulating 
endoderm gene expression including developmental, signaling, and metabolic pathways. 
Importantly, I show that one of these lncRNAs, LL18, plays an important role in lung 
development by acting upstream of the critical transcription factor Nkx2.1 and 
downstream of Wnt/b-catenin signaling to regulate lung endoderm gene expression and 
morphogenesis. 
 
2.3 Identification of lncRNAs in the developing and postnatal lung 
To identify and begin to characterize the lncRNA transcriptome in the lung, I performed 
RNAseq on E12.5 and adult mouse lung polyadenylated RNA. Pair-end reads were 
aligned to the mouse reference NCBI 37 release using GSNAP (Wu and Nacu 2010). 
Cufflinks was used to assemble 141,614 unique transcripts from E12.5 and adult lung 
RNAseq. The assembled transcripts were compared and annotated using Cuffmerge 
against the Ensembl (ver 67) gene annotations. Transcripts that mapped to known 
lncRNAs were retained and transcripts mapping to all other known genes were removed. 
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Transcripts defined by Cuffmerge as unknown, that were also mulit-exonic and longer 
than 200 nucleotides were considered putative lncRNAs. These putative lncRNAs were 
then filtered for potential coding ability using phylogenetic codon substitution frequency 
(PhyloCSF) and by scanning all potential open reading frames per transcript against the 
protein domains in Pfam. Moreover, I only included lncRNAs that did not overlap 
extensively with exons of coding genes and were not located entirely within the intron of 
a coding gene. These analyses resulted in the identification of 363 lncRNAs, 200 of 
which were previously annotated and 163 of which are novel (Fig. 2.1A). Using DNAse 
hypersensitivity sites 5’ of each lncRNA locus as a guide (Rosenbloom et al. 2013), I 
found that DNA binding motifs for forkhead box (Fox), SP1/Krox, and serum response 
factors (SRF) factors were enriched in lung lncRNA regulatory regions (Fig. 2.1B). The 
high enrichment of Fox binding motifs upstream of lung lncRNA loci suggests regulation 
by forkhead transcription factors, which are known to regulate foregut development as 
well as lung endoderm and mesoderm development (Wan et al. 2004b; Shu et al. 2007; 
Zhou et al. 2008; Chokas et al. 2010; Yu et al. 2010; Li et al. 2012; Parris et al. 2013).  
 
While nucleotide conservation of lung lncRNAs across placental mammals was low 
(29%) as has been reported previously for lncRNAs in general (Fig. 2.2) (Derrien et al. 
2012), many of these lncRNAs have syntenic transcripts in the human genome 
indicating that they are conserved based on genomic location rather than nucleotide 
sequence (Fig. 2.1C). Our data also show that previously annotated lncRNAs that I 
uncovered in our analysis are more likely to have syntenic human transcripts (Fig. 2.1C). 
Lung lncRNAs located near PCGs are more syntenic than lncRNAs located in gene 
deserts (Fig. 2.1D). Furthermore, lung lncRNAs located near transcription factor loci 
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more often have syntenic human transcripts than lncRNAs found near non-transcription 
factor PCGs (Fig. 2.1E). This syntenic conservation of lncRNAs near transcription factor 
loci suggests a potential spatial relationship between these two gene subsets. 
 
To further assess the potential spatial correlation between lncRNAs and transcription 
factor loci, I measured the genomic distance between lncRNAs and transcription factor 
loci. Using our mouse lung lncRNA dataset, I found that the lung lncRNAs in our 
database were more likely to be genomically located near transcription factors than other 
nontranscription factor PCGs (Fig. 2.3A). This enrichment was observed with all 
lncRNAs annotated in both the mouse and human genomes and increases as the 
distance from the lncRNA decreases (Fig. 2.3A). Together these observations support a 
conserved spatial correlation between lncRNA loci and transcription factor loci.  
 
To validate this spatial correlation between lncRNAs and transcription factors, I utilized a 
recently published methodology that allows a direct comparison between different 
classes of PCGs and their spatial relationship with genomic loci (Fig. 2.3B) (Favorov et 
al. 2012). This method also indicates a statistically positive spatial correlation between 
lncRNA and transcription factors in our lung dataset as well as those annotated in the 
Ensembl database (Fig. 2.3B-E). Importantly, lncRNAs were spatially correlated with 
transcription factors more so than other classes of PCGs such as signaling proteins and 
structural proteins. While other classes of PCGs may also be positionally correlated with 
lncRNAs, our data suggests that transcription factors are particularly enriched near 
lncRNAs. 
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2.4 Characterization of the genomic organization of a subset of lung lncRNAs  
From the initial RNAseq based screen of the lung transcriptome, I chose seven lung 
lncRNAs (LL) for in-depth characterization. Due to the ability of some lncRNAs to 
regulate the expression of neighboring PCGs (Orom et al. 2010b; Wang et al. 2011; 
Berghoff et al. 2013), four lung lncRNAs (LL18, LL33, LL35, and LL66) were selected 
based on the close genomic proximity to transcription factors known to play a critical role 
in lung development. LL18, which I have named NANCI, for Nkx2.1 Associated Non-
Coding Intergenic RNA, is 2.5 kb downstream of Nkx2.1, a transcription factor that is a 
global regulator of anterior foregut and lung development and the earliest known marker 
of lung endoderm progenitor fate (Fig. 2.4A) (Kimura et al. 1996). LL35 is 2.5kb 
downstream of Foxa2, a forkhead transcription factor that is essential for endoderm and 
lung development (Fig. 2.4B) (Wan et al. 2004a; Wan et al. 2005). Both NANCI and 
LL35 are transcribed in the sense orientation relative to their protein-coding neighbors. 
PCR using multiple primers pairs, 5’ RACE, and the presence of unique Pol2 and 
H3K4me3 marks indicates that NANCI and LL35 transcripts are driven from unique loci 
that are not linked to their PCGs (Fig. 2.4A,B and data not shown). In contrast, LL33 and 
LL66 are transcribed in an antisense orientation to their protein-coding neighbors. LL33 
has multiple start sites that are upstream of or overlapping with the first exon of Gata6, 
an important endoderm transcription factor that is essential for lung epithelial 
differentiation and regeneration (Fig. 2.5) (Yang et al. 2002; Zhang et al. 2008).  LL66 is 
located 1.4 kb upstream of Foxf1, a forkhead transcription factor that plays an important 
role in the development of the pulmonary mesenchyme and vasculature and has been 
implicated in the pathogenesis of the lethal disorder alveolar capillary dysplasia (Fig. 
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2.4C) (Stankiewicz et al. 2009). LL66, also known as Fendrr, was recently shown to be 
important in lateral plate mesoderm development, similar to its neighboring PCG Foxf1 
(Grote et al. 2013; Sauvageau et al. 2013). Q-PCR analysis confirms the differences in 
E12.5 and adult mouse lung expression observed in the RNAseq analysis for NANCI 
and LL35 (Fig. 2.6A-D). However, RNAseq revealed increased expression of LL66 in the 
adult lung relative to the E12.5 lung whereas Q-PCR showed little change (Fig. 2.6E,F). 
 
Three other lncRNAs (LL1, LL12, LL34), which are all located in relative gene deserts, 
were selected due to their high level of expression in the E12.5 lung relative to the adult 
lung. LL1 and LL12 are previously identified lncRNAs and are known snoRNA host 
genes (Fig. 2.4D, E) (Nakamura et al. 2008; Kretz et al. 2012) Tanaka et al., 2000). LL1 
is the mouse orthologue of the human lncRNA anti-differentiation non-coding RNA 
(ANCR), which is up-regulated in multiple types of cancer and inhibits osteoblast and 
keratinocyte differentiation (Kretz et al. 2012; Du et al. 2013; Zhu and Xu 2013). LL12 is 
annotated as SnoRNA host-gene 5 (Snhg5) in both the mouse and human genome and 
has been implicated in translocation induced B-cell lymphoma and recurrent prostate 
cancer (Du et al., 2013; Tanaka et al., 2000). In contrast, LL34 is a novel lncRNA, which 
is expressed in the E12.5 lung but is nearly undetectable in the adult lung (Fig. 2.4F). Q-
PCR analysis confirms that expression of all three of these lncRNAs is dramatically 
down-regulated in the adult lung compared to the E12.5 lung (Fig. 2.6G,H). I also 
confirmed that these lncRNAs do not encode for a detectable protein using in vitro 
transcription/translation assays (Fig. 2.7). 
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2.5 LncRNAs associated with transcription factors exhibit spatial and temporal 
patterns of expression highly similar to their protein-coding neighbors 
While the genome wide expression of some lncRNAs has been reported, little data is 
available on the spatial and temporal pattern of lncRNA expression during tissue 
development. Therefore, I performed extensive in situ hybridization (ISH) and Q-PCR 
analysis at different times of lung development and in different tissues to characterize 
our subset of lung lncRNAs. NANCI expression is observed in the developing lung, 
thyroid, and ventral forebrain in a pattern nearly identical to Nkx2.1 (Fig. 2.8A and Fig. 
2.9A-D). Within the developing lung, both genes are expressed throughout the 
developing epithelium with lower levels found in the large airway epithelium (Fig. 2.8A). 
Expression of NANCI persists in the adult with notable expression observed in large 
airway epithelium (Fig. 2.8A). The human orthologue of NANCI, which is annotated as 
surfactant associated transcript A3 (SFTA3), is also a lncRNA and is expressed in a 
similar pattern as human NKX2.1 in both airway and alveolar epithelium (Fig. 2.10). This 
conserved expression pattern may be explained by conserved binding motifs for known 
regulators of foregut and lung development (Smad, Forkhead, and Gata) found in the 
NANCI promoter locus (Fig 2.11). Despite low sequence conservation between mouse 
and human NANCI (26%), their identical expression patterns suggest that there may be 
an evolutionarily conserved function. LL35 exhibits strong expression in the lung 
epithelium, floor plate, gut endoderm, and liver in a pattern similar to that of Foxa2 (Fig. 
2.8B and Fig. 2.9E-H). LL66 is expressed primarily the mesenchyme of the developing 
lung and posterior gut, similar to Foxf1 (Fig. 2.9C and Fig. 2.9I-L). These expression 
patterns were confirmed using Q-PCR using E12.5 and adult lung cDNA (Fig. 2.9M-N).  
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The expression of LL33 is more restricted than Gata6 itself. Within the developing lung, 
Gata6 is robustly expressed in the developing epithelium and vascular smooth muscle 
(VSM), while LL33 expression can be detected in the VSM but is expressed at low levels 
in the developing epithelium (Fig. 2.5B). Outside of the lung, LL33 expression is 
observed primarily in the heart (Fig. 2.5D-H). During early heart development, LL33 was 
detectable in the atrio-ventricular canal region and in the developing heart valves (Fig. 
2.5D-F). In contrast, Gata6 is expressed throughout most of the heart, including the 
myocardium (Fig. 2.5I-K) (Morrisey et al. 1996). By E16.5, LL33 expression expands into 
the myocardium such that by E18.5 its expression is similar to that of Gata6 in the heart 
(Fig. 2.5 G,H,L,M).  
 
2.6 Expression patterns of lung lncRNAs located in gene deserts 
We next looked at expression patterns of those lung lncRNAs not associated with a 
transcription factor or PCG. At E12.5 and E14.5, LL1/ANCR is expressed in the distal 
airway epithelium and at lower levels in the lung mesenchyme (Fig. 2.12A, arrows and 
Fig. 2.9 O). Expression in proximal airway epithelium is not observed (Fig. 2.12A, 
arrowheads). During development, LL1 expression diminishes until it is no longer 
detectable in the adult lung by ISH. Of note, the developing epidermis expresses high 
levels of LL1 as has been reported for human ANCR, suggesting that it may play a 
similar role in regulating differentiation of mouse keratinocyte progenitors (Fig. 2.9P) 
(Kretz et al. 2012). LL12 expression is observed in the embryonic lung epithelium and 
persists at low levels in the adult lung (Fig. 2.12B and Fig. 2.9Q). LL12 is also expressed 
robustly in the embryonic liver where expression remains high in the adult (Fig. 2.9Q,R). 
LL34 is expressed in the developing lung endoderm at E12.5 and E14.5 and its 
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expression is rapidly down-regulated such that it is not observed in the adult lung (Fig. 
2.12C). Expression of LL34 is absent in tissues other than the lung at E12.5 by Q-PCR 
(Fig. 2.9S). At E10.5, LL34 expression is observed throughout the anterior to posterior 
axis of the gut endoderm (Fig. 2.9T-W). In the adult, LL34 expression is only detectable 
at low levels in the intestine by Q-PCR (Fig. 2.9S).  
 
2.7 Loss of function for select lung lncRNAs reveals important roles in endoderm 
development  
To define the function of a select subset of lncRNAs in lung epithelial cells, I performed 
shRNA-mediated knockdown of NANCI and LL34 in the mouse lung epithelial cell line 
MLE12. These lncRNAs represent different the two major categories of transcripts 
identified by our analysis including those located near transcription factor loci (NANCI) 
and novel lncRNAs expressed in the developing but not adult lung (LL34). Of note, both 
lncRNAs are expressed in MLE12 cells and the selected shRNAs exhibited between 80-
95% knockdown efficiency upon optimization of viral transduction (Fig. 2.13 and data not 
shown). Changes in the transcriptome of MLE12 cells upon loss of lncRNA expression 
were assessed using microarray assays, which demonstrated that each lncRNA 
regulated unique cellular pathways in lung epithelial cells. Loss of NANCI expression 
resulted in a significant change in lung epithelial gene expression with more than 1000 
genes, up or down-regulated compared to scrambled shRNA expression (Fig. 2.14A,B). 
Less dramatic effects were observed with knockdown of LL34, although loss of this 
lncRNA resulted in the altered expression of several hundred genes (Fig. 2.14A,B). 
Interestingly, there was little overlap between the genes altered by NANCI knockdown in 
comparison to LL34 (Fig. 2.14A,B).  
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A large number of lung epithelial development genes were down-regulated by loss of 
NANCI expression such that respiratory and lung development were top categories of 
gene expression changes upon NANCI knockdown (Fig. 2.14C,D and GSE52389). 
Importantly, Nkx2.1 was down-regulated along with many targets of Nkx2.1 such as 
Sftpc, Abca3, and Aqp5 (Fig. 2.14E). Foxp1, Foxp2, Sox9, and other genes not known to 
be directly regulated by Nkx2.1 were also down regulated after loss of NANCI 
expression by both microarray and Q-PCR analysis (Fig. 2.14F and GSE52389). 
Knockdown of NANCI in the human lung adenocarcinoma cell line H441 likewise 
resulted in decreased expression of NKX2.1 and AQP5 (Fig. 2.15). These data suggest 
that in both mice and humans NANCI regulates expression of the essential lung 
transcription factor Nkx2.1 and, in turn, Nkx2.1 target genes. 
 
LL34 was found to be essential for the expression of several critical lung developmental 
genes including Bmp2, Foxa1, Gata6, Fgfr2, Fgfr3, Fgf18, Jag1, and Tgfb3 as noted by 
microarray and Q-PCR analysis (Fig. 2.14G,K and GSE52389). Tube development was 
one of the top categories of genes altered by knockdown of LL34 (Fig. 2.14H). 
Interestingly, loss of LL34 resulted in decreased expression of several important 
components of the retinoic acid (RA) pathway including Aldh1a1 and Rarg (Fig. 2.14K 
and GSE52389). Decreased expression of these genes as well as other components of 
the RA pathway including Aldh1a2, Aldh1a3, and Cyp2b1 was confirmed by Q-PCR (Fig. 
2.14I). Many of the developmental regulators whose expression was decreased upon 
loss of LL34 are known targets of RA signaling (Fig. 2.14J). Of the 403 known RA 
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targets expressed in MLE12 cells, 58 demonstrated altered levels of expression 
following knockdown of LL34 (Balmer and Blomhoff 2002) (GSE52389). These data, 
along with the restricted expression of LL34 in early foregut endoderm, suggest that 
LL34 may modulate RA signaling in the early foregut and lung endoderm.  
 
2.8 NANCI acts upstream of Nkx2.1 and downstream of Wnt signaling to regulate 
lung epithelial gene expression 
The loss of function data for NANCI indicates its importance for Nkx2.1 expression and 
function during lung endoderm development. Given the central role that Nkx2.1 plays in 
anterior foregut and lung endoderm development, I chose to further explore the role of 
NANCI and determine how its regulation of Nkx2.1 effects lung epithelial differentiation. 
To determine how much of NANCI’s effects on gene expression are mediated in part or 
in full by Nkx2.1, I attempted to rescue the knockdown of NANCI and, in turn, loss of 
Nkx2.1 expression with ectopic overexpression of Nkx2.1. These experiments showed 
that increased Nkx2.1 expression rescued the expression of its target genes Abca3, 
Sftpc, and Aqp5 as well as partial rescue of Aqp1 expression (Fig. 2.16B,C). Moreover, 
ectopic expression of Nkx2.1 lead to increased endogenous Nkx2.1 expression (Fig. 
2.16A). Such auto-regulation of Nkx2.1 has been previously suggested by the finding of 
conserved Nkx2.1 binding sites in its promoter (Shaw-White et al. 1999; Das et al. 
2011). Interestingly, expression of NANCI itself was unaffected by overexpression of 
Nkx2.1 suggesting that Nkx2.1 does not regulate NANCI expression (Fig. 2.16A), further 
demonstrating distinct differences in regulation of these two loci. Overexpression of 
Nkx2.1 did not rescue expression of Nrp1, Nrp2, Cdh1, Foxp1, and Foxp2 suggesting 
that NANCI acts independently of Nkx2.1 to regulate the expression of these important 
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developmental regulators (Fig. 2.17). I next assessed whether NANCI could promote 
Nkx2.1 expression using overexpression of the full-length NANCI transcript in MLE12 
cells. Overexpression of NANCI led to increased Nkx2.1 expression suggesting that 
NANCI is capable of promoting Nkx2.1 expression in lung epithelium (Fig. 14D). 
 
Previous data has demonstrated that Wnt signaling is an essential inducer of Nkx2.1+ 
lung endoderm progenitors during anterior foregut development and in in vitro 
differentiation of pluripotent stem cells into lung epithelium (Goss et al. 2009; Harris-
Johnson et al. 2009; Longmire et al. 2012; Mou et al. 2012). Our data showing that 
ectopic Nkx2.1 expression in the context of loss of NANCI expression results in 
restoration of the expression of several Nkx2.1 target genes as well as the ability of 
ectopic NANCI to increase Nkx2.1 expression, suggests that NANCI acts upstream of 
Nkx2.1 to regulate lung epithelial gene expression. To further explore how NANCI acts in 
the hierarchy of lung epithelial gene transcription, I assessed NANCI expression in in 
vivo models of loss of Nkx2.1 and Wnt signaling in the early lung endoderm. Nkx2.1-/- 
lungs are dysplastic and exhibit decreased expression of several known target genes 
including Sftpc, Scgb1a1, and Aqp5 (Minoo et al. 1999). While the Nkx2.1 transcript was 
absent in Nkx2.1-/- lung epithelium as expected, NANCI expression was readily observed 
and maintained a proximal to distal expression gradient as it did in normal embryonic 
lungs (Fig. 2.16E-H). In contrast, loss of Wnt/ β-catenin in the anterior foregut endoderm 
of Shhcre:Ctnnb1flox/flox mutants, results in a loss of both Nkx2.1 and NANCI expression 
(Fig. 2.16I-L). Together, these data imply a model in which NANCI acts upstream of 
Nkx2.1 and downstream from Wnt/β-catenin signaling to regulate a suite of critical lung 
developmental genes (Fig. 2.16M). 
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Consistent with the observation that NANCI promotes Nkx2.1 expression, NANCI 
interacts strongly with Wdr5/trithorax transcriptional activating complex but not 
Ezh2/polycomb repressive complex similar to other activating lncRNAs (Figure 2.18) 
(Zhao et al. 2008; Khalil et al. 2009; Wang et al. 2011; Ulitsky and Bartel 2013). In 
contrast, LL12 interacts strongly with Ezh2/polycomb as has been previously shown 
(Zhao et al. 2010). Moreover, loss of NANCI reduces H3K4me3 marks imposed by the 
trithorax complex at the Nkx2.1 locus (Fig. 2.16N,O). Together, these data imply a model 
where NANCI acts upstream of Nkx2.1 and downstream of Wnt/β-catenin signaling to 
regulate a suite of critical lung developmental genes (Fig. 2.14M). Moreover, these data 
suggest that NANCI recruits the trithorax complex to activate Nkx2.1 expression, making 
it one of the earliest markers for lung endoderm specification (Fig. 2.14P).  
 
2.9 Knockdown of NANCI in the developing mouse lung results in disruption of 
epithelial differentiation and loss of Nkx2.1 target gene expression 
Many lncRNAs, especially ones located close to PCGs, are transcribed from genomic 
regions that overlap potential enhancer elements (Orom et al. 2010a). Therefore, to 
further characterize the role of the NANCI non-coding transcript in lung epithelial 
development without affecting the NANCI genomic locus, I performed in vivo knockdown 
of NANCI using the human SFTPC promoter, which is active throughout the developing 
lung epithelium. I utilized the previously demonstrated ability of shRNAs to be processed 
from miRNA precursor transcripts to generate a SFTPC driven knockdown construct 
(Fig. 2.19A) (Wang et al. 2007). Five F0 SFTPC-NANCIshRNA transgenic mice were 
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generated with an average NANCI knockdown of 43% at E17.5 (Fig. 2.20A). SFTPC-
NANCIshRNA transgenic lungs had reduced saccule formation as noted by H&E staining 
and increased mesenchymal thickness between airways (Fig. 2.19B,D). Many of the 
genes down-regulated after NANCI knockdown in MLE12 cells were similarly affected in 
SFTPC-NANCIshRNA transgenic lungs including Nkx2.1 and its targets such as Sftpc, 
Abca3, and Aqp5 (Fig. 2.20A). Likewise, Scgb1a1, an Nkx2.1 target gene not expressed 
in MLE12 cells, was downregulated in SFTPC-NANCIshRNA transgenic lungs (Fig. 2.20A). 
Decreased expression of both Aqp1 and Cdh1 were also observed similar to the NANCI 
knockdown in MLE12 cells (Fig. 2.20B). However, levels for Sox2, Sox9, and Id2 were 
unchanged suggesting that in these experiments lung endoderm progenitors were not 
drastically perturbed (Fig. 2.20B). Immunostaining for Cdh1 shows that the distal airway 
epithelium of SFTPC-NANCIshRNA transgenic lungs retained a columnar morphology as 
compared to control littermates, indicating defects in distal sacculation/alveolarization 
(Fig. 2.20E). Immunostaining also confirms the reduction in Scgb1a1 expression in the 
proximal airways in SFTPC-NANCIshRNA transgenic lungs, consistent with defects in 
differentiation of the secretory epithelial lineage (Fig. 2.19G). Sftpc+ alveolar epithelial 
type 2 cells were more focally located in SFTPC-NANCIshRNA transgenic lungs rather 
than dispersed as observed in transgene negative littermates (Fig. 2.19G).  
 
To determine whether the in vivo knockdown of NANCI mimicked decreased Nkx2.1 
expression, Nkx2.1+/- lungs were examined at E17.5. Nkx2.1+/- lungs had an ~40% 
decrease in Nkx2.1 expression (Fig. 2.20C). As in SFTPC-NANCIshRNA transgenic lungs, 
the Nkx2.1+/- mutant lungs had reduced saccule formation and increased mesenchymal 
thickness, as noted by H&E staining (Fig. 2.19C,D). These mutants also had similar 
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reductions in Sftpc, Abca3, Aqp5, Scgb1a1, and Aqp1, as noted in SFTPC-NANCIshRNA 
transgenic lungs (Fig. 2.20C,D). The number of Sftpc+ distal saccules was also 
decreased in a manner similar to the SFTPC-NANCIshRNA transgenic lungs (Fig. 2.19H). 
However, the level of Cdh1 expression was not affected in Nkx2.1+/- lungs (Fig. 2.20D). 
In contrast, while there were changes in the morphology of the distal airway epithelium 
of Nkx2.1+/- lungs as noted by Cdh1 immunohistochemistry, these changes were not as 
dramatic as noted in SFTPC-NANCIshRNA transgenic lungs (Fig. 2.20F). Together, these 
data suggest that NANCI regulates lung epithelial development in vivo in large part 
through its regulation of the critical transcription factor Nkx2.1. 
2.10 Discussion 
While different methodologies have resulted in the cataloging of thousands of lncRNAs, 
it has remained difficult to assess which portion of these transcripts play a functional role 
in the cells and tissues where they are expressed. Using conservative criteria to focus 
on lncRNAs that may play a functional role in lung development, I identified 363 
lncRNAs and show that they are spatially correlated with transcription factors important 
for development of the anterior foregut and lung. Importantly, I have identified and 
characterized NANCI, a lncRNA located near the important lung endoderm regulator 
Nkx2.1 and have shown that NANCI acts upstream of Nkx2.1 and downstream of Wnt/β-
catenin to regulate lung epithelial gene expression. In contrast, LL34 regulates RA 
signaling, which is critical for foregut endoderm development. Taken together, our data 
provide a novel catalogue of lncRNAs in the foregut and lung and show that several of 
these play unique and essential roles in foregut and lung epithelial gene expression and 
development. 
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Our data show that lncRNA loci are spatially correlated with transcription factor loci. 
These transcription factor associated lncRNAs are more conserved at the syntenic level 
with the human genome than other lncRNAs. Moreover, in several cases they have 
expression patterns remarkably similar to their neighboring transcription factors, 
suggesting that these lncRNAs are closely associated with the expression and function 
of their neighboring transcription factors. I identified NANCI as a critically important 
lncRNA located near the lineage regulator Nkx2.1. NANCI’s expression is identical to 
Nkx2.1, which correlates with its functional necessity for normal Nkx2.1 expression. The 
correlation between NKX2.1 and NANCI is also found in the human lung even though 
NANCI is poorly conserved at the nucleotide level. Surprisingly, NANCI expression 
persists in the absence of Nkx2.1 expression indicating that Nkx2.1 is not required for 
NANCI expression. This is supported by the lack of conserved Nkx2.1 DNA binding 
motifs within the NANCI promoter (Fig. 2.11).  This finding was unexpected as the 
Nkx2.1 expression pattern is unique and was previously recognized as the earliest 
marker of anterior foregut endoderm committed to the lung and thyroid fate (Longmire et 
al. 2012; Mou et al. 2012). Our data showing that NANCI acts upstream of Nkx2.1 
suggests that NANCI is an earlier marker than Nkx2.1 of anterior foregut lung fate. Our 
data shows that both NANCI and Nkx2.1 expression are lost upon inactivation of Wnt/β-
catenin signaling in the anterior foregut endoderm, placing NANCI downstream of this 
pathway in lung endoderm development. Interestingly, a patient was recently identified 
with a chromosomal deletion that encompassed most of NANCI but left the NKX2.1 
locus intact (Barnett et al. 2012). This patient had symptoms characteristic of NKX2.1 
haploinsufficiency including respiratory distress, suggesting that NANCI has a similar 
role of regulating NKX2.1 in the human lung. Knockdown of NANCI in human cells 
results in decreased NKX2.1 expression, further supporting a conserved role for NANCI 
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in human development. Together, these findings indicate that NANCI acts between 
Wnt/β-catenin signaling and Nkx2.1 to regulate a broad array of lung endoderm specific 
genes, in part through regulation of Nkx2.1 itself.  
 
Not all lncRNAs located near transcription factors that I identified were expressed in an 
identical pattern as their neighboring PCG. LL33, which is located next to the Gata6 
locus, exhibited divergent expression pattern in both the developing lung and heart. 
Where Gata6 is expressed at high levels in the developing lung epithelium, LL33 is 
expressed at low levels in this tissue. Moreover, LL33 expression is not observed at 
significant levels in the developing myocardium of the heart until E18.5 whereas Gata6 is 
expressed in this tissue from the earliest stages of cardiac development. Such distinct 
differences may indicate tissue specific regulatory roles for these lncRNAs during 
development.  
 
LL34 is specifically expressed throughout the anterior to posterior axis of early gut 
endoderm and its expression continues in the early lung endoderm. However, its 
expression is extinguished by late gestation, making it the one of the most embryonic-
specific lung lncRNAs identified in our study. This expression pattern correlates with 
data showing that loss of LL34 leads to decreased expression of several essential 
components of the RA signaling pathway. RA signaling plays a critical role in both early 
foregut patterning and lung development. Loss of RA signaling leads to lung agenesis 
while additional studies suggest a role for RA signaling in other regions of gut endoderm 
including in the pancreas (Martin et al. 2005; Wang et al. 2006; Chen et al. 2007; Bayha 
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et al. 2009; Chen et al. 2010). Given LL34’s restricted expression in the gut endoderm in 
early development and the important role for RA signaling in endoderm development, 
this lncRNA is likely a key regulator of foregut development through modulation of RA 
signaling. 
 
The lncRNAs in our data set that are in close proximity with important transcription 
factors could be considered enhancer RNAs (eRNAs), which are thought to regulate 
their neighboring PCGs through various mechanisms including recruiting chromatin 
remodeling complexes or acting as genomic enhancers of the neighboring PCGs (Orom 
et al. 2010a). Our data showing that NANCI binds to TrxG/Wdr5 complexes suggests 
that this transcript may serve this type of function in regulating Nkx2.1 gene expression 
during foregut and lung development. Interestingly, other lncRNAs in our database such 
as LL12 bind to both TrxG/Wdr5 and PRC2/Ezh2 at high levels suggesting that it may 
play both activating and repressive roles in regulating gene transcription. Of note, LL12 
was previously found to be associated with Ezh2 in a genome wide survey of polycomb 
associated lncRNAs (Zhao et al. 2010). Further experiments disrupting these 
interactions specifically will be required to fully assess their importance in regulating 
NANCI function. 
 
Our database of lung lncRNAs reveals important features of this class of transcripts and 
also identifies several important players in both lung and foregut development. I have 
characterized the tissue specific expression patterns of several of these lncRNAs 
revealing that they are often expressed in a pattern exquisitely similar to their 
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neighboring PCGs. These data bolster and extend an emerging concept that lncRNAs 
are an important regulator of cell lineage differentiation during tissue development and 
suggests that a subset act on neighboring transcription factors to regulate their 
expression and function.  
 
2.11 Materials & Methods 
Library Preparation 
Total RNA was extracted from E12.5 and adult mouse lungs using the RNAEasy kit 
(Qiagen) and used in the preparation of seqeunicng libraries using the Illumina TruSeq 
IRNA sample preparation kit. Paired-end reads were sequenced on a HiSeq 2000 at a 
depth of 4 samples per lane to achieve an average 60 million reads per library.  Two 
libraries per time point were analyzed. 
 
Alignment and Transcript Assembly 
Paired end reads were aligned to the mouse reference genome (build NCBI37/mm9) 
using the read mapper GSNAP version 2012-07-20 (Wu and Nacu 2010). GSNAP was 
executed in the mode to detect both novel and known splice sites. Known splice sites 
were obtained from Ensembl build 67. Cufflinks was then used to assemble the 
transcriptome for each of the four individual samples (Trapnell et al. 2013). These 
individual assemblies where then merged and annotated using Ensembl 67 into a single 
collection of transcripts using Cuffmerge. Expression quantification and differential 
expression analysis was performed on the transcript using Cuffdiff.  Expression values in 
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the form of Fragments Per Kilobase of exon per Million reads mapped(FPKM) were 
imported into custom database for further analysis.  
 
LncRNA identification pipeline 
Potential lncRNAs were discovered using the same pipeline describe by Cabili et al 
(Cabili et al. 2011). Briefly transcripts that were multi-exonic, larger than 200 nucleotides 
and called with a class code of ‘u’ in Cuffmerge were retained as potential novel 
lncRNAs. To remove transcripts which might be novel protein coding genes, PhyloCSF 
was used to assess the protein coding potential of each transcript by examining the 
over-representation of evolutionary signatures characteristic of alignments of conserved 
coding regions, such as the high frequencies of synonymous codon substitutions and 
conservative amino acid substitution (Lin et al. 2011). Transcripts with a PhyloCSF score 
greater than 100, which roughly indicated a false positive rate of 10% when comparing 
know non-coding transcripts, were excluded for further analysis. Transcripts were also 
excluded if they contained a known protein-coding domain.  Pfam scan 
(ftp://ftp.sanger.ac.uk/pub/databases/Pfam/) was used to search all potential open 
reading frames against Pfam (Release version 26, PfamA and PfamB). Genebank 
accession numbers: LL18/NANCI (mouse: KF856953, human: KF856952) and LL34: 
KF876689. 
 
Motif Enrichment 
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DNAse hypersensitivity sites (Encode) were used to predict protein binding regions 
within lncRNA promoters 2.5kb upstream and 300bp downstream of lncRNA 
transcription starts sites. DNA sequences overlapping with lncRNA promoter regions and 
DNAse hypersensitivity sites were created using BEDTools (Quinlan and Hall 2010). 
Novel motifs were discovered using the tool MEME (Czaplinski et al.) and set to find 5 
most overrepresented motifs in the input sequences.  Discovered motifs were then 
matched to known motifs in the TRANSFAC database (Matys et al. 2006), using the tool 
TOMTOM (Gupta et al. 2007) . 
 
Neighbor gene analysis and spatial correlation 
Genes from Ensembl were annotated as transcription factors using data from the animal 
transcription factor database (http://www.bioguo.org/AnimalTFDB/index.php) (Czaplinski 
et al.). A 2x2 tables using distances widnows of 5,10,20,25 and 50 kb of counts was 
constructed with lncRNAs near Transcription factor loci, lincRNAs near Non-transcription 
factor PCG, PCGs near Transcription loci and PCGs near non-Transcription factor loci. 
This count table was used in a single sided Fisher’s exact test  to determine if the 
proportion of lncRNAs near transcription factors was different than that of PCG with near 
transcription factors. 
 The R package GenometriCorr (Czaplinski et al.) was used to examine the spatial 
correlation of lncRNAs with PCGs. Genes groups were formed using the animalTFDB 
database for transcription factors, signal proteins define by gene ontology (GO:0038023) 
and structural proteins define by gene ontology (GO: (GO:0005198). GenometriCorr 
implements various statistical approaches to assess whether the positions of two sets of 
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intervals are associated in genomic space. The 363 lncRNAs from the mouse lung and 
lncRNAs in Ensembl were compared against groups of PCGs defined as transcription 
factors, signaling proteins or structural proteins using the GenomtriCorr relative distance 
test. For a positive correlation reference the adult mouse lung H3K4me3 sites, a 
promoter mark were compared against protein coding genes expressed in the mouse 
lung from determined using our RNA-seq data (FPKM > 5) The distributions relative 
distances between lncRNA and the categories of PCGs were plotted use R and tested 
for a significance difference to the uniform null distribution using Kolmogorov-Smirnov 
test. 
 
Human Syntenic Transcripts 
Mouse lung lncRNA loci were mapped to syntenic human (GRCh37/hg19) regions using 
the Liftover tool available at the UCSC genome browser website. Human Ensembl 
version 75 was used to determine which genes were located in the syntenic regions.  
 
5’ and 3’RACE, and Full-Length LncRNA Cloning 
 5’RACE was performed with the TaKaRa 5’RACE Core Kit (Clontech, Mountain 
View, CA) per manufacturer’s instructions using the PCR primers listed in Table 2.1. The 
final reaction products were cloned and sequenced using the TOPO TA Cloning kit and 
pCR4 vector (Life Technologies, Grand Island, NY). Primer 1 (Table 2.1) was used for 
first-strand synthesis from total RNA extracted from MLE12 cells with Superscript II, per 
manufacturer’s protocol. 3’RACE products were subsequently amplified with nested 
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PCR primers (Table 2.1). These products were also subsequently closed into the TOPO 
vector pCR4. Based on the results of 5’RACE and 3’RACE, PCR primers were designed 
to amplify full-length transcripts for each lncRNA of interest. LA Taq (Clontech, Mountain 
View, CA) for full-length transcript amplification. Each product was cloned into TOPO 
pCR4, sequenced, and then subcloned into the plasmid backbones as described 
elsewhere in this Methods section. 
 
In-Vitro Transcription-Translation Assay 
 The Promega TnT Quick Coupled Transcription/Translation System and 
Transcend Non-Radioactive Translation Detection System (Madison, WI) was used to in-
vitro transcribe and translate each full-length lncRNA from the T7 promoter of a 
pcDNA3.1+ plasmid, per manufacturer’s instructions. Following completion of the 
transcription-translation reaction, 1uL of the reaction product was added to 15uL SDS 
sample buffer, heated to 100C for 2 minutes to denature the proteins, and then loaded 
onto a 4-12% 1mm 15W NuPage SDS-polyacrylamide gel (Life Technologies, Grand 
Island, NY). Protein products labeled with the biotinylated Transcend tRNA were 
detected with streptavidin antibody and Western Blue reagent, per manufacturer’s 
instructions. The luceriferase T7 control DNA plasmid supplied with the TnT Quick 
Coupled Transcription/Translation System was used as a positive control.  
 
Animals 
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The generation and genotyping of the Nkx2.1-/-, Shhcre, and Ctnnb1flox/flox mice have been 
previously described (Brault et al. 2001; Harfe et al. 2004; Taniguchi et al. 2011; 
Taniguchi et al. 2013). All animal work was performed under the approval and guidance 
of the University of Pennsylvania Institutional Animal Care and Use Committee. 
 
Quantitative Real-Time PCR 
Total RNA was isolated from indicated tissues or cell lines using Trizol (Invitrogen, 
Carlsbad, CA) per manufacturer’s protocol. cDNA was synthesized from total RNA by 
using SuperScript Strand Synthesis System (Invitrogen, Carlsbad, CA, USA). 
Quantitative real time PCR was performed using the SYBR green system (Applied 
Biosystems, Foster City, CA, USA) with primers listed in the Table 2.2. GAPDH 
expression values were used to control for RNA quality and quantity. Five biologic 
replicates were used for all cell lines experiments, and biologic triplicates for in vivo 
experiments, unless otherwise noted. Data shown are the mean ± SEM. 
 
Histology 
Tissues were fixed in 4% paraformaldehyde, embedded in paraffin wax and sectioned at 
5 mm intervals. Immunohistochemistry was performed using the following antibodies: 
mouse anti-phopho-histone3 (Cell Signaling Technology, Danvers, MA, USA; 1:200), 
goat anti-CC10 (Santa Cruz, Santa Cruz, CA, USA; 1:20), rabbit anti-SP-C (Chemicon, 
Billerica, MA, USA; 1:500), rabbit anti-Nkx2.1 (Santa Cruz, 1:50), mouse anti-Cdkn1a 
(Santa Cruz, 1:100), rabbit anti-Sox9 (Santa Cruz, 1:100), rabbit anti-Rbl2/p130 (Abcam, 
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Cambridge, MA, USA; 1:50), rabbit anti-Par3 (Upstate, Billerica, MA, USA; 1:100), rabbit 
anti-Sox2 (Seven Hills Bioreagents, Cincinnati, OH, USA; 1:500), rabbit anti-Cdh1 (Cell 
Signaling, 1:100). Slides were mounted with Vectashield mounting medium containing 
DAPI (Vector Laboratories, Burlingame, CA, USA). In situ hybridization was performed 
as described (Cohen et al., 2007; Zhang et al., 2008). Previously described probes were 
used to analyze Nkx2.1, Gata6, and Foxa2 expression (Goss, 2009 #1031;Zhang, 2007 
#1032). Probes for other genes were amplified from using the primers listed in Table 2.3. 
 
Human Lung Sample Collection 
 Neonatal lung samples were collected through an institutional review-board 
(Nagarajan et al.)-approved registry-biorepository, “Molecular and Clinical Analysis of 
Syndromic and Isolated Anomalies of the Foregut”, at The Children’s Hospital of 
Philadelphia. Fetal lung samples were collected through an IRB protocol at Temple 
University, Philadelphia, PA. 
 
Cell Culture Methods 
HEK-293T, MLE12, and H441 cell lines obtained from ATCC (Manassas, VA) were used 
for all experiments. HEK-293T cells were cultured in DMEM (Life Technologies, Grand 
Island, NY) + 10%FBS + 1% penicillin/streptomycin at 37C, 5% CO2. Antibiotic-free 
conditions were used during transfection. MLE-12 cells were cultured in the HITES 
medium (Ham’s F12 (Mediatech, Manassas, VA), insulin 0.005mg/mL, transferrin 0.01 
mg/mL, transferrin 0.01 mg/mL, sodium selenite 30 nM, hydrocortisone 10 nM, beta-
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estradiol 10 nM, HEPES 10 mM, and L-glutamine 2 mM) + 2% FBS + 1% 
penicillin/streptomycin. H441 cells were cultured in RPMI-1640 (Mediatech, Manassas, 
VA) + 10%FBS + 1% penicillin/streptomycin at 37C, 5% CO2. 
Lentiviral shRNA Knockdown 
Suitable target regions for each lncRNA were chosen based on the guidelines outlined 
by Birmingham et. al. (Birmingham et al. 2007). Five distinct regions of each target were 
chosen for shRNA design. Regions containing known SNPs or repeat elements were 
specifically avoided. A minimum of five shRNAs were designed against these regions 
using RNAi Consortium’s publically available design tool 
(http://www.broadinstitute.org/rnai/public/seq/search). Each target sequence was 
independently verified to be unique through a separate BLAST search. shRNAs were 
screened for efficiency; the shRNA construct with maximum knockdown was selected for 
subsequent analyses. Sequences of shRNA target sites can be located in Table 2.4.  
For knockdown in MLE12 cells shRNA oligos were synthesized by Integrated 
DNA technologies (Coralville, IA), phosphorylated, annealed to their complementary 
partner, and were then cloned into the pLKO.1-GFP vector. Lentivirus was produced by 
transfecting HEK-293T cells at 50-70% confluency with the viral packaging plasmids 
psPAX2 & pMD2.G, and the appropriate pLK0.1-shRNA plasmid with FuGENE6 
(Promega, Madison, WI). A total of 4ug of DNA (2ug pLKO.1-shRNA, 1.5ug psPAX2, 
500ng pMD2.G) + 12uL FuGENE6 was used to transfect each well of a 6-well plate for 
screening assays. A total of 10ug DNA (5ug pLKO.1-shRNA, 3.75ug psPAX2, 1.25ug 
pMD2.G) + 30uL FuGENE 6 was used to transfect 10cm plate for subsequent 
experiments. Fresh media was added 12 hours after transfection. Virus was collected 48 
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hours following transfection by passing the virus-containing media through a 0.45 
micrometer strainer, and then concentrated with Amicon 100k Ultracentrifugation filters 
(Millipore, Billerica, MA) by centrifugation at 2,800 x g for 15 minutes. The viral 
concentrate was reconstituted in an equivalent volume of MLE12 media (composition 
described above), and then applied to MLE12 cells with fresh media in a 1:4 ratio with 
polybrene, 8ug per mL media. Fresh media was added 12 hours after addition virus. 
MLE12 cells cultured for 65 hours after infection before collecting and isolating total 
RNA. A similar protocol was used to infect H441 cells except the H441 cells were 
exposed to virus for 18 hours and cultured in H441 media (composition described 
above).  
 
Overexpression of NANCI and Nkx2.1 rescue of NANCI knockdown 
NANCI was cloned into pLenti 7.3/V5-DEST using the gateway cloning system, primers 
listed in Table 2.5. Lentivirus was produced in HEK-293T cells and used to infect MLE12 
cells at 50-70% confluency, as described above. Infected MLE12 cells were grown for 65 
hours before collecting and isolating total RNA. Full length Nkx2.1 was cloned into the 
pCMV-Tag2B vector as previously described (Zhang, 2007 #1032). MLE12 cells were 
infected with NANCI shRNA lentivirus, as described above, and allowed to grow for 24 
hours. MLE12 cells were then transfected with a pCMV-Tag2B-Nkx2.1 vector using the 
Lonza 4D-Nucleofector system and allowed to grow for another 48 hours before isolating 
RNA. 
 
Microarray Analysis 
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RNA was isolated from MLE12 cells following infection with either a scrambled control 
shRNA or lncRNA target shRNA in triplicate. Biotinylated cRNA probe libraries were 
generated form these RNA samples and used with Affymetrix Mouse Gene 2.0ST 
arrays. Microarray data were analyzed using the Oligo package available at the 
Bioconductor website (http://www.bioconductor. org). The raw data were background-
corrected by the Robust Multichip Average (RMA) method and then normalized by an 
invariant set method. Differential gene expression between the control and mutant mice 
was analyzed by the Limma package available at the Bioconductor website. P values 
obtained from the multiple comparison tests were corrected by false discovery rates. 
Heatmap displays were created using the freely Dissertation.doc R and the library 
heatmap2. Gene Ontology enrichment analysis was performed using the website 
DAVID. The Gene Expression Omnibus accession number for the microarray data is 
GSE52389.  
RNA Co-Immunoprecipitaton 
RNA coimmunoprecipitation was carried out as previously described (Moran et 
al. 2012). MLE12 cells were grown to 90% confluency on twelve 10cm plates, and then 
harvested following trypsinization. The cells were washed twice with sterile PBS, and 
were then cross-linked with 0.3% formaldehyde in PBS at room temperature for 10 
minutes. The reaction was quenched with glycine at a final concentration of 0.125M. 
Cells were then pelleted, washed with PBSx2, and resuspended in 1.2mL RIPA buffer 
supplemented with protease inhibitors (1 cOmplete protease inhibitor tablet (Roche, 
Indianapolis, IN) and RNase inhibitors (62.5uL RNaseOUT + 125uL SuperaseIN (Life 
Technologies, Grand Island, NY)). The cell suspsension was incubated at 37C for 30 
minutes, and during this period was vortexed for 30 seconds at 5 minute intervals. The 
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cells were then homogenized with a Dounce homogenizer for 1 minute. The cell lysate 
was centrifuged to pellet the debris, and the supernatant was transferred to a clean tube. 
A 200uL aliquot was set aside as the Input sample, and 500uL was used for each pull-
down reaction (500uL for IgG reaction, 500uL for target antibody reaction).  
Dynabeads Protein G (Life Technologies, Grand Island, NY) were used for 
immunoprecipitation following manufacturer’s instructions. The beads were resuspended 
by vortexing for 30 seconds, and then 100uL aliquots were transferred to clean tubes 
and resuspended in RIPA buffer supplemented with protease and RNase inhibitors. 2ug 
of target antibody (either anti-Ezh2 (Millipore), or anti-Wdr5 (Bethyl Laboratories, Inc.)) 
was added to the first tube and 2ug of polyclonal IgG antibody to the second tube. The 
antibody-bead mixture was intubated at 4C with shaking for two hours. The beads were 
then washed with 500uL RIPA buffer, and resuspended in 500uL MLE12 cell lysate. The 
antibody-bead-cell lysate mixture was incubated at 4C with shaking for 2 hours. Next, 
the beads were washed with high-salt RIPA buffer (1M NaCL, 1%NP-40, 0.5% sodium 
deoxycholate, 0.1% SDS, 50mM Tris-HCl, 1mM EDTA) and resuspended in Buffer C ( ). 
10ug proteinase K was added to each reaction mixture, and incubated at 42C for 30 
minutes, followed by incubation at 65C for 4 hours, to reverse the formaldehyde 
crosslinks and free the bound RNA. RNA was then isolated from this sample, as well as 
the Input, using Trizol, in a standard fashion per manufacturer’s protocol. cDNA was 
synthesized as described above with random hexamers, and cDNA content quantified by 
Q-PCR. (Table 2.1) As previously described, U1 rRNA was used as an internal control, 
Hmbs as a negative control, and LL12/Snhg5 as a positive control for the EZH2 
pulldown (Grote, et al 2013; Zhao J, et al 2010).  
Generation of NANCI shRNA knockdown transgenics  
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The 3.7 kb human SFTPC promoter transgenic expression vector has been described 
previously (Yang et al. 2002; Li et al. 2012). The NANCI shRNA construct used above 
was used to generate an shRNA-miRNA cassette construct, as described previously 
(Wang et al. 2007). This was cloned downstream of the human SFTPC promoter and the 
SV40 polyadenylation sequence, excised from the resulting plasmid, purified and 
injected into FVBN fertilized oocytes as previously described (Yang et al. 2002; Li et al. 
2012). Embryos were collected at E18.5, and gene expression was measured by Q-PCR 
(Table 2.1). Whole lungs were isolated; the left lung was fixed for histology and the right 
lung was used to isolate total RNA. 
 
Mesenchymal thickness calculations 
H&E staining was preformed on SFTPC-NANCIshRNA transgenic lungs, Nkx2.1+/- lungs, 
and littermate control lungs for both genotypes. For each lung section two pictures were 
taken at 200x near the top and middle of the lung section. These pictures were 
overlayed with a uniform grid. Two horizontal and two vertical lines were chosen at 
random from each grid. Along a uniform length of each line the mesenchymal length and 
number of intersecting airways were measured and these values were then summed 
across all four lines. The total mesenchymal length was then divided by the total number 
of intersecting airways to obtain the average mesenchymal thickness for that picture. 
The mesenchymal thickness of the two pictures were then averaged to get the 
mesenchymal thickness for a lung section. The number of lung sections analyzed = 5 
(SFTPC-NANCIshRNA transgenic lungs and control littermates), 6 (Nkx2.1+/- lungs), or 4 
(Nkx2.1+/+ lungs). 
52	  
	  
Table 2.1. RACE primers. 
 
Primer	  
Designation	   Sequence	  
LL12-­‐RACE-­‐RT	   CAATTCTCTCAGATG	  
LL12-­‐5'RACE-­‐S1	   GCACGTTCACAAGGACAATG	  
LL12-­‐5'RACE-­‐S2	   GTGCTGTTCCGAAGGTACTA	  
LL12-­‐5'RACE-­‐A1	   AGTCTCAGAAGCCTCCAAATC	  
LL12-­‐5'RACE-­‐A2	   CACTCACCGACAAGACAAAGA	  
LL12-­‐3'RACE-­‐A	   GGAGCCCAAAGCATCTGAGAGAAT	  
LL12-­‐3'RACE-­‐B	   AGCCTGCGTGTGAAGATCCTA	  
LL34b-­‐RACE-­‐RT	   GAGAATACTGACTTC	  
LL34-­‐5'RACE-­‐S1	   GAACTGGCAAGAGTGTCCTT	  
LL34-­‐5'RACE-­‐S2	   TATGTGTGCAGCAGGAAAGG	  
LL34-­‐5'RACE-­‐A1	   GGCAGGAGGATCTTGTGTTT	  
LL34-­‐5'RACE-­‐A2	   TGGGTTTGGTGGCTGTATATG	  
LL34b-­‐3'RACE-­‐A	   GCAAGGCATTCCGAAGATAAAC	  
LL34b-­‐3'RACE-­‐B	   CATAGTAAGGGCAGTGGGTATTC	  
NANCI-­‐RACE-­‐RT	   AGGCGCATCTTCTTG	  
NANCI-­‐5'RACE-­‐S1	   GAGAAGCTGTCTCAAGACCT	  
NANCI-­‐5'RACE-­‐S2	   CCAGATAAGAGGAAGGAGAGAGAGGT	  
NANCI-­‐5'RACE-­‐A1	   GAAAGTCTGCGAATCTTCCT	  
NANCI-­‐5'RACE-­‐A2	   AAACCAGATCCAAACATCGC	  
NANCI-­‐3'RACE-­‐A1	   GCATCCTTGGAGGTCAGAATAA	  
NANCI-­‐3'RACE-­‐B1	   TTCCTCCAGCACACACAAA	  
NANCI-­‐3'RACE-­‐A2	   TGTTTAGATGGCGGACATTCA	  
NANCI-­‐3'RACE-­‐B2	   TCGGAGACTCACCTGCAATA	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Table 2.2. Q-PCR primers.  
Gene Forward Primer Reverse Primer 
Abca3 TTCATCACCTGATGGCGGTGAAC ACGCATGATGGCTTTGTCTACAGC 
Aldh1a1 GCAGCAGGACTCTTCACTAAA CACTGGGCTGACAACATCATA 
Aldh1a2 GTATATGGGAGCCCTCATCAAG TGTCTATGCCGATGTGAGAAG 
Aldh1a3 TGATGCTGGCCTGGAAAC TGATGAGAGAGGCTAGGTACAG 
Aqp1 TCCTCCCTAGTCGACAATTC GCAGAGTGCCAATGATCTC 
Aqp5 ATGAACCCAGCCCGATCTTT ACGATCGGTCCTACCCAGAAG 
Bmp2 AAGCAACAGAAGCCCAGTT ACCATGGTCGACCTTTAGGA 
Cdh1 AGCTGTCTACCAAAGTGACGCTGA ACATGAGCAGCTCTGGGTTGGATT 
Cyp26b1 ATACCAGCAGTTTGTGGAGAAT TCACGGATAGCCTTCTCTAGG 
Cyp51 GGCCTTAACATAGCCCACTT CACATTTCTTTCTCCGCTTTCTC 
Dhcr24 GAGTCATCGTCCCACAAGTATG GGCATAGAACAGGTCTGAGTTT 
Dhcr7 CCTGACTTCTGCCACAGATT CAGCCCATTCACCTCATACTT 
Endogenous Nkx2.1 TCCTCGGAAAGACAGCATCAGCTT TCGTGTGCTTTGGACTCATCGACA 
Fdft1 TTCTATAACCTGCTGCGATTCC GCGACTGGTCTGATTGAGATAC 
Fgf18 CAAGGGCAAGGAGACAGAAT TCTCAATGAACACGCACTCC 
Fgfr2 TTGCTTCGGGCAAGTAGTC CCTTCTCTGTGGCATCATCTT 
Fgfr3 TGAAGCACGTGGAAGTGAA CTCCTTGTCGGTGGTGTTAG 
Foxa1 CAGGATGTTAGGGACTGTGAAG TGACAGGGACAGAGGAGTAG 
Foxa2 ATCCGACTGGAGCAGCTACTACGC TGTATGTGTTCATGCCATTCATCCC 
Foxf1 GGAGCAGCCATACCTTCACCAAA ATGCTGGGCGACTGTGAGTGATA 
Foxp1 CGAATGTTTGCTTACTTCCGACGC ACTTCATCCACTGTCCATACTGCC 
Foxp2 GCCAGGCTGTGAAAGCATATGTGA CATTTGCACTCGACATTGGGCAGT 
GAPDH TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG 
GATA6 ACAGCAAGATGAATGGCCTCAGCA TGTGACAGTTGGCACAGGACAGT 
Id2 GCCACAGAGTACTTTGCTATCATTCG ACCCTGAACACGGACATCAGCAT 
Jag1 TGACCAGAACGGCAACAA CTGCAGTCACCTGGAAGTTTA 
LL1 TCCCGGATGGCTGTATTAACGCA GACCGGCTCGGGTGGATC 
LL12 CCATTGTTCTTCGCGTCTTC ATCAATTCTCTCAGATGCTTTGG 
LL33 GGCTGCGAGAAGGGAATTGAACAT GCCTTTCATAAATGCAGCCACGCT 
LL34 GAACCTGCTGCCTCGACTAGAGAT GCCTTTCCTTCACTATATGCTCCG 
LL35 TTTGGCCAAGGGAGAAAGCTCAGA CTTCAGGTAAGTTACAGGCACCGT 
LL66 ATTCACGATCCCAGGTGGACTT CCTATTCGGAGCTCTCTGGTTTCCAT 
NANCI AGGAACGCCTCAATCTGCATCTCA CCATTGACTGAATTGTCCACGGCA 
Nkx2.1 ATGGTACGGCGCCAACCCAGA CATGCCACTCATATTCATGCCGCT 
Nrp1 GCGAAGGAGGATGGAGAG TATGGTCCCGCCACATTT 
Nrp2 GTTTCCTCTTACCTGGGTTT GTGATGTAGCCAGCATCTT 
Nsdhl CCAGTTGGTCCCAATCCTAA ATTCTCCACGAAGGTGAAGTC 
Rarg CAGCACTAAGGGAGCAGAAA GGAGTCGTCCTCAAACATCTC 
Ret CAATGAGACTACTGGCCTTCTC CAGAAAGACCTGGAGGAAGATG 
Sc4mol CAGACTCCTTCACCACAAGAG TCCAAGGGATGTGCGTATTC 
Sox2 TGCACATGGCCCAGCACTA TTCTCCAGTTGCCAGTCCAG 
Sox9 AGACCAGTACCCGCATCTGCACAA TCTCTTCTCGCTCTCGTTCAGCA 
SPC AGCAAAGAGGTCCTGATGGAGAGT CACAACCACGATGAGAAGGCGTTT 
Sqle AGAGCCCGACAGGATAGTT GATGGGCATTGAGACCTTCTAC 
Tgfb1 TAATGGTGGACCGCAACAA CTTCCCGAATGTCTGACGTATT 
Tgfb3 AGGGCAGTCAGAGGAAGAA GATCCTGCCGGAAGTCAATATAA 
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Table 2.3. In situ hybridization primers. 
Gene Forward primer Reverse primer 
LL12 TGCAACGAGGATTTGGAGGCTTCT TTGTGTCACTGGCTATGCACTCCT 
LL34 TGGATGCTGGGAAGGATTTCCTGA TTGAGCAAGCCATGACCTTTCCTG 
LL35 TGCGTGAAAGACTCTGCTGGA TCAGGGCAGGATTCCTCAGTTGTT 
LL66 ATGCATACAACAGGCGGAGGATCT AATAGATGGCTGAAGGCTGGAGCA 
Foxf1 ATGCATACAACAGGCGGAGGATCT AATAGATGGCTGAAGGCTGGAGCA 
LL1 TCCCGGATGGCTGTATTAACGC ACAGGTTAACACACCTCAATTGCT 
NANCI ACAGCAAGAAGATGCGCCTGTGA GCGGCTATTATTTCTTGAGTTCCTTTGGTG 
LL33 GGGATTTCTTTCGACAAGCTG TTGAGAGTCTACACCCTTCCT 
 
Table 2.4. shRNA target sequences. 
Construct Target sequence 
LL34b_shRNA1 CGAAGGGACCAGTGAAGATAA 
LL34b_shRNA2 CTCATCTGCTCCCAGTTAATT 
LL34b_shRNA3 CCCATTGTAGGAAGCTAATTT 
LL34b_shRNA4 GGCAGTGGGTATTCAACTATA 
LL34b_shRNA5 CACTCAGTATCTTCTTCAAAT 
NANCI_shRNA1 CATCAGCTGCAGGACAAATAT 
NANCI_shRNA2 CCAAAGGAACTCAAGAAATAA 
NANCI_shRNA3 CCATATCAACATGGAATTTAT 
NANCI_shRNA4 GCTTGGCTTGTTTGATGTTTA 
NANCI_shRNA5 TGAGAGTCTTCCAAGAGATTT 
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Table 2.5. Full-length transcript primers. 
Primer Designation Sequence 
Restriction 
Enzyme 
NANCI (human)-FT-F CGGGGTACCCGATGTTTAGCATCCCAAAGCTG Kpn I 
NANCI (human)-FT-R AGCTCTGCGGCCGCAAATTCATAAGAACTGCTTTCCT Not I 
NANCI-FT-F CGGGGTACCCGGGAAGCAGTTCTCTCAG Kpn I 
NANCI-FT-R AGCTCTGCGGCCGCTTAACAAGGAATAGAAGTTT Not I 
LL12-FT-F TGACAGAAGCTTTTGTCGGTGAGTGAGTTACAGTCG HindIII 
LL12-FT-R GATGTAGATATCCACTGCCAGAATAAGGAAATAGCTC EcoRV 
LL34-FT-F GATGTAAAGCTTAGCTTAGGGCTTGAGTACGA HindIII 
LL34-FT-R GCTCATGGTACCGCTTGGTTGTCAATGCTTGTT KpnI 
LL35-FT-F TAGGTAGGTACCCTCCCTCCGAGCGCAGGAC KpnI 
LL35-FT-R ATCGTAGATATCCCATGCCCAGCCTATATATTTGT EcoRV 
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Figure 2.1. Identification of the mammalian lung lncRNA transcriptome. 
 
Figure 2.1. Identification of the mammalian lung lncRNA transcriptome. RNA-seq 
was performed on E12.5 and adult lungs to identify 141,614 transcripts generated from 
41,554 loci. (A) These were filtered for size, coding potential, and expression to generate 
a catalog of 363 lncRNAs expressed in the mouse lung. (B) Motif enrichment analysis 
highlights the three most enriched transcription factor DNA binding sites in the 59 
regulatory regions of lung lncRNAs. (C) The majority of lncRNAs in this study have a 
human syntenic transcript, with previously annotated lncRNAs being more likely than 
novel lncRNAs to have a human syntenic transcript. (D) lncRNAs found within 20 kb of 
PCGs are more likely to have a human syntenic transcript than lncRNAs with no PCG 
gene nearby. (E) lncRNAs with PCG genes that were transcription factors are more 
likely to have syntenic human transcripts that those with nontranscription factor PCGs
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Figure 2.2. Conservation plot showing reduced conservation of lung lncRNAs in 
comparison to protein coding genes. 
 
Figure 2.2. Conservation plot showing reduced conservation of lung lncRNAs in 
comparison to protein coding genes. Using analysis as outlined in Siepel et. al. 
(Siepel et al. 2005), a PhastCons conservation score of 0.57 was used as a cutoff for 
conservation across placental mammals. All genes with a PhastCons score higher than 
0.57 score are considered conserved (right of the dashed red line). 
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Figure 2.3. lncRNAs are spatially correlated with transcription factors. 
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Figure 2.3. lncRNAs are spatially correlated with transcription factors. (A) The odds 
of a lncRNA being close to a transcription factor locus are statistically greater in lung 
lncRNAs identified in this study and from the Ensembl mouse and human annotated 
databases than in PCGs in general. (B) Spatial relationships were determined using the 
GenomtriCorr program, which computes relative distances between genomic features, 
which were then plotted and compared with a uniform random distribution (dashed line). 
The distributions above the line show a positive spatial correlation, while those below the 
line show an anti-correlation in spatial position. The distance between lung H3K4me3 
marks and lung PCGs provides a positive control for spatial correlation between two 
genomic regions. (C) Lung lncRNAs identified in this study show a greater spatial 
correlation to transcription factors than other functional classes of PCGs, such as 
signaling or structural proteins. (D) This spatial correlation is also true for all lncRNAs 
annotated in the mouse Ensembl database. (E) Table of correlation coefficients and P-
values from comparisons of the distance distributions for gene groups versus a uniform 
distribution. 
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Figure 2.4. Genomic structure of lncRNAs expressed during lung development 
and homeostasis. 
 
 
Figure 2.4. Genomic structure of lncRNAs expressed during lung development 
and homeostasis. Gene plots for LL18/NANCI (A), LL35 (B), LL66/Fendrr (C), LL1/Ancr 
(D), LL12 (E), and LL34 (F). The gene plots contain RNA-seq data from both E12.5 and 
adult lungs combined with Pol II and H3K4me3 ChIP-seq (chromatin 
immunoprecipitation [ChIP] combined with deep sequencing) data are from ENCODE 
(Rosenbloom et al. 2013). Transcripts were assembled from RNA-seq data using 
Cufflinks (purple) and compared with gene annotations in Ensembl (yellow).
61	  
	  
Figure 2.5. Identification of LL33, a lncRNA associated with Gata6, and its 
expression during lung and cardiac development. 
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Figure 2.5. Identification of LL33, a lncRNA associated with Gata6, and its 
expression during lung and cardiac development. Geneplot for LL33 showing 
multiple start sites that are near or overlap with the 5’ end of the mouse Gata6 gene (A). 
Expression of LL33 and Gata6 during lung development (B). Note lower expression of 
LL33 in the developing lung epithelium (B, arrows), and expression in the vascular 
smooth muscle of the large pulmonary blood vessels for both LL33 and Gata6 (B, 
arrowheads). Expression of LL33 and Gata6 in various embryonic and adult mouse 
tissues using Q-PCR (C). Expression for each gene is relative to expression in the lung 
at that stage. Expression of LL33 (D-H) and Gata6 (I-M) during cardiac development. 
Note high level expression of LL33 and Gata6 in the developing atrio-ventricular canal 
(D and I, arrows) and in the developing atrio-ventricular valve leaflets (F and K, arrows). 
Expression of LL33 is not observed in the myocardium of heart up to E14.5 (E, J, 
arrows) but is observed at E18.5 and adult (G, H, L, M). Scale bars=100µm (B, D, F, I, 
K) and 500µm (E, G, H, J, L, M). 
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Figure 2.6. Expression levels of lncRNAs during lung development and 
homeostasis. 
 
Figure 2.6. Expression levels of lncRNAs during lung development and 
homeostasis. Expression as measured in FPKMs is shown for lncRNAs and their 
associated PCGs at E12.5 and adult lungs: NANCI and Nkx2.1 (A), LL35 and Foxa2 (C), 
and LL66 and Foxf1 (E). Expression as measured in FPKMs is shown for lncRNAs not 
associated with PCGs: LL1, LL12, and LL34 (G). Q-PCR data for lncRNAs and their 
associated PCGs: NANCI and Nkx2.1 (B), LL35 and Foxa2 (D), and LL66 and Foxf1 (F). 
Expression as measured by Q-PCR is shown for lncRNAs not associated with PCGs: 
LL1, LL12, and LL34 (H). All changes in gene expression shown by Q-PCR are 
statistically significant (p<0.05). 
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Figure 2.7. In vitro transcription/translation reactions for lung lncRNAs. 
 
Figure 2.7. In vitro transcription/translation reactions for lung lncRNAs. In vitro 
transcription/translation reactions were performed for LL1, LL12, LL18/NANCI-mouse, 
LL18/NANCI-human, LL34 and LL35 along with the luciferase control plasmid. The 
luciferase positive control generated a predicted 62 kDa protein while none of the 
lncRNA transcripts generated detectable protein products. 
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Figure 2.8. Temporal and spatial expression of lncRNAs located near transcription 
factor loci during lung development. 
 
 
66	  
	  
Figure 2.8. Temporal and spatial expression of lncRNAs located near transcription 
factor loci during lung development. ISH was used to determine the expression 
patterns of NANCI and Nkx2.1 (A), LL35 and Foxa2 (B), and LL66 and Foxf1 (C), during 
lung development. Note the expression of Nkx2.1 and NANCI in the distal lung 
epithelium (A, arrows) and at lower levels in the developing proximal airways (A, 
arrowheads). Note the expression of Foxa2 and LL35 in the distal lung epithelium (B, 
arrows) and at higher levels in the developing proximal airways (B, arrowheads). 
Expression of Foxf1 and LL66 is observed in the mesenchyme surrounding both the 
distal lung epithelium (C, arrows) and proximal airways (C, arrowheads). (Ai) Airways. 
Bars, 100 mm. 
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Figure 2.9. Temporal and Spatial expression of lncRNAs outside of the lung. 
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Figure 2.9. Temporal and Spatial expression of lncRNAs outside of the lung. 
Outside of the lung, NANCI and Nkx2.1 expression is observed in the developing thyroid 
(A and C, arrows) at E14.5 and ventral forebrain (B and D) at E14.5. LL35 and Foxa2 
expression are observed in the developing anterior foregut endoderm and floor plate at 
E10.5 (E and G, arrows and arrowheads, respectively) and the developing liver at E12.5 
(F and H). LL66 and Foxf1 expression is observed in the mesenchyme surrounding the 
posterior gut (I and K, arrows) and surrounding the esophagus and trachea (J and L, 
arrowheads) at E12.5. Q-PCR analysis of NANCI, LL35, and LL66 and their associated 
transcription factors in the indicated tissues at E12.5 (M) and in the adult (N). Expression 
of LL1 by Q-PCR in various tissues at both E12.5 and in the adult (O). Expression of LL1 
is noted in the developing limb epidermis at E15.5 (P, arrow). Expression of LL12 by Q-
PCR in various tissues at both E12.5 and in the adult (Q). Expression of LL12 is noted in 
the developing liver at E12.5 (R). Expression of LL34 by Q-PCR in various tissues at 
both E12.5 and in the adult (S). Expression of LL34 is noted throughout the gut 
endoderm extending from the anterior region of the embryos through the posterior region 
(T-W, arrows). LL34 expression is noted in both the esophagus and trachea at E10.5 (V, 
arrow and arrowhead). All values are relative to lung expression. Ai=airways, Li=liver, 
E=esophagus, T=trachea. Scale bars=100µm (A-E, G, I-L, T-W), 250µm (P, R), and 
500µm (F, H). 
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Figure 2.10. Comparison of human NKX2.1 and NANCI/LL18 expression in the 
lung. 
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Figure 2.10. Comparison of human NKX2.1 and NANCI/LL18 expression in the 
lung. Neonatal (two months old) human lung sections were used in ISH studies with a 
probe against the human NKX2.1 (A) and NANCI (B) transcripts. Human NKX2.1 is 
expressed in both proximal airway epithelium (Ai) and in alveolar epithelium (AV) but 
absent in pulmonary blood vessels (BV). Human NANCI is expressed in an identical 
pattern. Arrows indicate alveolar epithelium expressing both NKX2.1 (A) and NANCI (B). 
NKX2.1 (C) and NANCI (D) also have similar expression patterns in human embryonic 
lungs (18 weeks gestational age). Both genes are expressed in distal airways 
(arrowheads) and large proximal airways (Ai), but not blood vessels (BV) Scale 
bars=100µm. 
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Figure 2.11. Transcription factor binding motifs are conserved in NANCI promoter 
locus. 
 
Figure 2.11. Transcription factor binding motifs are conserved in NANCI promoter 
locus. Computational predicted transcription factor binding sites in the promoter region 
of NANCI. Conserved predicted sites determined using the phastCons score above 0.75 
are highlighted in red. Gata, TTF-1 (Nkx2.1), Forkhead, LEF/TCF, and Smad 
transcription factors were analyzed because of their known role in foregut and lung 
epithelial development. Only Gata, Fox, and Smad binding sites were identified in 
conserved regions between the mouse and human NANCI promoter region. 
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Figure 2.12. Temporal and spatial expression of lung lncRNAs located in relative 
gene deserts. 
 
Figure 2.12. Temporal and spatial expression of lung lncRNAs located in relative 
gene deserts. ISH was used to determine the expression of LL1/ANCR (A), LL12 (B), 
and LL34 (C) during lung development. (A–C) Expression of all three lncRNAs is noted 
in the distal lung epithelium at E12.5 and E14.5 (arrows). At E14.5, expression of 
LL1/ANCR and LL12 is low in proximal airway epithelium of the lung, while LL34 
expression is observed in this region (arrowheads). (A,C) By E16.5, expression of LL1 
and LL34 is significantly decreased in the lung. (B) Only LL12 exhibits notable 
expression at E16.5 and in the adult. (Ai) Airways. Bars, 100mm. 
73	  
	  
Figure 2.13. Testing of shRNAs against NANCI and LL34. 
 
Figure 2.13. Testing of shRNAs against NANCI and LL34. Five different shRNAs 
were tested against NANCI (A) and LL34 (B) in MLE12 cells. These initial screens were 
then use to optimize viral transduction in MLE12 cells for optimized knockdown and 
microarray studies. NANCI-shRNA 1 and LL34-shRNA 2 were used for additional 
experiments (A and B, blue asterisks).  
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Figure 2.14. shRNA-mediated loss-of-function experiments reveal distinct roles for 
NANCI and LL34 in lung epithelial gene. 
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Figure 2.14. shRNA-mediated loss-of-function experiments reveal distinct roles for 
NANCI and LL34 in lung epithelial gene. (A,B) Venn diagram of microarray analysis of 
NANCI and LL34 shRNA knockdowns showing the number of both down-regulated and 
up-regulated genes. (C) Heat map of lung epithelial genes altered by knockdown of 
NANCI. (D) DAVID/GO (gene ontology) analysis shows that genes related to tube, 
respiratory, and lung development (green bars) are top categories altered by NANCI 
knockdown. (E) qPCR shows that Nkx2.1 and several of its targets are decreased by 
knockdown of NANCI expression. (F) qPCR also shows that expression of additional 
genes important for lung development were also down-regulated by knockdown of 
NANCI. (G) Heat map for lung developmental and RA pathway genes altered by 
knockdown of LL34. (H) DAVID/GO analysis shows that genes related to tube 
development (green bar) are a top category altered by LL34 knockdown. Expression of 
RA pathway components (I) and lung developmental genes known as RA targets (J) was 
verified by qPCR. (J) Note that Fgf18 and Jag1 are not RA targets (blue bars). (K) RA 
pathway diagram showing genes affected by decreased LL34 expression in red. All heat 
maps represent genes in the indicated category selected by GO analysis. All changes in 
gene expression shown by qPCR are statistically significant (P < 0.05). 
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Figure 2.15. Knockdown of NANCI in human cell line results in decreased levels of 
NKX2.1. 
 
Figure 2.15. Knockdown of NANCI in human cell line results in decreased levels of 
NKX2.1. Using shRNAs, NANCI was knocked down in the human lung adenocarcinoma 
cell line H441. This resulted in a significant decrease in the expression of NKX2.1 and its 
target AQP5 as seen by Q-PCR. Other NKX2.1 targets, such as SFTPC and SCGB1A1, 
are not expressed in this cell line. All changes in gene expression shown by Q-PCR are 
statistically significant (p<0.05). 
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Figure 2.16. NANCI acts upstream of Nkx2.1 and downstream from Wnt/β-catenin 
to regulate lung gene expression. 
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Figure 2.16. NANCI acts upstream of Nkx2.1 and downstream from Wnt/β-catenin 
to regulate lung gene expression. (A) Ectopic Nkx2.1 expression rescues endogenous 
Nkx2.1 expression but not NANCI expression in the presence of NANCI shRNA 
knockdown. (B) Ectopic Nkx2.1 expression rescues endogenous Sftpc, Abca3, and 
Aqp5 expression in the presence of NANCI shRNA knockdown. (C) Expression of Aqp1 
is partially rescued by exogenous Nkx2.1 expression in the presence of NANCI 
knockdown. (D) Overexpression of NANCI in MLE12 increases Nkx2.1 expression. 
Nkx2.1 (E,F) and NANCI (G,H) expression in control lungs (E,G) or Nkx2.1-/- lungs (F,H) 
at E14.5. Note the loss of Nkx2.1 expression but persistent NANCI expression in  
Nkx2.1-/- lungs. Nkx2.1 (I,J) and NANCI (K,L) expression in the control (I,K) or 
Shhcre:Ctnnb1flox/flox mutant (J,L) anterior foregut at E9.5. (M) Together, these data 
indicate that NANCI acts downstream from Wnt/β-catenin but upstream of Nkx2.1 to 
regulate lung gene expression. (N) ChIP assay for H3K4me3 marks at the Nkx2.1 
promoter, the GAPDH promoter, and an unrelated intergenic region. (O) The level of 
knockdown achieved for NANCI and the level of decreased Nkx2.1 expression using 
scrambled and NANCI-specific shRNAs used in the H3K4me3 ChIP assays. (P) Model 
of how NANCI potentially recruits trithorax/Wdr5 complexes to the Nkx2.1 locus to 
promote Nkx2.1 gene expression. Bars, 100 mm. (*) P < 0.01; (**) P < 0.05. 
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Figure 2.17. Expression of genes not affected by Nkx2.1 rescue in the presence of 
a NANCI shRNA knockdown in MLE12 cells. 
 
Figure 2.17. Expression of genes not affected by Nkx2.1 rescue in the presence of 
a NANCI shRNA knockdown in MLE12 cells. Expression of Nkx2.1 with simultaneous 
knockdown of NANCI in MLE12 cells did not significantly rescue the expression of 
Foxp1, Foxp2, Nrp1, Nrp2, or Cdh1. p>0.05 for all assays. 
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Figure 2.18. RIP assays showing interaction of NANCI with Wdr5/trithorax and 
LL12 with both Wdr5/trithorax and Ezh2/polycomb. 
 
Figure 2.18. RIP assays showing interaction of NANCI with Wdr5/trithorax and 
LL12 with both Wdr5/trithorax and Ezh2/polycomb. RIP assays were performed 
using MLE12 cells and antibodies to Ezh2 (A) or Wdr5 (B). Note enrichment of NANCI in 
Wdr5 immunoprecipitates and enrichment of LL12 in Ezh2 and Wdr5 
immunoprecipitates. Hmbs was used as a negative control mRNA for these experiments. 
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Figure 2.19. In vivo knockdown of NANCI results in defective lung epithelial 
morphogenesis similar to Nkx2.1 haploinsufficiency. 
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Figure 2.19. In vivo knockdown of NANCI results in defective lung epithelial 
morphogenesis similar to Nkx2.1 haploinsufficiency. (A) The shRNA used in the in 
vitro studies was cloned into the miR-34 premiRNA backbone as previously described 
(Wang, 2007 #1008) and expressed in the developing lung epithelium using the human 
SFTPC promoter. (B) H&E staining shows a thickened mesenchyme and narrower 
airways in SFTPC-NANCIshRNA transgenic lungs versus nontransgenic controls. (D) 
Calculation of mesenchymal thickness confirms reduced airway sacculation in SFTPC-
NANCIshRNA transgenic lungs. (C,D) This same mesenchymal thickening and reduced 
airway sacculation was also seen in Nkx2.1+/- lungs. SFTPC-NANCIshRNA transgenic 
lungs and Nkx2.1+/- lungs also exhibit decreased Scgb1a1 expression in the proximal 
airways (E,F, dotted lines) as well as decreased expression and improper organization 
of Sftpc+ cells in the distal airways (G,H, arrowheads). Two different examples from 
different transgenic animals or mutants are shown in E–H to demonstrate consistency of 
phenotype. Bars: B,C top panels, 500 mm; B,C (bottom panels), G,H, 100 mm; E,F, 50 
mm. All changes in gene expression shown by qPCR are statistically significant ([*] P < 
0.05) except for the difference in mesenchymal thickness between SFTPC-NANCIshRNA 
transgenic lungs and Nkx2.1+/- lungs. (n.s.) Nonsignificant. 
 
 
83	  
	  
Figure 2.20. NANCI in vivo knockdown results in decreased expression of Nkx2.1 
and disrupted epithelial architecture. 
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Figure 2.20. NANCI in vivo knockdown results in decreased expression of Nkx2.1 
and disrupted epithelial architecture. Q-PCR was used to assess the average 
knockdown efficiency in SFTPC-NANCIshRNA transgenic lungs at E17.5 and expression of 
Nkx2.1 and its target genes including Nkx2.1, Scgb1a1, Sftpc, Abca3, and Aqp5 which 
are all significantly down-regulated (A). Other genes found to be downregulated upon 
NANCI knockdown in MLE12 cells are also downregulated in SFTPC-NANCIshRNA 
transgenic lungs at E17.5 including Aqp1 and Cdh1 (B). Sox2, Sox9, and Id2 expression 
are not altered (B). IHC reveals disrupted architecture in the distal airways (arrows) of 
NANCI knockdown lungs, which have a similar Cdh1 staining pattern as proximal 
airways (arrowheads) (E). In Nkx2.1+/- lungs many of the same genes as in SFTPC-
NANCIshRNA transgenic lungs are downregulated (C and D). However, Cdh1 expression 
is unaffected (D) but the distal epithelial architecture is disrupted (F).  
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Chapter 3: The NANCI-Nkx2.1 gene duplex buffers Nkx2.1 
expression to maintain lung development and homeostasis  
 
The data presented in this chapter is currently under review at Nature Cell Biology. 
Zheng Cui helped generate the NANCIcreERT2:RFP mouse line. David Tischfield and Isis 
Cendan helped analyze brain samples. Michael P. Morley and Apoorva Babu performed 
bioinformatic analysis. MinMin Lu and Su Zhou performed tissue sectioning and 
histological staining. Yumiao Han performed mass spectrometry analysis of protein 
isolates.  
3.1 Summary 
A subset of long-noncoding RNAs (lncRNAs) are spatially correlated with transcription 
factors (TFs) across the genome, but how these lncRNA-TF gene duplexes regulate 
tissue development and homeostasis is unclear. I have identified a feedback loop within 
the NANCI-Nkx2.1 gene duplex that is essential for buffering Nkx2.1 expression, lung 
epithelial cell identity, and tissue homeostasis. Within this locus, Nkx2.1 directly inhibits 
NANCI, while NANCI acts in cis to promote Nkx2.1 transcription. Although loss of NANCI 
alone does not adversely affect lung development, concurrent heterozygous mutations in 
both NANCI and Nkx2.1 leads to persistent Nkx2.1 deficiency and reprogramming of 
lung epithelial cells to a posterior endoderm fate. This disruption in the NANCI-Nkx2.1 
gene duplex results in a defective perinatal innate immune response, tissue damage, 
and progressive degeneration of the adult lung. These data point to a mechanism where 
lncRNAs act as rheostats within lncRNA-TF gene duplex loci that buffer TF expression, 
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thereby maintaining tissue specific cellular identity during development and postnatal 
homeostasis. 
 
3.2 Introduction 
Long noncoding RNAs, RNA transcripts 200 nucleotides or longer that do not encode a 
functional protein, have been shown to regulate a wide variety of biological processes 
(Wapinski and Chang 2011; Li and Chang 2014; Meller et al. 2015; Li et al. 2016). 
Despite growing evidence that lncRNAs play important roles in regulating gene 
expression, their role in tissue development and homeostasis remains unclear (Li and 
Chang 2014; Feyder and Goff ; Perry and Ulitsky). Recent work from our lab and others 
has identified a class of lncRNA that are spatially located near critical transcription factor 
(TF) genes (Guttman et al. 2009; Ulitsky et al. 2011; Herriges et al. 2014). These TF-
lncRNA duplexes can be further divided into those that reside upstream and embedded 
within the regulatory region of TFs or those that reside downstream and outside of the 
proximal promoter and regulatory elements of the TF gene. This spatial localization is 
conserved across species with mouse and human TF-lncRNA duplexes exhibiting 
common syntenic locations in the genome, which suggests a critical regulatory function 
for regulating gene expression.  
 
In both mice and humans the lncRNA NANCI (Nkx2.1 Associated Noncoding Intergenic 
RNA) is located downstream of the TF Nkx2.1, a major regulator of pulmonary 
development and homeostasis (Herriges et al. 2014). Inactivation of Nkx2.1 during 
development leads to dramatic loss in branching morphogenesis along with defective 
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lung epithelial lineage differentiation (Minoo et al. 1995; Minoo et al. 1997), while 
postnatal loss of Nkx2.1 expression results in defects associated with a loss of lung 
epithelial homeostasis and respiratory failure (Snyder et al. 2013). Despite the 
importance of maintaining Nkx2.1 expression in the lung, little is known about how its 
expression is regulated (Herriges and Morrisey 2014).   
 
Here I show that within the NANCI-Nkx2.1 duplex, NANCI plays an essential role in 
regulating tissue identity by acting as a transcriptional rheostat to buffer Nkx2.1 
expression. During lung development and in adult lung homeostasis, NANCI acts in cis 
to positively regulate Nkx2.1, and in turn, Nkx2.1 directly inhibits NANCI expression. 
Together this generates a negative feedback loop between NANCI and Nkx2.1, which 
buffers against dramatic reductions in Nkx2.1 expression. NANCI expression is also 
controlled through interactions with Hnrnpab and Hnrnpd, which promote turn-over of the 
NANCI transcript to modulate NANCI expression, and in turn Nkx2.1 expression. 
Surprisingly, loss of NANCI expression by itself has a minimal impact on lung 
development and homeostasis. However, concurrent in trans mutations of both NANCI 
and Nkx2.1 disrupt the buffering loop, resulting in persistent Nkx2.1 deficiency. This 
persistent loss of Nkx2.1 expression leads to defects in the perinatal innate immune 
system and progressive lung degeneration due to a loss of lung epithelial cell identity 
and cellular reprogramming to a posterior endoderm fate. Together, these findings 
establish a new paradigm for TF-lncRNA duplexes in which lncRNAs act as rheostats to 
buffer expression of critical TFs to maintain cell fate and normal tissue homeostasis. 
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3.3 Expression of NANCI in a subset of Nkx2.1+ cells during lung, brain, and 
thyroid development 
To fully examine the expression of NANCI in a cell lineage specific fashion as well as the 
consequences of loss of NANCI function, I generated a NANCI reporter line 
(NANCIcreERT2:RFP) that also disrupts expression of NANCI (Fig. 3.1A). The 
NANCIcreERT2:RFP allele contains a polyadenylated cassette encoding a tamoxifen-
inducible cre recombinase (creERT2) linked to a TdTomato red fluorescent protein 
(RFP) that replaces much of exon 1 in the NANCI locus including the splice donor site. 
This allows for the isolation and characterization of NANCI expressing cells including 
tamoxifen inducible lineage tracing. The reporter construct was inserted into a region 
lacking H3K4me1 or DNAse hypersensitivity peaks, suggesting the insertion is not 
directly influencing a genomic enhancer region (Fig. 3.2A) (Consortium 2012). The 
NANCIcreERT2:RFP reporter line exhibits broad expression of RFP throughout the lung 
epithelium, consistent with previous NANCI in situ hybridizations expression patterns 
(Herriges et al. 2014) (Fig. 3.1B). However, in both embryonic and adult lungs I identified 
a subset of Nkx2.1+ cells that expressed little or no RFP (Fig. 3.1C,D white arrow 
heads). In contrast, I were unable to find any RFP+/Nkx2.1- cells suggesting that NANCI 
is not expressed in cells lacking Nkx2.1 expression. 
 
Outside of the lung, NANCI and Nkx2.1 are co-expressed in the forebrain and thyroid 
(Herriges et al. 2014). To characterize NANCI expression in the brain I compared RFP 
and Nkx2.1 expression at E12.5 and E18.5. At E12.5, NANCI was expressed in the 
medial ganglionic eminence (MGE), anterior entopeduncular/preoptic area (PoA), 
hypothalamus, and developing globus pallidus (Fig. 3.2B). This expression pattern 
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overlapped with that of Nkx2.1. At E18.5, NANCI continued to be expressed in most 
Nkx2.1+ cells of the hypothalamus and globus pallidus. In the thyroid NANCI expression 
was restricted to the Nkx2.1+ epithelium (Fig. 3.3A).  As in the lung, NANCI expression 
was more variable than Nkx2.1 expression. 
 
3.4 NANCI preferentially expressed in alveolar type 2 and secretory epithelial cells 
in the mature lung 
To further explore the expression of NANCI and how it relates to cell lineage identity in 
the lung, I used fluorescence-activated cell sorting (FACS) to isolate adult lung epithelial 
cells from NANCIcreERT2:RFP/+ mice based on RFP expression (Fig. 3.4A). This sorting 
generated three populations (RFP-High, RFP-Med, and RFP-Low), which were further 
analyzed by quantitative real time PCR (Q-PCR) to measure RFP, NANCI, and Nkx2.1 
expression (Fig. 3.4B). The expression of NANCI, as well as Nkx2.1, correlated with 
RFP expression from the NANCIcreERT2:RFP/+ line. This suggests that the NANCIcreERT2:RFP/+ 
reporter accurately reflects the variations in NANCI expression, which in turn correlates 
with Nkx2.1 expression.  
 
Gene expression analysis of the RFP-High population reveals that it is composed 
primarily of Sftpc+ alveolar type 2 (AT2) cells and, to a lesser extent, Scgb1a1+ 
secretory cells (Fig. 3.1E). Foxj1+ ciliated cells and Pdpn+ alveolar type 1 (AT1) cells 
are primarily restricted to the RFP-Med and RFP-Low populations. Analysis of these cell 
types by immunohistochemistry (IHC) verifies that AT2 and secretory cells (Fig. 3.1F, 
yellow arrows) express higher levels of RFP than neighboring epithelial cells (white 
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arrowheads). Likewise, ciliated and AT1 cells (Fig. 3.1F and Fig. 3.4E, yellow arrows) 
exhibit lower expression of RFP than neighboring epithelial cells (white arrowheads). 
Although they were not detectable by Q-PCR, neuroendocrine cells also express RFP at 
higher levels than the surrounding epithelial cells (Fig. 3.4E). FACS sorting of epithelial 
cells using an Nkx2.1GFP reporter line likewise reveals three distinct populations of 
Nkx2.1 expressing lung epithelium (Fig. 3.1G, Fig. 3.4C,D). However, unlike NANCI 
expression, Nkx2.1 expression does not clearly separate the five lung epithelial cell 
lineages examined by Q-PCR or IHC (Fig. 3.1H, Fig. 3.4F). These data suggest that 
NANCI expression levels, but not Nkx2.1 expression, can delineate epithelial cell 
lineages in the lung with the highest levels of NANCI expression found in AT2 and 
secretory cells.  
 
3.5 NANCI expression is essential for normal levels of Nkx2.1 expression  
Our previous work suggested that shRNA mediated knockdown of NANCI lead to 
decreased Nkx2.1 expression (Herriges et al. 2014). Therefore, I analyzed expression of 
NANCI and Nkx2.1 in NANCIcreERT2:RFP/creERT2:RFP homozygous mice. At E18.5 
NANCIcreERT2:RFP/creERT2:RFP mice show an almost complete loss of NANCI expression by 
Q-PCR and in situ hybridization (Fig. 3.5A, Fig. 3.6B). This reduced NANCI expression 
resulted in decreased expression of Nkx2.1 and known target genes including Abca3, 
Sftpa, and Sftpc, while genes not directly regulated by Nkx2.1 (Pdpn, Foxj1) were 
unaffected (Fig. 3.6A). In adult mice, loss of NANCI results in a 24% reduction in Nkx2.1 
expression, which did not lead to significant changes in the expression of Nkx2.1 target 
genes. To determine if expression of other genes are significantly effected upon loss of 
NANCI expression, I used RNA-seq to compare gene expression in E18.5 wild-type and 
91	  
	  
NANCIcreERT2:RFP/creERT2:RFP lung epithelial cells. Surprisingly, these data did not reveal 
significant alterations in gene expression upon loss of NANCI expression, suggesting 
that the moderate effect that loss of NANCI has on Nkx2.1 expression does not result in 
a dramatic effect on overall lung epithelial gene expression (Fig. 3.6D).  
 
Despite reduced Nkx2.1 expression, NANCIcreERT2:RFP/creERT2:RFP mutants display no 
discernable morphological defects at E18.5 or 10 weeks of age (Fig. 3.6C). This is 
consistent with the fact that Nkx2.1+/- mice have similarly reduced Nkx2.1 expression 
levels, but no clear morphological defects at these stages. Thus, while NANCI promotes 
Nkx2.1 expression during lung development, loss of NANCI alone does not reduce 
Nkx2.1 expression sufficiently to induce detectable morphological defects.  
 
3.6 NANCI and Nkx2.1 form a negative feedback loop that buffers Nkx2.1 
expression 
To test whether Nkx2.1 regulates NANCI expression, I analyzed NANCI expression in 
Nkx2.1GFP/+ mice, in which the coding region and 3’ UTR of one Nkx2.1 allele are 
replaced by GFP (Longmire et al. 2012). At E18.5 these mice have a 25% increase in 
expression of NANCI, indicating that Nkx2.1 inhibits NANCI expression (Fig. 3.5B). 
Likewise, NANCI expression in Nkx2.1GFP/+ mice increases two- and three-fold at 10 
weeks and 6 months of age, respectively. This increase in NANCI expression with age 
correlates with increased relative Nkx2.1 expression, such that Nkx2.1GFP/+ mice express 
wild-type levels of Nkx2.1 by 6 months. Analysis of NANCI and Nkx2.1 expression in the 
brains of Nkx2.1GFP/+ mice indicates a similar feedback loop exists in the brain (Fig. 
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3.2C). Furthermore, using chromatin immunoprecipitation:Q-PCR (ChIP-PCR), I found 
that Nkx2.1 binds to a predicted Nkx2.1 binding site within the NANCI promoter, 
suggesting that Nkx2.1 directly inhibits NANCI expression (Fig. 3.7A,B). This is 
consistent with the ability of Nkx2.1 to directly repress expression of genes including 
Nrp2 (Nobrega-Pereira et al. 2008). Together, this indicates that NANCI and Nkx2.1 
form a negative feedback loop that can buffer Nkx2.1 expression, especially in situations 
of compromised Nkx2.1 expression such as in Nkx2.1GFP/+ mice.  
 
To further test this buffering feedback loop, I generated mice with concurrent in trans 
mutations of NANCI and Nkx2.1 (NANCIcreERT2:RFP/+:Nkx2.1GFP/+). If NANCI acts in cis, 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice should display a further reduction in Nkx2.1 
expression. Indeed, at E18.5, 10 weeks, and 6 months of age, 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice had a significant reduction in Nkx2.1 expression 
relative to the other genotypes (Fig. 3.5B). At 6 months these mice also have increased 
expression of GFP, which is expressed from the Nkx2.1 locus in cis to the remaining 
intact NANCI locus (Fig. 3.5C). This is consistent with NANCI acting in cis, but not trans, 
to promote expression of the neighboring Nkx2.1 gene (Fig. 3.5D). Thus, NANCI and 
Nkx2.1 act in concert as a buffering system to control the expression of this gene duplex. 
Examination of TF-associated lncRNAs in the mouse and human genome shows that 
there is a unique subset of lncRNAs that are located downstream of TFs in a similar 
duplex formation as NANCI-Nkx2.1 (Fig. 3.5E). These downstream sense lncRNAs may 
act through a different mechanism than divergent lncRNAs, which often overlap the 
regulatory regions of their neighboring coding gene (Guttman et al. 2009; Sauvageau et 
al. 2013; Herriges et al. 2014; Akerman et al. 2016; Anderson et al. 2016). Thus, NANCI 
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is one of many downstream TF-associated lncRNAs and may serve as a paradigm for 
similar lncRNAs, including those located near the critical TF’s Foxa2 and Neurog1 (Fig. 
2.4) (Table 3.1).  
 
3.7 hnRNPab and hnRNPd regulate Nkx2.1 expression through their ability to 
modulate NANCI transcript stability 
To identify proteins that interact with NANCI and regulate its expression and/or function, 
I used mass spectrometry to identify NANCI-protein interactions in a murine lung 
epithelial cell line. 44 proteins were found to be consistently enriched in the NANCI 
pulldown relative to pulldown with a control RNA transcript of similar length (Table 3.2, 
Fig. 3.7C). This included Hnrnpab, Hnrnpd, and Hnrnpa2b1, which were verified by 
Western blots (Fig. 3.7D). Hnrnpab and Hnrnpa2b1 have been shown to mediate the 
function of the lncRNA lincRNA-Cox2 (Carpenter et al. 2013). In contrast, Hnrnpd 
promotes RNA degradation (Brewer 1991; Zhang et al. 1993; White et al. 2016) and 
Hnrnpab, a member of the same subfamily, may serve a similar function (Akindahunsi et 
al. 2005; Czaplinski et al. 2005). To test the ability of these proteins to regulate NANCI 
activity, I used shRNAs to knockdown their expression in MLE12 cells (Fig. 3.7E). 
Knockdown of Hnrnpab and Hnrnpd, but not Hnrnpa2b1, resulted in increased 
expression of NANCI and Nkx2.1 (Fig. 3.5F). Together this suggests that Hnrnpab and 
Hnrnpd regulate NANCI transcript stability and in turn Nkx2.1 expression (Fig. 3.5G).  
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3.8 The NANCI-Nkx2.1 buffering loop is essential for lung epithelial development 
and the perinatal innate immune response 
To determine the effects of disrupting the NANCI-Nkx2.1 buffering loop during 
development, I analyzed pulmonary morphology and gene expression at E18.5 and at 
postnatal day 4 (P4). At E18.5, both Nkx2.1GFP/+ and NANCIcreERT2:RFP/+:Nkx2.1GFP/+ 
mutants have mild morphological defects in the developing alveolar space as indicated 
by extended distal airspaces that lacked much of the alveolar septation found in wild-
type mice (Fig. 3.8A). Moreover, at this time point both Nkx2.1GFP/+ and 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants have reduced expression of markers for several 
lung epithelial cell lineages, indicative of delayed pulmonary development (Fig. 3.8B,C). 
Nkx2.1GFP/+ and NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants exhibit ectopic expression of 
Hnf4a, a transcription factor expressed in hindgut epithelium, consistent with previous 
work suggesting Nkx2.1 represses a posterior endoderm transcription program (Snyder 
et al. 2013). 
 
By P4 Nkx2.1GFP/+ mice express normal levels of many lung epithelial markers, except 
Sftpc, suggesting compensatory mechanisms for maintaining Nkx2.1 expression in the 
perinatal period (Fig 3.8D-F). In contrast, the NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants 
exhibit alveolar simplification and decreased expression of lineage markers for AT2, 
secretory, multi-ciliated, and AT1 cells (Fig. 3.8F). At P4, Hnf4a expression had 
increased dramatically in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants, suggesting increased 
activation of ectopic posterior endoderm transcriptional pathways in these mutants due 
to persistent Nkx2.1 deficiency.  These data suggest that without NANCI in cis, the 
functional Nkx2.1 allele is unable to normalize perinatal Nkx2.1 expression. 
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In addition to alveolar simplification and developmental delay, 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at P4 display a localized severe perinatal 
inflammatory response. This response is exemplified by engorged distal airspaces filled 
with a mixture of proteinaceous debris and immune cells (Fig. 3.9A). Flow analysis 
indicates a dramatic influx of neutrophils in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at P4 
(Fig. 3.9B). These mutants display gaps in the epithelial barrier in both the proximal and 
distal airways (Fig. 3.9C white arrowheads) as well as E-cadherin positive cells in the 
airway lumen (Fig. 3.9C yellow arrows). This suggests a loss of epithelial barrier 
integrity, which likely contributes to the severe inflammatory response.  
 
To better characterize the causes of this perinatal phenotype I used RNA-seq to 
compare gene expression in wild-type, Nkx2.1GFP/+ and NANCIcreERT2:RFP/+:Nkx2.1GFP/+ 
lung epithelium at E18.5, prior to evidence of an immunological response. By gene 
ontology (GO) analysis, NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants displayed altered 
expression of several gene categories including increased mitotic cell division and 
decreased expression of genes involved in regulation of immune response (Fig. 3.9D). 
Combined with the reduced expression of lung epithelial lineage markers, this data 
suggest the lung epithelium in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants is more proliferative 
but immature compared to wild-type controls or Nkx2.1GFP/+ mutants.  
 
In the immune response categories, expression of colony stimulating factor 2 (Csf2) was 
significantly decreased in  mutants. Csf2 is a key regulator of epithelial barrier function 
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and a cytokine that promotes granulocyte and monocyte maturation (Overgaard et al. 
2015; Whitsett and Alenghat 2015). Csf2 deficiency leads to pulmonary alveolar 
proteinosis (PAP), in which the pulmonary airspace is filled with non-cellular debris, 
similar to the phenotype observed in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at P4. Q-
PCR verified that Csf2 is significantly down-regulated in Nkx2.1GFP/+ and 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at E18.5, but only in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ 
mutants at P4 (Fig. 3.9E). Nkx2.1 binds to the Csf2 promoter, suggesting Nkx2.1 directly 
activates Csf2 expression in the maturing pulmonary epithelium (Fig. 3.9G and H).  
 
Despite reduced expression of Csf2, perinatal NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutant 
lungs contain a large population of neutrophils, suggesting up-regulation of other 
cytokines that recruit neutrophils. Using our RNA-seq data as well as Q-PCR, I found 
that the cytokine secreted phosphoprotein 1 (Spp1), also known as osteopontin, was up-
regulated in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at E18.5 (Fig. 3.9F). Spp1 promotes 
recruitment of neutrophils, consistent with the increased neutrophil population in 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutant lungs (Zissler et al. 2016). However, I did not 
observe Nkx2.1 binding to the Spp1 promoter, suggesting that up-regulation of Spp1 is a 
secondary response to the barrier defects in these lungs (Fig. 3.9G and H, Table 3.3). 
This is consistent with previous Nkx2.1 ChIP-seq data showing that Nkx2.1 binds to the 
Csf2 promoter, but not the Spp1 promoter (Snyder et al. 2013). Taken together, these 
data suggest that the perinatal phenotype observed in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ 
mutants results from multiple defects including Csf2 deficiency, elevated Spp1 
expression, and a loss of epithelial barrier integrity.  
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Despite the profound perinatal phenotype seen in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants, 
these animals survive to at least four weeks of age when the lung reaches maturity. 
Unlike the earlier time points, at four weeks of age Nkx2.1 expression is not significantly 
different between Nkx2.1GFP/+ and NANCIcreERT2:RFP/+:Nkx2.1GFP/+  lungs (Fig. 3.10A). This 
increase in Nkx2.1 expression is not accompanied by increased expression in NANCI, 
suggesting a NANCI-independent mechanism is responsible for the normalization of 
Nkx2.1 expression. By four weeks of age, the exogenous immune cells and PAP 
phenotype have also resolved and lung morphology is similar to that of wild-type lungs 
(Fig. 3.10B). Furthermore, expression of pulmonary cell type markers has largely 
normalized to wild-type levels in these mutants (Fig. 3.10C). At this stage Csf2 
expression has increased and Spp1 expression has decreased in 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ lungs, counterbalancing the earlier altered expression of 
these cytokines and correlating with a resolution of the innate immune response 
observed in the perinatal period.  
 
3.9 Disruption in the NANCI-Nkx2.1 gene duplex leads to a failure of pulmonary 
homeostasis and reprogramming of lung epithelium to a posterior endoderm fate 
While NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants were relatively normal at four weeks of age, 
adult 10 week old mutants began to exhibit inflammation of the large airways as well as 
basal and mucousal cell metaplasia (Fig. 3.11A). This phenotype was accompanied by 
Nkx2.1 deficiency, consistent with the known role of Nkx2.1 in inhibiting airway 
inflammation (Maeda et al. 2011). I also observed reduced expression of Scgb1a1, a 
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marker of the airway secretory cell lineage (Fig. 3.11G). In contrast to the perinatal 
period, the inflammatory reaction at 10 weeks was not associated with significant 
alterations in Csf2 or Spp1 expression (Fig. 3.11G). 
 
Alveolar simplification and bronchiolization of the alveoli was observed in 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at 10 weeks (Fig. 3.11A, black arrowheads). 
Bronchiolization of the alveoli is characterized by cells resembling bronchiolar epithelium 
lining normal or thickened alveolar walls (Wang et al. 2009). These bronchiolized distal 
alveoli consist primarily of Sox2+/Scgb1a1+ cells, suggesting they represent airway 
secretory cells (Fig. 3.11B). While I did not observe any Sox2+/Pdpn+ alveolar type 1 
cells or Sox2+/Foxj1+, multi-ciliated epithelial cells, there were rare Sox2+/Sftpc+ and 
Scgb1a1+/Sftpc+ cells (Fig. 3.11C-F). At 10 weeks of age there is also a resurgence of 
ectopic Hnf4a expression in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants (Fig. 3.11G). Pdpn 
and Scgb1a1 expression is decreased in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at 10 
weeks indicating disruption in the NANCI-Nkx2.1 regulatory gene duplex and defects in 
AT1 and secretory cell homeostasis (Fig. 3.11G).  
 
Six month old NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants exhibit further progression of the 
phenotypes observed at earlier stages. RNA-seq analysis of the lung epithelial cells at 
six months of age revealed decreased expression of genes involved in respiratory and 
epithelial development, but increased expression of genes involved in digestion, 
confirming the reprogramming of pulmonary epithelial cells to a posterior endoderm fate 
(Fig. 3.12A and B, Fig. 3.13A). At this time airway inflammation has resolved, but there 
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is a dramatic loss of pulmonary secretory cells and ectopic expansion of goblet 
(Muc5ac+) and basal (Krt5+/Trp63+) cells (Fig. 3.12C, Fig. 3.13B). The bronchiolization 
of the alveolar region has progressed concomitantly with a sharp decrease in expression 
of the AT2 marker Sftpc (Fig. 3.12G and Fig. 3.13A). The bronchiolized alveolar region 
contains epithelium bearing markers of secretory and ciliated cells of the proximal 
airways as well as ectopic Krt5+/Trp63+ cells in the distal airspaces, suggesting either 
loss of alveolar epithelium and extension of airway basal cells into the alveolar space or 
a reprogramming of alveolar epithelium into a basal cell phenotype (Fig. 3.12I,J, Fig. 
3.13B). Importantly, these bronchiolized regions contain Sox9+/Hnf4a+ cells, resembling 
hindgut stem cells (Fig. 3.12G,H). Additional markers of hindgut endoderm including 
Lgr5, Vsig1, Lgals4, and Ctse are also dramatically increased in 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at six months (Fig. 6H). The 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ peripheral  epithelium is highly apoptotic and degenerative 
at this stage (Fig. 3.13C). This correlates with increased expression of immune response 
genes and recruitment of macrophages to clear cellular debris in the airways (Fig. 3.12B, 
Fig 3.13D,E). These molecular and cellular changes result in a dramatic loss of alveolar 
structure in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutants at this time point (Fig. 3.12C).  These 
phenotypes are in contrast to all of the other genotypes examined, including Nkx2.1GFP/+ 
mice, whose gene expression profile and morphology are indistinguishable from those of 
wild-type mice (Fig. 3.12C and Fig. 3.13A-C). At these timepoints the adult brain showed 
no major morphological defects (data not shown). However, the thyroid of both 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ and Nkx2.1GFP/+ mutants exhibit similar morphological 
defects as well as elevated serum TSH levels, consistent with hypothyroidism due to 
Nkx2.1 deficiency (Fig. 3.3B,C) (Kusakabe et al. 2006). 
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Examination of cell proliferation in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mutant lungs at 6 
months reveals that the Scgb1a1+ secretory cells found in the distal bronchiolized 
alveoli are highly proliferative (Fig. 3.13F,H). In contrast, Sftpc+ AT2 cells in these 
mutants do not exhibit an increase in proliferation suggesting that they are not 
responding to the loss of homeostasis by re-activating a pro-growth regenerative 
program (Fig. 3.13G,H). These data indicate that loss of the NANCI-Nkx2.1 rheostat 
function on the gene duplex leads to a cell lineage specific loss of lung epithelial 
homeostasis caused in part by a reprogramming of distal alveolar epithelium towards a 
more posterior endoderm fate. This loss of lung epithelial cell identity also appears to 
reduce the regenerative potential of resident AT2 cells, possibly due to the loss of their 
native cell fate. Taken together, these studies reveal that NANCI acts as an important 
rheostat of Nkx2.1 expression that is necessary for maintaining lung epithelial cell 
identity and function.  
 
3.10 DISCUSSION 
Several reports have shown that lncRNAs regulate protein-coding genes in cis, however, 
few have revealed the in vivo consequences of this regulation (Feyder and Goff 2016; 
Kotzin et al. 2016; Quinn and Chang 2016).  Genetic inactivation of lncRNAs have often 
resulted in no apparent phenotype, leading to the conclusion that many if not most 
lncRNAs have little impact on gene regulation and tissue development or that their loss 
is compensated for by other mechanisms (Eissmann et al. 2012; Zhang et al. 2012; 
Sauvageau et al. 2013; Kohtz 2014). The present study shows that while the loss of the 
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lncRNA NANCI alone does not affect overall lung development or homeostasis in a 
significant manner, NANCI is required to maintain Nkx2.1 expression. Loss of NANCI’s 
rheostat function in situations of compromised Nkx2.1 expression leads to profound 
innate immune defects and a reprogramming of lung epithelium towards a posterior 
endoderm phenotype. The overall effect on adult tissue homeostasis is dramatic and 
provides critical insight into how lncRNAs function as transcriptional rheostats, which are 
essential for buffering neighboring protein-coding genes including master transcription 
factors such as Nkx2.1.   
 
Previous studies have revealed that lncRNAs are more often found near TFs than other 
categories of protein coding genes (Guttman et al. 2009; Ulitsky et al. 2011; Herriges et 
al. 2014).  Interestingly, mutations in TFs underlie many human congenital 
haploinsufficient diseases (Dang et al. 2008). In particular, NKX2.1 haploinsufficiency 
causes a rare but often lethal disorder called Brain-Lung-Thyroid Syndrome (BLTS) 
(Hamvas et al. 2013). Symptoms in BLTS patients include respiratory failure along with 
serious thyroid and neural dysfunction. However, there is a wide variation in the 
phenotypes observed in BLTS patients with many lacking a notable phenotype in any 
one of the tissues that express NKX2.1. In addition to BLTS, alterations in NKX2.1 have 
been associated with different forms of lung cancer (Yang et al. 2012; Yamaguchi et al. 
2013). Given the critical role for TFs such as NKX2.1 in both development and tissue 
homeostasis, exquisite control of their expression levels is essential. This fine control 
likely requires multiple modes of regulation, but the role of TF-associated lncRNAs in this 
system is largely unknown.    
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While lncRNA expression has been shown to be highly tissue specific, characterization 
of in vivo expression patterns has been hampered by the lack of reporters and the 
inability to use standard antibody protein detection techniques (Cabili et al. 2011). I have 
overcome these limitations by using a fluorescent and lineage tracing reporter system to 
characterize in detail the expression of NANCI and compare it at cellular resolution to its 
neighboring transcription factor and gene duplex partner Nkx2.1. I find that NANCI 
expression, while highly similar to Nkx2.1, shows cell lineage specific differences of 
expression in the embryonic and adult lung. The highest levels of NANCI expression are 
restricted to AT2 and secretory lineages suggesting that NANCI plays a preferential role 
in the development and homeostatic maintenance of these epithelial lineages. NANCI 
null mice have reduced expression of Nkx2.1, verifying previous studies indicating the 
NANCI promotes Nkx2.1 expression (Herriges et al. 2014). Surprisingly, Nkx2.1 appears 
to repress NANCI expression through directly binding to the NANCI promoter, similar to 
how Nkx2.1 directly represses expression of Nrp2, suggesting a feedback loop within the 
NANCI-Nkx2.1 gene duplex (Nobrega-Pereira et al. 2008). The net effect of this loop is 
to buffer against drastic changes in Nkx2.1 expression, as illustrated by the 
normalization of Nkx2.1 expression in ageing Nkx2.1GFP/+ mice.  Thus, our studies point 
to a new model for lncRNA regulatory function whereby lncRNAs act as rheostats that 
buffer expression of neighboring TFs. This model suggests that lncRNAs in such 
lncRNA-TF duplexes are not an absolute requirement for expression of neighboring TFs, 
but instead act as fine-tuning rheostats that ensure proper TF expression in response to 
genetic or environmental stress.  
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Utilizing in vivo loss of function models for NANCI and Nkx2.1, I show that loss of NANCI 
expression leads to reduced Nkx2.1 expression, but not major morphological defects. 
This suggests as yet unknown compensatory mechanisms for regulating Nkx2.1 
expression in the absence of NANCI. However, by the end of gestation, both Nkx2.1GFP/+ 
and NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice show signs of pulmonary developmental delay 
(Fig. 3.14). Postnatal Nkx2.1GFP/+ mice up-regulate NANCI in a compensatory fashion, 
which increases Nkx2.1 expression back to wild-type levels and restores normal 
pulmonary maturation. In contrast, concurrent in trans heterozygous loss of both NANCI 
and Nkx2.1 leads to persistent Nkx2.1 deficiency at all stages of life. At P4, this 
deficiency begins to reprogram lung epithelial cell identity causing ectopic expression of 
a hindgut transcriptional program and delay development of pulmonary epithelial cells 
necessary for proper lung homeostasis. The persistent Nkx2.1 deficiency in 
NANCIcreERT2:RFP/+;Nkx2.1GFP/+ aged mutants leads to a severe pulmonary degenerative 
phenotype by six months as the normal alveolar structure is replaced by ectopically 
reprogrammed airway and hindgut-like cells. These reprogrammed lung epithelial cells 
cannot maintain lung alveolar epithelial cell identity and are unlikely to be able to 
efficiently perform gas exchange. This progressive and degenerative phenotype 
indicates that while a complete loss of NANCI can be compensated for in the presence 
of two intact Nkx2.1 alleles, further decrease in Nkx2.1 expression due to deletion of one 
allele, results in a failure to maintain expression of this critical transcription factor. This in 
turn results in a loss of adult lung epithelial cell fate. 
 
There have been several lncRNAs identified near important TFs including Gata6, Foxa2, 
Foxf1, and eHand (Guttman et al. 2009; Sauvageau et al. 2013; Herriges et al. 2014; 
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Anderson et al. 2016). These syntenically conserved lncRNAs are found either upstream 
or downstream of their neighboring TF. However, it has been unclear whether the 
relative localizations or orientations reflect unique functions. The lncRNA Upperhand, 
which is located 150bp upstream and anti-sense to the TF Hand2, has been shown to 
play an almost essential role for expression of the TF Hand2 (Anderson et al. 2016). The 
lncRNA Fendrr similarly shares a divergent promoter region with the TF Foxf1, but like 
NANCI, Fendrr is not absolutely necessary for expression of its neighboring TF 
(Sauvageau et al. 2013). In contrast, NANCI is located downstream and sense to 
Nkx2.1. This orientation is observed in a significant subset of lncRNAs associated with 
crucial TFs like Foxa2 and Neurog1 (Supp. Table. 1) (Herriges et al. 2014). The 
downstream orientation of these lncRNAs away from the upstream regulatory regions of 
neighboring coding genes suggests a different mode of action than those that share 
divergent promoters with the neighboring TF. The NANCI-Nkx2.1 duplex provides a 
novel model for how this subset of lncRNAs function as rheostats to buffer expression of 
neighboring TF genes. This category of lncRNAs, including NANCI, are likely critical for 
maintaining TF expression in response to genetic or environmental stress.  Thus, it will 
be important to assess their function in trans to their neighboring TF using compound 
mutants such as described here. Given the diverse functions identified thus far for 
lncRNAs, it is essential that their functions be assessed fully and carefully in vivo to 
define their contribution to tissue development and homeostasis. Analysis and 
comparison of these lncRNAs will help to reveal the common and unique mechanisms 
necessary for their ability to act as buffering rheostats for TF expression.  
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3.11 Materials & Methods 
Animals 
The Nkx2.1GFP mouse line was a generous gift from Darrell Kotton at BU, and its 
construction has been previously described (Longmire et al. 2012).  The NANCIcreERT2:RFP 
mouse was constructed by inserting an expression cassette consisting of an IRES 
sequence, creERT2 cDNA linked to a 2A self-cleaving peptide sequence linked to a 
TdTomato cDNA, and a polyadenylated stop site into the first splice donor site of NANCI.  
Full details on the construction of this reporter line are available upon request. All animal 
studies were performed under guidance of the University of Pennsylvania Institutional 
Animal Care and Use Committee. 
 
Isolation of Adult Epithelial Cells by FACS 
Adult epithelial cells were collected as previously described (Frank et al. 2016). 
NANCIcreERT2-TdTomato and Nkx2.1GFP/+ adult lungs were harvested and processed into 
single cell suspensions using a dispase (Collaborative Biosciences)/collagenase (Life 
Technologies)/DNase solution.  Epithelial cells were sorted from the single cell 
suspension using either a MoFlo Astrios EQ (Beckman Coulter) or FACSJazz (BD 
Biosciences) flow cytometer with antibody staining for CD31-PECy7 (eBioscience), 
CD45-PECy7 (eBioscience), and EpCAM-APC (eBioscience).  Following negative 
selection for CD31 and CD45, epithelial cells were isolated by positive selection for 
EpCAM then separated based on RFP or GFP expression and sorted into Trizol LS.  
 
106	  
	  
Pulmonary Quantitative Real-Time PCR  
E18.5 and P4 lungs were harvested and processed into single cell suspensions using a 
dispase (Collaborative Biosciences)/collagenase (Life Technologies)/DNase solution.  
Epithelial cells were enriched using an EpCAM antibody (eBioscience, 17-5791-82) and 
Dynabeads (Invitrogen, Sheep anti-Rat IgG) following manufacturer’s instructions. Adult 
lungs (4 weeks, 10 weeks, and 6 months) were harvested and total RNA was isolated 
using Trizol (Invitrogen, Carlsbad, CA) per manufacturer’s protocol. cDNA was 
synthesized from total RNA by using SuperScript Strand Synthesis System (Invitrogen, 
Carlsbad, CA, USA). Quantitative real time PCR was performed using the SYBR green 
system (Applied Biosystems, Foster City, CA, USA) with primers listed in Table 3.4. 
GAPDH expression values were used to control for RNA quality and quantity.  
 
Forebrain Quantitative Real-Time PCR 
For analysis of forebrain transcription, brain regions caudal to the expression of Nkx2.1 
at the junction of the hypothalamus were removed and the remaining forebrains were 
placed in TRIzol reagent (Invitrogen). RNA was extracted using the PureLink RNA Mini 
kit (Invitrogen). cDNA was synthesized using the VILO cDNA synthesis kit (Invitrogen). 
qPCR was conducted using Taqman Gene Expression Assays (Applied Biosystems). 
Each sample was run in triplicate on the same plate, on a Stratagene MX3005P real-
time PCR machine (La Jolla, CA) following the manufacturer’s recommended protocol. 
 
RNA-seq analysis 
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E18.5 lung epithelial cells from wild-type, NANCIcreERT2:RFP/creERT2:RFP, Nkx2.1GFP/+, and 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ lungs (3 samples per genotype) collected as described for 
Q-PCR and RNA was isolated using Trizol. The University of Pennsylvania Next-
Generation Sequencing Core performed library preparation and RNA-seq for these 
samples. 6 month epithelial cells were sorted into Trizol as described for FACS, however 
epithelial cells were not sorted into distinct populations based on RFP or GFP 
expression. Samples were collected from 3 wild-type, 3 Nkx2.1GFP/+, and 4 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ lungs. Library preparation and sequencing for these 
samples was performed at GENEWIZ, LLC.  
 
Fastq files were assessed for quality control using the FastQC program. Fastq files were 
aligned against the mouse refence genome (mm9) using the STAR aligner (Dobin et al. 
2013). Duplicate reads were flag using the MarkDuplicates program from Picard tools. 
Per gene read counts for Ensembl (v67) gene annotations were computed using the 
Rsubread R package with duplicate reads removed. Gene counts represented as counts 
per million (CPM) were first nominalized using TMM method in the edgeR R package 
and genes with 25% of samples with a CPM > 1 were removed and deemed low 
expressed. The data was transformed using the VOOM function from the limma R 
package (Law et al. 2014). Differential gene expression was performed using a linear 
models with the limma package. Heatmaps and PCA plots were generated in R. Gene 
Ontology enrichment analysis for the Biological Process was performed using R 
package GAGE. The Gene Expression Omnibus accession number for the RNA-seq 
data is GSE92304.  
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TF-lncRNA duplex identification 
Gene annotation and position information was obtained from the GENCODE project for 
human (v25) and mouse (v12) (Harrow et al. 2012).Genes annotated with 
transcript_type of “lincRNA” and “bidirectional_promoter_lncRNA” were used to define 
lncRNAs.  The distance between each protein coding gene to the closet non-overlapping 
lncRNA was computed using the closest function in the Bedtools suite. Protein coding 
genes were annotated and filtered as transcription factors using the AnimalTFDB 2.0 
database (Zhang et al. 2015)  
 
Flow cytometric analysis of immune populations  
Flow cytometry was used to identify immune cells in P4 lungs. P4 lungs were harvested 
and processed into a single cell suspension as described for FACS. Cells were stained 
Aqua Live/Dead viability stain to exclude dead cells. Cells were then stained with one of 
two standard panels of antibodies listed in Table 3.5. After staining for 30 minutes on ice, 
cells were washed in PBS and run for data acquisition with a BD LSR11 Cytometer 
utilizing the FACS Diva Software (BD Bioscience). Data was analyzed using FlowJo. For 
identification of neutrophils and Ly6c+ monocytes I used the following strategy. After 
exclusion of dead cells all other cells expressing the common leukocyte marker CD45 
were identified. Cd11b+ myeloid cells were then divided into ly6gHigh neutrophils and 
Ly6c+ monocytes. For identification of B-cells (B220+) and CD4+ T-cells I used the 
following strategy. After exclusion of dead cells all other cells expressing the common 
leukocyte marker CD45 were identified and lymphocytes were selected using their side 
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scatter and forward scatter profiles. For identification of CD4+ T-cells I gated the 
population CD4+ cells. B-cells were identified as those cells that were CD4-/CD8- as well 
as B220+. 
 
TSH test 
Serum was collected from 10 week old mice and analyzed for TSH levels by ELISA 
following manufacturer’s instructions (Thyroid Stimulating Hormone Kit, Cloud-Clone 
Corp., ABIN415519) 
 
ChIP:PCR 
ChIP:PCR was performed as previously described (Snyder et al. 2013). Adult lung 
epithelial cells were isolated from a single cell suspension using an EpCAM antibody 
(eBioscience, 17-5791-82) in conjunction with anti-APC microbeads (Miltenyi Biotec, 
130-090-855) and LS columns (Miltenyi Biotec, 130-042-401). These cells were 
sonicated using a Bioruptor for 8 minutes (30 seconds ON, 30 seconds off) and Nkx2.1-
bound DNA was purified using an Nkx2.1 antibody (Millipore, 07-601) and the MAGnify 
ChIP kit following manufacturer’s instructions. Q-PCR was performed on the isolated 
samples using primers listed on Table 3.4 and normalize to samples isolated using a 
Rabbit IgG antibody. The mouse genome (mm9, human hg19) was scanned for the 
occurrence of Nkx2-1 motifs using the FIMO program from the MEME suite (Grant et al. 
2011). 
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Sample Preparation for Mass Spectrometry 
The MLE12 cell line was obtained from ATCC (Manassas, VA) and cultured in the 
HITES medium (Ham’s F12 (Mediatech, Manassas, VA), insulin 0.005mg/mL, transferrin 
0.01 mg/mL, transferrin 0.01 mg/mL, sodium selenite 30 nM, hydrocortisone 10 nM, 
beta-estradiol 10 nM, HEPES 10 mM, and L-glutamine 2 mM) + 2% FBS + 1% 
penicillin/streptomycin. One week before collection half of the MLE12 cells were 
switched to SILAC media containing labeled Lysine and Arginine. RNA-pulldown assay 
was performed as previously described (Tsai et al. 2010). Proteins were pulled down 
using either biotinylated NANCI or biotinylated IRES-GFP-Puro mRNA, a processed 
transcript of similar length to NANCI.  In each of three experiments, one transcript was 
used to pull down proteins from SILAC-labeled nuclear extract and the alternate 
transcript was used to pull down proteins from unlabeled nuclear extract. To avoid 
protein enrichment due to the SILAC labeling, I alternated which transcript was used to 
pull down from the SILAC labeled nuclear extract. The eluted samples were run in a 
12% Bis-Tris gel (Life Technologies) and proteins resolved were visualized by Silver 
staining. The entire lanes were then excised, diced into 1mm3 pieces taking precautions 
against keratin contamination and were alternatively washed in water followed by 
100mM NaHCO3 and dehydration in acetonitrile. The samples were reduced using 5mM 
dithiothreitol (Sigma) at 55°C and alkylated by 14mM iodoacetamide (Sigma) at room 
temperature in the dark. This was followed by in-gel digestion using 1:100 ratio of 
sequencing grade modified trypsin (Promega, Madison, WI) to protein ratio overnight at 
37°C. These peptides were extracted in the solution outside the gel pieces. These were 
subsequently de-salted using C18 reversed phase cartridges (Sep-Pak, Waters) and 
dried to remove organic solvents.  The dried peptides were resuspended in 0.1 % acetic 
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acid for LC-MS/MS analysis and loaded onto an Easy-nLC system (Thermo Fisher 
Scientific, San Jose, CA, USA), coupled online with an Orbitrap Elite mass spectrometer 
(Thermo Scientific). Paired SILAC-labeled and unlabeled samples were combined 
loaded on a pulled-tip fused silica column with a 100 µm inner diameter packed in-house 
with 12 cm of 3µm C18 resin (Reprosil-Pur C18-AQ using solvents, 0.1% formic acid in 
water (solvent A) and 0.1% formic acid in acetonitrile (solvent B). A gradient of 95 
minutes was set for peptide elution from 2-35% buffer B. The mass spectrometer were 
operated in positive ion mode and in the data dependent mode with dynamic exclusion 
enabled (repeat count: 1, exclusion duration: 0.5 min). Full MS scan (m/z 350 to 1650) 
was collected at a resolution of 60,000 at an AGC target value of 1x106. MS2 scans of 
the most intense peptide ions was performed using CAD (normalized collision energy = 
35%, isolation width = 2 m/z) at an AGC target value of 1x104 or HCD (normalized 
collision energy = 36%, isolation width = 2 m/z, resolution = 15,000) at an AGC target 
value of 5x104 . Ions with a charge state of one and a rejection list of common 
contaminant ions (exclusion width = 10 ppm) were excluded from the analysis. 
 
Proteomics data analysis  
MS data were analyzed using Proteome Discoverer 1.4 (Thermo Scientific) for protein 
identification/quantification. Mouse UniProt database was used for Mascot searches for 
assigning peptide sequences and identification of proteins. The search was performed 
for precursor ion mass tolerance of 10 ppm, fragment ion mass tolerance of 0.6 Da, 
trypsin digestion and two missed cleavages. Dynamic modifications set were 
carbamidomethylation of cysteine, and oxidation of methionine. Common contaminants 
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such as keratin and trypsin were eliminated and only peptides with an FDR<1% were 
considered. 
 
Western blot 
The mass spectrometry results were verified by western blot analysis of proteins isolated 
using NANCI, NANCI anti-sense, and IRES-GFP-Puro transcripts. Antibodies were used 
to test the enrichment of Hnrnpab (rabbit, Sigma Aldrich, 1:100), Hnrnpa2b1 (mouse, 
Santa-Cruz, 1:200), and Hnrnpd (rabbit, Millipore, 1:1000).  
 
In Vitro Lentiviral shRNA Knockdown 
Lentiviral work was performed as previously described (Herriges et al. 2014) with the 
exception that shRNA oligos (Table 3.6) were annealed into the pLKO.1-Neo vector 
generously provided by the Winslow Lab. MLE12 cells cultured for 6 days in media 
containing 50 ug/ml Geneticin, to select for infected cells, before collecting and isolating 
total RNA.  
 
Pulmonary and thyroid histology 
Postnatal lungs were inflated with 2% paraformaldehyde under constant pressure of 
25cm (P4) or 30 cm (4 weeks, 10 weeks, or 6 months) water and allowed to fix 
overnight.  E18.5 lungs and dissected thyroids were fixed overnight in 2% 
paraformaldehyde. Tissue was embedded in paraffin and sectioned. Hematoxylin and 
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eosin staining was performed to examine tissue morphology. In situ hybridization was 
performed as previously described (Herriges et al, 2014). Immunohistochemistry was 
used to detect protein expression using the following antibodies on paraffin sections: 
Cleaved Caspase 3(rabbit, Biocare, 1:25), E-Cadherin (rabbit, Cell Signaling, 1:100), 
F4/80 (rat, Biolegend, 1:50), GFP (goat, Abcam, 1:100), Hnf4a (goat, SantaCruz, 1:40), 
Ki67 (rabbit, Abcam, 1:50), Krt5 (rabbit, Covance, 1:1500), Muc5ac (mouse, Abcam, 
1:100), Nkx2.1 (rabbit, Santa Cruz, 1:50), Pgp9.5 (mouse, RDI, 1:100), Pdpn (mouse, 
Hybridoma Bank, 1:50), P63 (mouse, Santa Cruz, 1:50), RFP (rabbit, Rockland, 1:250), 
Scgb1a1 (goat, Santa Cruz, 1:20), Sftpc (goat, Santa Cruz, 1:50), and Sox9 (rabbit, 
Santa Cruz, 1:100).  
 
Forebrain Histology 
Embryonic mice were dissected on ice-cold PBS and fixed overnight at 4 ̊C in RNase-
free 4% PFA in 1x PBS. Embryos were then washed two times in 1x PBS and 
cryoprotected by immersion through sucrose (15 and 30% sucrose in 1x PBS; solutions 
were changed once embryos had sunk). Afterwards they were embedded in freezing 
compound and sectioned coronally at 12 um on a cryostat (Leica) and collected onto 
slides (Superfrost slides; Fisher Scientific, Fair Lawn, NJ). After allowing the sections to 
dry for 30 minutes, brain sections were pre-incubated for one hour in blocking buffer (5% 
bovine serum albumin with 0.1% Triton-X-100). Sections were then incubated overnight 
at 4 ̊C with the following primary antibodies: mouse Nkx2.1 (mouse, Abcam, 1:200), RFP 
(rabbit, Rockland, 1:1000). 
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Statistical Analysis 
Statistical analysis was performed on the data using Prism 7.  Two-tailed student t-test 
was used for comparison of two experimental groups. Statistical data was considered 
significant if P < 0.05. 
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Table 3.1. Mouse downstream sense TF-associated lncRNAs. 
lncRNA Ensemblid 
Associated 
TF Name 
Distance 
between 
genes 
(bp) 
 
lncRNA Ensemblid 
Associated 
TF Name 
Distance 
between 
genes 
(bp) 
ENSMUSG00000006462 Cebpb 760 
 
ENSMUSG00000097483 Zfp640 151247 
ENSMUSG000000503342 Mef2c 54302 
 
ENSMUSG00000097633 Zfp219 17249 
ENSMUSG00000051008 Srebf1 83860 
 
ENSMUSG00000097712 Smad7 118711 
ENSMUSG00000055972 Bach1 50730 
 
ENSMUSG00000097879 Zfp931 38960 
ENSMUSG00000056771 Tead4 23666 
 
ENSMUSG00000098053 Pdx1 4873 
ENSMUSG00000072982 Zfp354a 12289 
 
ENSMUSG00000098659 Hnf4g 1139507 
ENSMUSG00000079603 Gata3 259236 
 
ENSMUSG00000099957 En1 13749 
ENSMUSG00000085427 Sp3 122711 
 
ENSMUSG00000100119 Emx2 27780 
ENSMUSG00000085525 Zfp600 53075 
 
ENSMUSG00000100198 Myrfl 47369 
ENSMUSG00000085545 Lhx3 8535 
 
ENSMUSG00000100253 Hes6 5455 
ENSMUSG00000085743 Meis1 7663 
 
ENSMUSG00000100341 Zic4 15127 
ENSMUSG00000085950 Lhx2 54270 
 
ENSMUSG00000100354 Ikzf2 37427 
ENSMUSG00000086130 Zfp534 2649 
 
ENSMUSG00000100430 Tshz1 903768 
ENSMUSG00000086141 Foxa2 2675 
 
ENSMUSG00000100538 Tfap2b 4150 
ENSMUSG00000086519 Ttf1 1011 
 
ENSMUSG00000102052 Pax3 128892 
ENSMUSG00000086887 Sox5 177138 
 
ENSMUSG00000102408 Tbx19 45928 
ENSMUSG00000086975 Bcl11b 126363 
 
ENSMUSG00000102777 Batf3 23713 
ENSMUSG00000087220 Foxq1 3774 
 
ENSMUSG00000103043 Zbtb18 16615 
ENSMUSG00000087513 Zfp980 58489 
 
ENSMUSG00000103108 Nrf1 19436 
ENSMUSG00000087648 Adnp 26474 
 
ENSMUSG00000103283 Zfp729a 2446 
ENSMUSG00000092576 Obox6 7427 
 
ENSMUSG00000103413 Pbx3 60014 
ENSMUSG00000093594 Zfp933 13147 
 
ENSMUSG00000104529 Rbak 6436 
ENSMUSG00000093771 Nfxl1 16198 
 
ENSMUSG00000104861 Foxg1 2792 
ENSMUSG00000094002 Sox11 173632 
 
ENSMUSG00000108113 Zim1 8902 
ENSMUSG00000095369 Litaf 44479 
 
ENSMUSG00000108434 Zfp536 151036 
ENSMUSG00000096941 Twist2 141024 
 
ENSMUSG00000108621 Zfp619 3983 
ENSMUSG00000096975 Zfp945 28957 
 
ENSMUSG00000109091 Arnt2 13360 
ENSMUSG00000097039 Myc 47613 
 
ENSMUSG00000109364 Nr2f2 4249 
ENSMUSG00000097065 Zfp217 37973 
 
ENSMUSG00000109459 Zxdb 1213 
ENSMUSG00000097087 Irf8 123513 
 
ENSMUSG00000109957 Zfpm1 1921 
ENSMUSG00000097122 Rex2 75485 
 
ENSMUSG00000110304 Irx3 4278 
ENSMUSG00000097246 Relb 3924 
 
ENSMUSG00000110821 Hmg20a 42970 
ENSMUSG00000097266 Fosb 1927 
 
ENSMUSG00000110834 
2010315B0
3Rik 9666 
ENSMUSG00000097361 Neurog1 6566 
 
ENSMUSG00000110929 Sox14 15794 
ENSMUSG00000097393 Zfhx3 113593 
 
ENSMUSG00000111058 Smad6 15956 
ENSMUSG00000097454 Elk4 4194 
 
ENSMUSG00000111078 Prdm1 12854 
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Table 3.2. Proteins enriched in NANCI pulldown. 
 
Average of biological triplicates 
Protein 
Enrichment 
(NANCI/Control) Coverage (%) 
Unique 
Peptides 
StdDev of 
Enrichment 
Hnrnpa2b1 26.79590627 44.85666667 14.33333333 26.15743563 
Hnrnpa1 19.66187671 35.12 11.33333333 18.10851525 
Hnrnpa3 18.29597726 34.12333333 11.33333333 16.77301708 
Hnrnpd 12.29665657 17.98666667 5 8.110516941 
Cpsf2 11.73224101 5.843333333 4 15.29694165 
Fip1l1 10.4803819 13.31 4.666666667 7.507309066 
Hnrnpab 10.28538272 23.27666667 5.333333333 3.215671606 
Hnrnpa0 8.534377206 13.00666667 3 6.808525976 
Syncrip 7.441130536 22.31 11.33333333 1.988431812 
Hnrnpr 7.278811766 20.67666667 11.33333333 1.132265442 
Safb 6.80829836 6.19 6 0.435017981 
Skiv2l2 6.506552632 12.66 10.66666667 1.275821663 
Khdrbs1 6.377945304 8.203333333 3 5.905848634 
Myef2 5.454586745 6.68 3 4.649694068 
Wdr33 5.01726592 4.26 5 3.783690894 
Hnrnpm 3.654257552 22.08333333 13 1.682202127 
Dhx9 3.132474129 22.37333333 26.66666667 2.563036343 
Sf3a1 2.790971634 9.693333333 5.666666667 0.793932017 
Ddx27 2.769434557 2.72 1.666666667 1.79441774 
Ilf2 2.726481146 30 7.666666667 1.116342463 
Snrnp70 2.539140985 16.44333333 7 1.487063115 
Ilf3 2.302177706 22.42666667 17 1.313848777 
Vim 2.188881356 21.03 9 0.903050916 
Rpl10 2.02161603 19.31333333 3 0.517912843 
2500003M10Rik 2.003926274 23.21333333 4 0.468569706 
Pabpc1 1.95745962 8.28 5.333333333 0.222961394 
Gtpbp4 1.83163258 5.996666667 3.333333333 0.092200964 
Rpn1 1.790122807 2.026666667 1 0.730691352 
Rpl9 1.744151805 15.45 2 0.364928653 
Thoc4 1.74394875 37.38333333 6.333333333 0.542127773 
Rps11 1.658140994 17.67333333 4.333333333 0.195296788 
Nxf1 1.649534346 8.626666667 4.666666667 0.307953135 
Rpl11 1.580751905 12.92 2 0.159977791 
Rpl17 1.545133206 23.19 3.666666667 0.19199112 
Snrpb2 1.52733136 4.89 1 0.224194632 
Myh9 1.497093944 24.45333333 40.66666667 0.147991043 
Myl6 1.494592826 33.99333333 4.666666667 0.213168101 
Rpl23 1.493539705 28.80666667 3 0.345062806 
U2af1 1.44147518 5.44 1 0.027339661 
Rps4x 1.440583496 40.81 11.33333333 0.111729725 
Rps9 1.402494194 36.08666667 9.666666667 0.134070349 
U2af2 1.39301865 14.73666667 4 0.117876146 
Tpm1 1.373993681 12.92666667 3 0.050243088 
Acta1 1.282793569 28.38333333 9.666666667 0.042876571 
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Table 3.3. ChIP Q-PCR primers. 
Primer 
set Forward primer Reverse primer Target site (mm9) 
Result shown 
in figures 
Enrichment 
over IgG 
Hnf4a-1 
TGTCCACCTTGGT
GAGACTTGG 
TTGGTTTCTGAC
TGACACCTGGG 
chr2:163,372,594-
163,372,759  Yes No 
NANCI-1 
CCGCTTTGGGATG
CTAAACA 
CCGTGTAAACA
CGAGGACTTTC  
chr12:57,630,468-
57,630,574 Yes Yes 
Sftpb-1 
TCAAGAGCCAGGA
AGGAAGCT 
CCCAGGCTTCT
CAATCCTCTACT 
chr6:72,254,238-
72,254,300 Yes Yes 
Csf2-1 
GAACTACCTGAGTT
GTGGAATCT 
CCAGTTCTTGG
AAGGGCTTAT 
chr11:54,063,228-
54,063,344 Yes Yes 
Csf2-2 
GCCTTTGGGCAAG
CTCTA 
GAAGGTGGCTG
GAAAGAGAA 
chr11:54,063,535-
54,063,611 No No 
Csf2-3 
CTCAGGACCTTAG
CCTTTCTC 
GGAGTTCTGTG
GTCACCATTA 
chr11:54,063,117-
54,063,215  No No 
Csf2-4 
GGGCCTCCAGGCA
TATT 
AGGTGCTATGG
AAGCAAGAG 
chr11:54,063,431-
54,063,521 No No 
Spp1-1 
GATGCTCTTCCGG
GATTCTAAA 
AGGAAACACAC
ACAAAGCATTAC 
chr5:104,863,890-
104,863,981 No No 
Spp1-2 
ATGCTTTGTGTGTG
TTTCCTTT 
GGAGTGATGTG
TCATGAGGTT 
chr5:104,863,959-
104,864,076 No No 
Spp1-3 
GACTGTCTGGACC
AGCATTTA 
GCAAACCCAAG
CAAGGATG 
chr5:104,864,093-
104,864,175 No No 
Spp1-4 
GATGAGAGGTGGA
GAGGTAGAA 
ATCACCACCAA
GTCACCAATAA 
chr5:104,865,224-
104,865,326 Yes No 
Spp1-5 
CTCATGGTAGTTC
GTTGCTTTAAT 
GTCTGGAGTCT
CAGAGCTTATG  
chr5:104,865,069-
104,865,174 No No 
Spp1-6 
GATGCTCTTCCGG
GATTCTAAA 
AGGAAACACAC
ACAAAGCATTAC 
chr5:104,863,890-
104,863,981 No No 
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Table 3.4. Q-PCR primers. 
Q-PCR primers (Pulmonary) 
Gene Name Forward Primer Reverse Primer 
Abca3 TTCATCACCTGATGGCGGTGAAC ACGCATGATGGCTTTGTCTACAGC 
Anxa8 GGGTCTGGGTTGAAATGAGA ATCTCCCTGGGAAAAGCAG 
Csf2 CCGTAGACCCTGCTCGAATA TGCCTGTCACATTGAATGAA 
Ctse GCTGACTTTCGGAGGCTATG GAGAGAGGTCCCTGTGTCCA 
Foxj1 AGTGGATCACGGACAACTTCTGCT TTCTCCCGAGGCACTTTGATGAAG 
Gapdh TGCACCACCAACTGCTTAGC GGCATGGACTGTGGTCATGAG 
GFP AAGCTGACCCTGAAGTTCATCTGC CTTGTAGTTGCCGTCGTCCTTGAA 
Hnf4a GCTGTCCTCGTAGCTTGACC TTAAGAAGTGCTTCCGGGCT 
Hnrnpa2b1 TTTCAAAGCTTAAGCCACCA GTCTTTCTCATCTCGCTCGG  
Hnrnpab CGAGCGGGAACCAGAAC AGAGAATAAACCCAAACCCTCTT  
Hnrnpd TCCTATCACAGGGCGATCAA AGGATCAATGACTTTCCCATTCA  
Krt5 GACCCTCAACAACAAGTTTGCCTCCT ACTTGGTGTCCAGGACCTTGTTCT 
Lgals4 GGAGGGTTGTACCCAGGACT CAGTCCATCAACTTCCTCGG 
Lgr5 TGTGTCAAAGCATTTCCAGC CAGCGTCTTCACCTCCTACC 
Muc5ac AGCTTGATGGCCTAGTTGTT TTCAGGTAGCCATTGCTGAG 
NANCI CCTCAATCTGCATCTCAACCT TGGGACTACCGCCATATCT 
Nkx2.1 CGCCTTACCAGGACACCAT GCCCATGAAGCGGGAGA 
Pdpn AGGTACAGGAGACGGCATGGT CCAGAGGTGCCTTGCCAGTA 
P63 ATGTGTCCTTCCAGCAGTCAAGCA CTTGATCTGGATGGGGCATGTCTTC 
RFP CACTACCTGGTGGAGTTCAAG GATGGTGTAGTCCTCGTTGTG 
Safb GCTGAAGAAGCGGAACCT TCCCACCTTCATCTTCAATGG 
Scgb1a1 ATACCCTCCCACAAGAGACCAGGATA ACACAGGGCAGTGACAAGGCTTTA 
Sftpa ACTCCCATTGTTTGCAGAATC AAGGGAGAGCCTGGAGAAAG 
Sftpb GAACTGTGTAGCGCTCAGCC CTCTGATCAAGCGGGTTCAA 
Sftpc AGCAAAGAGGTCCTGATGGAGAGT CACAACCACGATGAGAAGGCGTTT 
Sox9 AGACCAGTACCCGCATCTGCACAA	   TCTCTTCTCGCTCTCGTTCAGCA	  
Spp1 TGGCTATAGGATCTGGGTGC ATTTGCTTTTGCCTGTTTGG 
Vsig1 GCCAGCAGACAGTGGAATTTA AAAGGGCTTGGAAGGTTTGA 
Q-PCR Taqman primers (Forebrain) 
Nkx2.1  Mm00447558 
NANCI CCTCAATCTGCATCTCAACCT TGGGACTACCGCCATATCT 
GAPDH Mm99999915_gl 
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Table 3.5. Flow cytometry antibodies. 
Antigen	   Dilution	   Company	   Catalog/Clone	  Number	  
Ly6c	   1:150	   BioLegend	   HK1.4	  
Ly6g	   1:100	  
BD	  
Pharmingen	   1A8	  
CD45	   1:100	   BioLegend	   30-­‐F11	  
CD8	   1:200	   eBioscience	   53-­‐6.7	  
B220	   1:200	   eBioscience	   RA3-­‐6B2	  
CD44	   1:400	   BioLegend	   IM7	  
CD11b	   1:200	  
BD	  
Pharmingen	   M1/70	  
NK1.1	   1:200	   BioLegend	   PK136	  
CD11c	   1:150	   eBioscience	   N418	  
CD4	   1:200	   BioLegend	   RM4-­‐4	  
CD3	   1:300	   BioLegend	   145-­‐2C11	  
 
Table 3.6. shRNA target sequences. 
Gene Target sequence 
Hnrnpab GGTTGTTGACTGTACAATAAA 
Hnrnpa2b1 GCTGTTTGTTGGTGGAATTAA 
Hnrnpd AGCTACAAACCATACTAAATT 
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Figure 3.1. NANCI is expressed in a subset of Nkx2.1+ pulmonary epithelial 
cells.
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Figure 3.1. NANCI is expressed in a subset of Nkx2.1+ pulmonary epithelial cells. 
(A) Schematic of NANCIcreERT2:RFP allele. (B) Comparison of NANCI-RFP and Nkx2.1 
expression during development. (C) Expression of NANCI-RFP and Nkx2.1 at E18.5 
showing that some Nkx2.1+ cells do not express NANCI as noted by arrowheads. (D) 
Expression of NANCI-RFP and Nkx2.1 in the adult lung showing that some Nkx2.1+ 
cells do not express NANCI as noted by arrowheads. (E) AT2 (Sftpc+) and secretory 
(Scgb1a1+) cells are enriched in the FACS isolated RFP-High adult pulmonary epithelial 
cells, while ciliated (Foxj1+) and AT1 (Pdpn+) cells are restricted in the RFP-Med and 
RFP-Low population. (F) The FACS data are confirmed by IHC using the cell lineage 
specific markers Sftpc (AT2), Scgb1a1 (Secretory), and Foxj1 (ciliated) with 
representative lineage marker positive (yellow arrow) and lineage marker negative (white 
arrowhead) cells displaying different levels of NANCI-RFP. (G) In contrast if cells are 
sorted by Nkx2.1-GFP, all four cell types are detectable in the GFP-High population. (H) 
These results are confirmed by IHC comparing representative lineage marker positive 
(yellow arrow) and lineage marker negative (white arrowhead), which have similar levels 
of Nkx2.1. Scale bars=100 µm (B) 25µm (C,D,F,H). For E and G mean ± s.e.m. were 
derived from n=6 and n=3 biological replicates respectively (* p<0.05, ** p<0.01, *** 
p<0.001, **** p<0.0001, n.s. p>0.05; two-tailed Student’s t-test). 
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Figure 3.2. NANCI and Nkx2.1 expression in the mouse brain.  
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Figure 3.2. NANCI and Nkx2.1 expression in the mouse brain. (A) Diagram of NANCI 
construct insertion site showing that this region is not enriched in the enhancer mark 
H3K4me1 nor DNase hypersensitivity marks. (B) NANCI-RFP and Nkx2.1 have highly 
similar expression patterns at E12.5 and E18.5. (C) Analysis of NANCI and Nkx2.1 
expression in NANCI and Nkx2.1 mutant brains suggests that NANCI and Nkx2.1 form a 
buffering loop, similar to their function in the lung epithelium. Cx = Cortex, MGE = Medial 
ganglionic eminence, Peoptic area = PoA, GP = Glubus pallidus, Hy = Hypothalamus. 
Scale bars=300µm (E12.5), 250µm (E18.5). E12.5 image is a composite of multiple 
images of the same section. For C box-and-whisker plots for E12.5 and E18.5 were 
derived from n=(9,4,4,3,4) and n=(4,6,4,4,4) biological replicates, respectively (* p<0.05, 
** p<0.01, *** p<0.001, **** p<0.0001, n.s. p>0.05; two-tailed Student’s t-test). 
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Figure 3.3. NANCI and Nkx2.1 expression in the mouse thyroid. 
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Figure 3.3. NANCI and Nkx2.1 expression in the mouse thyroid. (A) As in the lung, in 
the thyroid NANCI expression is limited to a subset of Nkx2.1+ epithelial cells (white 
arrowheads indicate Nkx2.1+/NANCI-RFP- cells). (B) At 10 weeks and 6 months of age 
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ thyroid morphological defects are similar to those seen in 
Nkx2.1GFP/+ thyroids. (C) Likewise both Nkx2.1GFP/+ mice and NANCIcreERT2:RFP/ 
+:Nkx2.1GFP/+ mice show similarly increased levels of TSH, suggesting hypothyroidism. 
Scale bars=50µm (A), 500 µm (B). For C mean ± s.e.m. were derived from n=(11,4,6,8) 
biological replicates (** p<0.01, n.s. p>0.05; two-tailed Student’s t-test). 
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Figure 3.4. NANCI-RFP reporter accurately reflects variability in NANCI 
expression. 
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Figure 3.4. NANCI-RFP reporter accurately reflects variability in NANCI 
expression. Adult lung epithelial cells from (A and B) NANCIcreERT2:RFP/+ and (C and D) 
Nkx2.1GFP/+ mice were sorted based on RFP and GFP expression, respectively. Analysis 
of the resulting populations by Q-PCR suggests that RFP and GFP expression 
accurately reflect variability in NANCI and Nkx2.1, respectively. IHC comparing (E) 
NANCI-RFP or (F) Nkx2.1 levels between AT1 (Pdpn+) and Neuroendocrine (Pgp9.5+) 
cells (yellow arrows) and neighboring lineage marker negative epithelial cells (white 
arrowheads). Scale bars=25µm. For B and D mean ± s.e.m. were derived from n=6 and 
n=3 biological replicates respectively (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001, 
n.s. p>0.05; two-tailed Student’s t-test). 
 
128	  
	  
Figure 3.5. NANCI and Nkx2.1 form a lncRNA-TF duplex that buffers Nkx2.1 
expression. 
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Figure 3.5 NANCI and Nkx2.1 form a lncRNA-TF duplex that buffers Nkx2.1 
expression. (A) NANCIcreERT2:RFP/ creERT2:RFP mice have reduced expression of NANCI and 
Nkx2.1 at E18.5 and 10 weeks of age. (B) In contrast, Nkx2.1GFP/+ mice have increased 
NANCI expression, indicating that Nkx2.1 inhibits NANCI. Thus NANCI and Nkx2.1 form 
a negative feedback loop that buffers Nkx2.1 expression. (C) Increased expression of 
RFP and GFP in 6 month old NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice. (D) These data 
suggest, a model in which NANCI acts in cis to regulate Nkx2.1 expression. (E) Spatial 
classification of lncRNA-TF based on genomic orientation of the lncRNA and TF 
identifies other duplexes with the lncRNA located downstream of the TF, similar to the of 
NANCI-Nkx2.1 duplex. (F and G) Knockdown of Hnrnpab and Hnrnpd, but not 
Hnrnpa2b1, results in increased expression of NANCI and Nkx2.1, suggesting that 
Hnrnpab and Hnrnpd inhibit NANCI stability. For A box-and-whisker plots for E18.5 and 
10 weeks were derived from n=(5,6) and n=(5,5) biological replicates, respectively. For B 
and C box-and-whisker plots for E18.5, 10 weeks, and 6 months were derived from 
n=(5,11,7,5), n=(6,9,5,8), and n=(9,5,8,8) biological replicates, respectively. For F mean 
± s.e.m. were derived from n=(6,6,5,6) biological replicates (* p<0.05, ** p<0.01, *** 
p<0.001, **** p<0.0001; two-tailed Student’s t-test). 
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Figure 3.6. Characterization of NANCIcreERT2:RFP/creERT2:RFP mice. 
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Figure 3.6. Characterization of NANCIcreERT2:RFP/creERT2:RFP mice. (A) 
NANCIcreERT2:RFP/creERT2:RFP mice have reduced expression of Nkx2.1 target genes, but not 
Foxj1 or Pdpn at E18.5. By 10 weeks of age expression of these genes have 
normalized. (B) In situ hybridization using a probe for NANCI verifies that 
NANCIcreERT2:RFP/creERT2:RFP lungs do not express detectable levels of NANCI. (C) Despite 
reduced expression of Nkx2.1, NANCIcreERT2:RFP/creERT2:RFP lungs do not have major 
morphological defects at E18.5 or 10 weeks of age, similar to Nkx2.1GFP/+ lungs. Scale 
bars=500µm (B), 200µm (C). For A box-and-whisker plots for E18.5 and 10 weeks were 
derived from n=(5,6) and n=(5,5) biological replicates, respectively (* p<0.05, ** p<0.01, 
n.s. p>0.05; two-tailed Student’s t-test).  
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Figure 3.7. Factors regulating NANCI expression. 
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Figure 3.7. Factors regulating NANCI expression. (A) The promoter of NANCI 
contains a predicted Nkx2.1 binding site and (B) Nkx2.1 ChIP:PCR indicates that Nkx2.1 
binds to this site, suggesting it directly inhibits NANCI expression (Hnf4a=negative 
control, Sftpb=positive control). (C) Mass Spectrometry identified 44 proteins that were 
consistently enriched in NANCI pulldown relative to control. The heatmap shows the 
average of three different pulldowns. (D) Interactions between NANCI and Hnrnpab, 
Hnrnpd, and Hnrnpa2b1 were verified by Western blot. The right panel shows the intact 
nature of the RNA transcripts used in the pulldown and mass spectrometry experiments. 
(E) Knockdown efficiency for shRNAs targeting these four proteins. Data for the controls 
(Hnf4a and Sftpb) in Fig. 3.7B is the same as in Fig. 3.9H. For B mean ± s.e.m. were 
derived from n=3 biological replicates. For E mean ± s.e.m. for Hnrnpab, Hnrnpd, and 
Hnrnpa2b1 were derived from n=(6,6), n=(6,5), and n=(6,6), respectively (* p<0.05, ** 
p<0.01, *** p<0.001, **** p<0.0001; two-tailed Student’s t-test). 
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Figure 3.8. Disruption of the NANCI-Nkx2.1 buffering loop leads to persistent 
developmental delay. 
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Figure 3.8. Disruption of the NANCI-Nkx2.1 buffering loop leads to persistent 
developmental delay. (A) At E18.5 NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice have a mild 
morphological defect in the developing alveolar space as noted by thickened septae in 
HE stained tissue. (B) IHC for cell type specific markers showing reduced expression of 
secretory (Scgb1a1) and AT2 cell (Sftpc) markers. (C) At E18.5, both Nkx2.1GFP/+ and 
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice exhibit decreased expression of several cell type 
specific markers and ectopic expression of the posterior endoderm marker Hnf4a. (D) By 
P4, only NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice exhibit significant alveolar simplification in 
HE stained tissue. (E) IHC for cell type specific markers showing reduced expression of 
secretory (Scgb1a1) and AT2 cell (Sftpc) markers at P4. (F) At P4 only 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ lungs reduced expression of the pulmonary cell type 
markers and ectopic expression of Hnf4a. In contrast, Nkx2.1GFP/+ mice have largely 
normalized development. Scale bars=200µm (A,D), 25µm (B,E). For C and F box-and-
whisker plots were derived from n=(5,11,7,5) and n=(6,5,7,5) biological replicates, 
respectively (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001; two-tailed Student’s t-test). 
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Figure 3.9. Severe perinatal immune response in P4 NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ 
mice. 
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Figure 3.9. Severe perinatal immune response in P4 NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ 
mice. (A) A subset of NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice display a localized and severe 
innate immune response at P4. (B) Flow analysis indicates that these mice have an 
increased infiltration of neutrophils, but not monocytes, B-cells, or helper-T-cells. (C) 
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ lungs have defects in epithelial barrier integrity as well as 
E-Cadherin+ cells in the airway lumen (white arrowheads and yellow arrows 
respectively). (D) Comparison of NANCIcreERT2:RFP/+:Nkx2.1GFP/+ and wild-type mice by 
RNA-seq indicates that the former have increased expression of genes involved in the 
mitotic cell cycle, but decreased expression of immune response genes. (E) 
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ lungs express lower levels of Csf2. (F) 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ lungs express higher levels of Spp1, (G) Diagram of 
Nkx2.1-enriched ChIP targets for Csf2 and Sftpb, with promoter region defined on 
H3K4me3 marks from Encode Project Mouse Lung tracks. (H) Nkx2.1 binds to the 
promoter of Csf2, but not Spp1. Data for the controls (Hnf4a and Sftpb) in I is the same 
as in Fig. 3.7B. Scale bars=50µm (A), 25µm (C). For B and H mean ± s.e.m. were 
derived from n=3 biological replicates. For E and F, E18.5 and P4 box-and-whisker plots 
were derived from n=(5,11,7,5) and n=(6,5,7,5), respectively (* p<0.05, ** p<0.01, *** 
p<0.001; two-tailed Student’s t-test). 
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Figure 3.10. Normalization of lung homeostasis in four week old 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice. 
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Figure 3.10. Normalization of lung homeostasis in four week old 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice. (A) Unlike E18.5 and P4, at four weeks of age, 
Nkx2.1 expression is not significantly different between Nkx2.1GFP/+ mice and 
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice. This is not accompanied by increased expression of 
NANCI, suggesting a NANCI-independent mechanism is responsible for increased 
expression of Nkx2.1 at this time. This normalization of Nkx2.1 is accompanied by 
normalization of (B) lung morphology and (C) lung epithelial gene expression. Scale 
bars=200µm. For A and C, P4 and 4 week box-and-whisker plots were derived from 
n=(6,5,7,5) and n=(10,13,9,8), respectively (* p<0.05, ** p<0.01, *** p<0.001, n.s. 
p>0.05; two-tailed Student’s t-test). 
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Figure 3.11. Disruption of NANCI-Nkx2.1 duplex buffering loop leads to failure of 
pulmonary homeostasis. 
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Figure 3.11. Disruption of NANCI-Nkx2.1 duplex buffering loop leads to failure of 
pulmonary homeostasis. (A) At 10 weeks of age NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice 
exhibit airway inflammation (HE staining, top row) as well as basal (p63 and Krt5 IHC, 
second row) and mucous cell metaplasia (Muc5ac IHC, third row). These mice also 
show signs of alveolar simplification and bronchiolization of the alveoli (HE staining, forth 
row). (B) Bronchiolized cells in the distal lungs of NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice at 
10 weeks are primarily Sox2+/Scgb1a1+. (C and D) These do not express Pdpn or 
Foxj1. (E and F) A small subset of these cells are Sox2+/Sftpc+ or Scgb1a1+/Sftpc+ 
(white arrowheads). (G) Q-PCR for lineage markers confirms a reduction in secretory 
(Scgb1a1) and AT1 (Pdpn) cells, but an increase in Hnf4a+ cells. Scale bars=200µm 
(A), 25µm (B-F). For G box-and-whisker plots were derived from n=(6,9,5,8) (* p<0.05, ** 
p<0.01, *** p<0.001; two-tailed Student’s t-test). 
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Figure 3.12. Progressive pulmonary degeneration and lineage reprogramming in 6 
month old NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice. 
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Figure 3.12. Progressive pulmonary degeneration and lineage reprogramming in 6 
month old NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice. (A) Principle component analysis of 
RNA-seq data from lung epithelial cells of 6 month old wild-type, Nkx2.1GFP/+, and 
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice. (B) GO analysis of these samples indicates that 
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice have upregulation of  of genes involved in digestion 
and innate immune response but decreased expression of genes involved in epithelial 
and respiratory morphogenesis. (C) By 6 months, inflammation around the large airways 
has receded, leaving behind fibrous tissue (HE staining, top row). The airway epithelium 
has reduced expression of the secretory cell marker Scgb1a1 but expanded expression 
of basal (p63 and Krt5) and goblet (Muc5ac) cell markers. Normal alveolar architecture 
is highly disrupted in NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ mice (HE staining, bottom row). (D-
G) The distal bronchiolized epithelium also includes (D) ciliated cells, (E and F) basal 
cells and (G) Sox9+/Hnf4a+ cells. (H) Q-PCR for hindgut markers. Scale bars=200µm 
(C), 25µm (D-G). For H box-and-whisker plots were derived from n=(8,3,5,5) biological 
replicates (* p<0.05, ** p<0.01, *** p<0.001, **** p<0.0001; two-tailed Student’s t-test). 
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Figure 3.13. Degeneration and lineage reprogramming in 6 month old 
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ lungs. 
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Figure 3.13. Degeneration and lineage reprogramming in 6 month old 
NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ lungs. At six months of age NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ 
lungs have (A) decreased expression of lung epithelial markers and (B) increased 
expression of goblet cell markers. (C) At six months of age NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ 
mice contain a large number of apoptotic cells as indicated by high levels of cleaved 
caspase-3. (D and E) At this time the airways are also filled with F4/80+ macrophages. 
(F) Scgb1a1+ cells in the bronchiolized epithelium proliferate in response to the ongoing 
injury, (G) while the remaining Sftpc+ AT2 cells are largely non-proliferative. (H) Cell 
type specific proliferation in NANCIcreERT2:RFP/ +:Nkx2.1GFP/+ lungs is quantified. Scale 
bars=50µm. For A and B box-and-whisker plots were derived from n=(8,3,5,5) biological 
replicates. For H mean ± s.e.m. were derived from n=5 biological replicates (* p<0.05, ** 
p<0.01, *** p<0.001, **** p<0.0001; two-tailed Student’s t-test). 
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Figure 3.14. Three stages of phenotypic progression in 
NANCICreERT2:RFP/+:Nkx2.1GFP/+ mice. 
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Figure 3.14. Three stages of phenotypic progression in 
NANCICreERT2:RFP/+:Nkx2.1GFP/+ mice. 
In this paper I see three phenotypic stages in the NANCICreERT2:RFP/ +:Nkx2.1GFP/+ mice, all 
of which are dependent on Nkx2.1 expression. First persistent Nkx2.1 deficiency leads 
to a perinatal developmental delay and ectopic expression of Hnf4a leading to an innate 
immune response (Stage I). Over the next 4 weeks, Nkx2.1 expression is upregulated 
inducing a normalization of development (Stage II). Finally, in the adult lung, persistent 
Nkx2.1 deficiency leads to degeneration of pulmonary epithelial lineages and a 
resurgence of a hindgut transcriptional program (Stage III). 
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CHAPTER 4: Conclusions and Future Directions 
 
4.1 Summary 
In recent years numerous labs have identified lncRNAs capable of regulating gene 
transcription and other complex biological processes. However, the importance of 
lncRNAs in vivo, especially within the contexts of lung development and homeostasis, is 
still poorly understood. In this dissertation, I have determined that lncRNAs are enriched 
near transcription factor (TF) loci and provided a detailed characterization of the 
expression and function of the novel lncRNA NANCI. This work establishes a new 
paradigm in which TF-associated lncRNAs act as rheostats to buffer their neighboring 
TF. Furthermore, this work has identified a novel regulator of the transcription factor 
Nkx2.1, which is critical for the maintenance of lung identity during development and 
homeostasis.  
 
In Chapter 2, I used RNA-seq to identify lncRNAs expressed in the embryonic and adult 
mouse lung. Surprisingly, I saw lncRNAs located near TF loci critical to pulmonary 
development including Nkx2.1, Gata6, Foxa2, and Foxf1. Further analysis revealed that 
lncRNAs are enriched near TF-coding genes in both the mouse and human genomes. I 
then proceeded to characterize the distinct expression patterns of seven lncRNAs. 
Those lncRNAs associated with TFs all had expression patterns highly similar to that of 
their neighboring TF, suggesting a regulatory relationship between these paired genes. 
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To test this hypothesis I used shRNAs to suppress expression of NANCI in human and 
mouse lung epithelial cell lines. In both cases, reduced expression of NANCI was 
associated with decreased expression of Nkx2.1 and known Nkx2.1 target genes. 
Likewise, shRNA-mediated suppression of NANCI in E17.5 mice phenocopied Nkx2.1 
haploinsufficiency. Together, this suggests that NANCI has a conserved function of 
promoting Nkx2.1 expression.  
 
In Chapter 3 I employed multiple mouse models, molecular, and proteomic techniques to 
further characterize the regulatory relationship between NANCI and Nkx2.1 during 
pulmonary development and homeostasis. These results verified my previous findings 
that NANCI promotes Nkx2.1 expression at the transcriptional level. Furthermore, I 
determined that Nkx2.1 directly represses NANCI transcription, indicating that NANCI 
and Nkx2.1 create a negative feedback loop. In Nkx2.1 heterozygotes this buffering loop 
leads to increased expression of NANCI, which is sufficient to normalize Nkx2.1 
expression and lung function. However, concurrent in trans mutations of NANCI and 
Nkx2.1 disrupt the feedback loop between these genes causing persistent Nkx2.1 
deficiency. This in turn leads to a defective innate immune response in the perinatal lung 
and progressive degeneration and reprogramming of the adult lung epithelium. 
 
These results provide important insight into both the function of TF-associated lncRNAs 
as well as the regulation of pulmonary development and homeostasis. In this chapter I 
will explore several areas of future research based on these findings. I will first focus on 
further elucidating the mechanism through which NANCI regulates Nkx2.1. Next I will 
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describe a screen to determine whether similar lncRNA-TF feedback loops exist for 
other lncRNA-TF duplexes. Finally, I will discuss experiments to characterize the role of 
Nkx2.1 during adult lung epithelial homeostasis and regeneration.  
 
4.2 How does NANCI regulate Nkx2.1 expression? 
In this dissertation I have demonstrated that NANCI acts in cis to regulate Nkx2.1 at the 
transcriptional level; however, the exact mechanism of this regulation is still unclear. 
Datum from chapter 2 suggest that Wdr5 may be bound by NANCI and recruited to the 
Nkx2.1 promoter (Fig. 2.18). Wdr5 is a component of the Trithorax complex, which 
promotes gene expression through inducing H3K4me3 at gene promoters. However, in 
chapter 3 the unbiased pulldown of proteins interacting with NANCI did not identify Wdr5 
or any other known components of the Trithorax complex (Table 3.2). This discrepancy 
may be due to use of crosslinking in experiments described in chapter 2, but not chapter 
3. Recent work on lncRNAs, including Xist, suggests a “hit-and-run” model, where the 
lncRNA may dissociate from the chromatin-modifying complex after the initial lncRNA-
dependent genomic localization (Sunwoo et al. 2015). These brief interactions would 
likely not be detected by the experiments performed in chapter 3. 
 
In order to detect the more ephemeral NANCI-protein interactions like those suggested 
by the “hit-and-run” model, I would need to use pulldown techniques that incorporate 
crosslinking. In recent years two new methods have been designed that would address 
this issue: comprehensive identification of RNA binding proteins by mass spectrometry 
(ChIRP-MS) and RNA antisense purification-mass spectrometry (RAP-MS) (Chu et al. 
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2015; McHugh et al. 2015). These techniques both involve crosslinking endogenous 
RNA-protein complexes and then extracting complexes using biotinylated DNA probes 
complementary to the RNA of interest. RNA-bound proteins are then identified by mass 
spectrometry and verified by western blots as described in chapter 3. Despite some 
technical differences these techniques have identified similar binding partners for the 
lncRNA Xist, and either could be used to identify NANCI-bound proteins (Chu et al. 
2015; McHugh et al. 2015). I could then suppress the NANCI-bound proteins in vitro by 
shRNA approaches to determines if they affect Nkx2.1 expression. If any NANCI-bound 
proteins are transcription factors or chromatin modifying complexes, it would also be 
important to see if loss of NANCI affects protein localization and regulation at the Nkx2.1 
promoter. To do this we would use ChIP-PCR to compare protein binding and histone 
marks in wild type and NANCIcreERT2/creERT2 E18.5 lung epithelial cells. To determine if 
NANCI itself binds the Nkx2.1 promoter directly or indirectly, I can use the techniques 
RAP and ChIRP (Chromatin Isolation by RNA Purification) (Chu et al. 2011; Engreitz et 
al. 2015). These variants of RAP-MS and ChIRP-MS use similar pulldown methods 
followed by sequencing to characterize lncRNA-bound genomic loci, instead of lncRNA-
bound proteins. Thus I could identify both proteins and genomic regions necessary for 
NANCI-mediated regulation of Nkx2.1. 
 
Previous work has established that lncRNAs contain distinct domains that are 
responsible for binding to their interacting proteins. This is exemplified by Hotair, which 
contains a 5’ domain that binds PRC2 as well as a 3’ domain that binds the 
LSD1/CoREST/RET complex (Tsai et al. 2010). To identify similar domains within 
NANCI I would employ CRISPRs to generate homozygous deletions of transcribed 
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domains within the NANCI locus in a mouse lung epithelial cell line (MLE12s). I would 
first delete 75bp and 280bp long conserved regions in the first and last exon of NANCI, 
respectively. These are the only regions of conserved sequence or exon structure 
between mouse and human, suggesting that they may be important for NANCI’s 
conserved function. To identify functional domains I would determine if loss of these 
domains affects Nkx2.1 expression or the ability of NANCI to bind to the proteins and 
genomic regions identified above. If deletion of these domains does not affect NANCI 
function, then I will generate a series of deletions tiling the entire NANCI transcript. 
Altogether, these studies would provide important insight into the components and 
mechanisms critical for NANCI-mediated regulation of Nkx2.1 expression. This work 
would also provide a more detailed frame of reference for studying other TF-associated 
lncRNAs.  
 
4.3 Do other lncRNAs act as rheostats that buffer the expression of neighboring 
TFs? 
The results presented in both chapters 2 and 3 identified lncRNAs associated with other 
TFs critical to development and homeostasis. Like NANCI, lncRNAs associated with 
Foxf1, Foxa2, and Gata6 are expressed in regions that express their neighboring TF, 
suggesting regulatory relationships within these lncRNA-TF duplexes. Ongoing work 
within the Morrisey and Swarr labs has determined that the lncRNA FALCOR (Foxa2 
Associated Long nonCOding RNA), which is located downstream and sense to the TF 
Foxa2, promotes expression of Foxa2 (Swarr et al., in preparation). Furthermore, Foxa2 
binds the FALCOR promoter and represses FALCOR expression, indicating that the 
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FALCOR-Foxa2 duplex forms a buffering loop similar to the one seen in the NANCI-
Nkx2.1 duplex. 
 
Although FALCOR and NANCI are both downstream of their neighboring TFs, the 
majority of previously studied TF-associated lncRNAs, including Fendrr and HOTTIP, 
are upstream and antisense to their neighboring TF (Wang et al. 2011; Sauvageau et al. 
2013). These divergent lncRNAs often share a promoter region with their neighboring TF 
and it is unknown whether they perform buffering functions like NANCI and FALCOR. 
Ablation of the lncRNA Fendrr in mice phenocopies haploinsufficieny of its divergent TF 
Foxf1, suggesting that Fendrr may regulate Foxf1 expression (Sauvageau et al. 2013). 
However, it is still unclear whether Fendrr and Foxf1 regulate one another’s expression. 
The lncRNA HOTTIP promotes expression of Hoxa13 and other Hoxa genes through 
recruitment of WDR5/MLL, but none of these genes have been shown to regulate 
expression of HOTTIP (Wang et al. 2011).  
 
To identify other lncRNAs that buffer expression of neighboring TFs I would start with a 
series of filters to select lncRNAs of interest. First I would select those mouse lncRNAs 
with human orthologs, as the presence of an orthologous lncRNA suggests a conserved 
biological function. While I would initially prioritize lncRNAs expressed in the lung, online 
databases such as ENCODE could be used to help identify tissues and cell lines 
expressing lncRNAs not found in the lung (Rosenbloom et al. 2013). I would then verify 
these findings and compare lncRNA and TF expression using in situ hybridization and 
Q-PCR. Those lncRNA-TF pairs with correlated expression would be prioritized, as this 
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suggests a potential regulatory relationship between the two factors. Finally, I would 
ensure that lncRNAs being screened include lncRNAs downstream of their neighboring 
TF, like NANCI, as well as divergent lncRNAs, like Fendrr, in order to determine if both 
orientations are capable of buffering neighboring TFs.  
 
To determine if a lncRNA regulates its neighboring TF, CRISPR/Cas9 strategies would 
be used to delete the promoter and first exon of the lncRNA in a mouse cell line that 
expresses that lncRNA. We would then use Q-PCR to measure expression of the 
neighboring TF. These experiments would need to be verified using shRNA-mediated 
suppression of the lncRNA to clarify that the lncRNA, not an overlapping regulatory 
element, is the functional unit. CRISPRs would then be used to eliminate expression of 
the TFs regulated by lncRNAs to determine whether these TFs in turn regulate lncRNA 
expression. Finally, CRISPRs targeting lncRNAs of interest can be used to generate null 
mouse lines. Using techniques similar to those described in chapter 3, we would then 
compare the affects of disrupting expression of the lncRNA, TF, or both in vivo. Together 
this will identify other lncRNAs capable of acting as rheostats for neighboring TFs and 
provide important insight into the regulation of critical TFs throughout the body. 
Furthermore, through comparison of these lncRNA-TF duplexes I could identify common 
genomic organizations or lncRNA motifs, making it easier to identify other lncRNA 
rheostats in the future.	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4.4 What is the role of Nkx2.1 in the adult pulmonary epithelium? 
Even though Nkx2.1 has been shown to play major roles during lung development, little 
is known about its role in the adult lung. Recent work demonstrated that complete loss of 
Nkx2.1 in the adult murine lung leads to rapid respiratory failure, suggesting that Nkx2.1 
is critical for pulmonary homeostasis (Kusakabe et al. 2006; Butt et al. 2008; Snyder et 
al. 2013). However, the scope of Nkx2.1 regulatory activity in the adult lung is still 
unclear. Nkx2.1’s role in pulmonary regeneration is likewise poorly characterized. As 
described in chapter 1, mature lung epithelial cells can proliferate and differentiate in 
response to injury to maintain lung function (Rawlins et al. 2009; Barkauskas et al. 
2013). While Nkx2.1 has been shown to promote proliferation and differentiation during 
development, there is no evidence that it plays a similar role during regeneration (Tagne 
et al. 2012). The following sections will cover experiments using mouse models to 
explore the role of Nkx2.1 in mature adult lung epithelial cells during homeostasis and 
regeneration 
 
4.5 Is Nkx2.1 necessary for maintenance and regeneration of the alveolar 
epithelium? 
In response to alveolar injury AEC2s have been shown to proliferate and differentiate to 
replace damaged epithelial tissue and prevent further degeneration (Barkauskas et al. 
2013). This is exemplified by regeneration following influenza infection, a well-studied 
pulmonary injury model that directly injures the lung epithelium leading to diffuse alveolar 
damage (Short et al. 2014). As described in chapter 3, adult 
NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice also exhibit a progressive degeneration of the distal 
alveolar epithelium. Surprisingly, we saw minimal AEC2 proliferation in these mice 
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despite significant damage to the alveolar epithelium (Fig. 3.13). This is consistent with 
the pro-proliferative function of Nkx2.1; however, the effects seem to be specific to 
AEC2s since neighboring CC10+ bronchiolized alveolar cells were proliferative 
(Yamaguchi et al. 2013).  
 
Recent work in the Morrisey lab has identified a subset of AEC2s, known as AEP 
(alveolar epithelial progenitor) cells, that are responsible for the majority of alveolar 
regeneration following influenza injury (Zacharias et al., in preparation). These cells were 
originally identified based on expression of Axin2, a marker of Wnt responsive cells. 
During homeostasis these cells are largely quiescent, but can give rise to a small 
number of AEC2s and AEC1s. Following influenza injury, AEP cells become more 
proliferative and give rise to the majority of new AEC2s during regeneration as well as 
new AEC1s and AEP cells. Comparison of AEPs and general AEC2s by RNA-seq 
revealed numerous differences between their gene expression profiles. Most notably, 
AEPs in both mice and humans have higher Nkx2.1 expression than general AEC2s 
(Zacharias et al., in preparation). Altogether, this suggests that Nkx2.1 may be required 
for AEP-dependent regeneration of the alveolar epithelium following injury.  
 
To test whether Nkx2.1 is necessary for AEP function I would investigate how loss of 
Nkx2.1 in AEPs affects pulmonary homeostasis and regeneration following influenza 
injury. In addition to high levels of Nkx2.1, AEPs uniquely express the surface marker 
Tm4sf1 (Zacharias et al., in preparation). The Morrisey lab has recently generated a 
mouse line, Tm4sf1-CreERT2, in which a tamoxifen inducible Cre recombinase cDNA is 
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inserted downstream of the Tm4sf1 promoter. Existing Rosa-YFP and floxed Nkx2.1 
(Nkx2.1fl/fl) lines allow for lineage tracing and Nkx2.1 ablation in Cre expressing cells, 
respectively. Thus I could generate Tm4sf1creERT2/+;RosaYFP/+ and 
Tm4sf1creERT2/+;Nkx2.1fl/fl;RosaYFP/+ mice, allowing for lineage tracing of AEPs in the 
presence or absence of Nkx2.1. To study these AEPs during homeostasis, adult mice (8 
weeks) of both genotypes would be given sufficient tamoxifen to label the majority of 
AEPS and then dissected at 3 or 6 months of age. To analyze AEPs during 
regeneration, mice will be given tamoxifen at 8 weeks and infected with influenza virus 
one week later. These animals would be dissected 14 or 28 days after injury, when the 
lung epithelium normally regenerates. Pulmonary tissue will then be analyzed for defects 
in morphology, cell composition, proliferation, and gene expression using histological 
analysis and Q-PCR. If Hnf4a+ or CC10+ epithelial lineages are seen in the alveoli of 
Tm4sf1creERT2/+;Nkx2.1fl/fl;RosaYFP/+ mice, this would suggest that the bronchiolization of 
the alveoli seen in NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice is in part due to defective AEPs 
(Fig. 3.12). Histological analysis of the lineage tracer YFP in combination with markers of 
proliferation and cell lineages will also be used to assess if loss of Nkx2.1 affects the 
ability of AEPs to proliferate and differentiate.  
 
To determine how loss of Nkx2.1 affects AEPs on a transcriptional level I will analyze 
gene expression in AEPs in the presence or absence of Nkx2.1. Fluorescence-activated 
cell sorting (FACS) with a Tm4sf1 antibody will be employed to isolate AEPs from 
Tm4sf1creERT2/+ and Tm4sf1creERT2/+;Nkx2.1fl/fl mice one week after tamoxifen treatment. 
Similar samples could also be harvested during alveolar regeneration to determine how 
loss of Nkx2.1 affects transcription during regeneration. To determine which genes 
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Nkx2.1 directly targets, I would perform Nkx2.1 ChIP-seq on isolated wild type AEPs 
from uninfected mice as well as mice recovering from influenza injury. Altogether, these 
experiments will help determine the role of Nkx2.1 in AEPs during homeostasis and 
regeneration.  
 
To further elucidate the importance of Nkx2.1 in the adult alveolar epithelium we could 
use Sftpc-CreERT2 and Hopx-CreERT2 lines to delete Nkx2.1 in the AEC2 and AEC1 
lineages, respectively (Rock et al. 2011; Takeda et al. 2011). These lines could be used 
in experiments similar to those described above for the Tm4sf1-CreERT2 line. Given the 
role of Nkx2.1 in promoting expression of Sftpa, Sftpb, and Sftpc in AEC2s, loss of 
Nkx2.1 in these cells will likely result in severe injury to the lung (Boggaram 2009). The 
role of Nkx2.1 in AEC1s on the other hand is harder to predict. While some AEC1 cells 
do express Nkx2.1, in general they seem to express Nkx2.1 at lower levels than the 
other pulmonary epithelial lineages (Fig. 3.1 and 3.4). Furthermore, if AEC1 function is 
reduced in response to loss of Nkx2.1, unaffected AEC2s may proliferate and 
differentiate to form replacement AEC1s that express Nkx2.1, diminishing any overall 
phenotype (Barkauskas et al. 2013). Altogether these experiments would help establish 
the importance of Nkx2.1 in maintenance and regeneration of the adult alveolar 
epithelium.  
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4.6 What role does Nkx2.1 play in maintenance and regeneration of the adult 
airway epithelium? 
Data presented in chapter 3 suggests that Nkx2.1 may also play an important role in 
maintaining the airway epithelium. The airways of NANCIcreERT2:RFP/+:Nkx2.1GFP/+ mice 
exhibited a progressive loss of secretory cell lineages, variable inflammation, and 
expansion of both goblet and basal cell lineages (Fig. 3.11 and 3.13). These results are 
consistent with previous work indicating that Nkx2.1 promotes expression of Scgb1a1, a 
marker of mature secretory cells (Boggaram 2009). Furthermore, overexpression of 
Nkx2.1 inhibits inflammation and mucous cell metaplasia within adult airways (Maeda et 
al. 2011). Together this suggests Nkx2.1 is critical for maintaining normal cellular 
composition of the lung airways.  
 
Similar to experiments described in the previous section, lineage specific Cre expressing 
mice could be used to analyze the role of Nkx2.1 in secretory (Scgb1a1-CreERT), 
ciliated (Foxj1-CreERT2), and basal cells (p63-CreERT2) (Rawlins et al. 2007; Rawlins 
et al. 2009; Lee et al. 2014). However, secretory and basal cells can each give rise to all 
three of these cell types following injury to the airway epithelium (Rawlins et al. 2009; 
Tata et al. 2013). Thus, ablating Nkx2.1 in any one lineage may have minimal affect as 
the other lineages can differentiate to produce unaltered cells of the affected lineage. 
Therefore, in order to fully understand the role of Nkx2.1 in the proximal airway it will 
also be important to ablate Nkx2.1 in all airway lineages using a Sox2-CreERT2 line 
(Arnold et al. 2011). Regardless of which Cre line is used, mice would be given 
tamoxifen at 8 weeks of age and then dissected at 3 or 6 months of age to determine the 
role of Nkx2.1 during airway homeostasis. To analyze the role of Nkx2.1 following airway 
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injury I would use naphthalene, an aromatic hydrocarbon that specifically induces airway 
epithelial cell necrosis leading to denuded airways and infection (Karagiannis et al. 
2012). For these studies mice will be given tamoxifen at 8 weeks of age, injured one 
week later, and dissected 14 or 28 days after injury. Samples would be analyzed using 
methods similar to those described in the previous section. These experiments would 
help determine if Nkx2.1 has a specific role in maintenance and regeneration of the 
airway epithelium.  
 
4.7 Closing Remarks 
In this dissertation I have characterized the critical role NANCI plays in regulating Nkx2.1 
expression and lung identity during pulmonary development and homeostasis. This work 
provides new insights into the regulation of Nkx2.1 and the in vivo function of 
transcription factor-associated lncRNAs. The future experiments proposed in this 
chapter will build on this work by providing significant advances in our understanding of 
both lncRNA biology and the regulation of adult lung homeostasis. 
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